KR20080006001A - Method for producing indole derivative having piperidine ring - Google Patents

Method for producing indole derivative having piperidine ring Download PDF

Info

Publication number
KR20080006001A
KR20080006001A KR1020077027992A KR20077027992A KR20080006001A KR 20080006001 A KR20080006001 A KR 20080006001A KR 1020077027992 A KR1020077027992 A KR 1020077027992A KR 20077027992 A KR20077027992 A KR 20077027992A KR 20080006001 A KR20080006001 A KR 20080006001A
Authority
KR
South Korea
Prior art keywords
formula
compound
following formula
represented
reaction
Prior art date
Application number
KR1020077027992A
Other languages
Korean (ko)
Inventor
나오유키 시모무라
아쓰시 가마다
마모루 미야자와
고이치 이토
Original Assignee
에자이 알앤드디 매니지먼트 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/126,209 external-priority patent/US20050256103A1/en
Application filed by 에자이 알앤드디 매니지먼트 가부시키가이샤 filed Critical 에자이 알앤드디 매니지먼트 가부시키가이샤
Publication of KR20080006001A publication Critical patent/KR20080006001A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/453Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/08Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

It is possible to commercially advantageously produce 1-{1-[2-(7-methoxy-2,2-dimethyl-4-oxochroman-8-yl)ethyl] piperidin-4-yl}-N-methyl-1H-indole-6-carboxamide by coupling (7-methoxy-2,2-dimethyl-4-oxochroman-8-yl)acetaldehyde, which is obtained by oxidizing 8-(2-hydroxyethyl)-7-methoxy-2,2-dimethylchroman-4-one, with N-methyl-1-(piperidin-4-yl)-1H-indole-6-carboxamide.

Description

피페리딘환을 가지는 인돌 유도체의 제조 방법 {METHOD FOR PRODUCING INDOLE DERIVATIVE HAVING PIPERIDINE RING}Method for producing indole derivatives having a piperidine ring {METHOD FOR PRODUCING INDOLE DERIVATIVE HAVING PIPERIDINE RING}

본 발명은, 5-HT1A 길항 작용 및 결합 작용을 가지며, 하부 요로 증상(lower urinary tract symptom), 특히 축뇨 증상(urinary storage symptom)의 예방제 또는 치료제로서 유용한 1-{1-[2-(7-메톡시-2,2-디메틸-4-옥소크로만-8-일)에틸]피페리딘-4-일}-N-메틸-1H-인돌-6-카르복사미드의 제조 방법에 관한 것이다.The present invention has 5-HT 1A antagonism and binding action and is useful as a prophylactic or therapeutic agent for lower urinary tract symptom, especially urinary storage symptom. -Methoxy-2,2-dimethyl-4-oxochroman-8-yl) ethyl] piperidin-4-yl} -N-methyl-1H-indole-6-carboxamide .

세로토닌 수용체의 하나로서 5-HT1A 수용체가 있으며, 5-HT1A 길항 작용이나 결합 작용을 가지는 화합물은 우울증, 불안증, 인지 장애, 배뇨 장애 등의 예방 또는 치료제로서의 사용이 기대되고 있다. 종래 기술에는 이러한 화합물로서, 피페리딘환을 가지는 각종 화합물이 보고되어 있다 (특허문헌 1: WO 99/06384호 팜플렛, 특허문헌 2: 일본 특개2002-114684호 공보, 특허문헌 3: WO 98/43956호 팜플렛 참조).As one of the serotonin receptors, there is a 5-HT 1A receptor, and a compound having a 5-HT 1A antagonistic action or a binding action is expected to be used as a prophylactic or therapeutic agent for depression, anxiety, cognitive disorders, urination disorders and the like. In the prior art, various compounds having a piperidine ring have been reported as such compounds (Patent Document 1: WO 99/06384 Pamphlet, Patent Document 2: Japanese Patent Application Laid-Open No. 2002-114684, Patent Document 3: WO 98/43956). Issue pamphlet).

본 발명자들은, 5-HT1A 길항 작용 및 결합 작용을 가지는, 신규한 피페리딘환 함유 인돌 유도체로서, 하기 일반식 (I)로 표시되는 화합물을 발견하여, 이미 특허출원한 바 있다(PCT/JP2005/008632호 및 미국특허출원 제11/126209호):MEANS TO SOLVE THE PROBLEM The present inventors discovered the compound represented by the following general formula (I) as a novel piperidine ring containing indole derivative which has 5-HT 1A antagonism and binding effect, and has already applied for the patent (PCT / JP2005). / 008632 and US patent application Ser. No. 11/126209):

Figure 112007086393561-PCT00001
Figure 112007086393561-PCT00001

[일반식 (I)에서,[In general formula (I),

R1 및 R2는, 서로 인접한 치환기이고, 이들 치환기 각각이 결합된 2개의 탄소 원자와 이들 치환기가 일체화되어, 치환기군 B1으로부터 선택되는 1개 내지 4개의 치환기로 치환될 수 있는,R 1 and R 2 are substituents adjacent to each other, and two carbon atoms to which each of these substituents are bonded and these substituents may be integrated to be substituted with 1 to 4 substituents selected from the substituent group B1,

(1) 5 내지 7원환식(員環式) 비(非)방향족 탄화수소환기(carbocyclic group), (1) 5- to 7-membered non-aromatic hydrocarbon ring groups,

(2) 5 내지 7원환식 비방향족 복소환기(heterocyclic group), (2) a 5 to 7 membered cyclic non-aromatic heterocyclic group,

(3) 6원환식 방향족 탄화수소환기 또는 (3) 6-membered cyclic aromatic hydrocarbon ring group or

(4) 5 내지 6원환식 방향족 복소환기를 형성하고, (4) forming a 5 to 6 membered cyclic aromatic heterocyclic group,

여기서, 치환기군 B1은, (1) 수소 원자, (2) 할로겐 원자, (3) 시아노기, (4) 수산기, (5) 니트로기, (6) 옥소기, (7) 카르복시기, (8) C3-8 사이클로알킬기, (9) C2-6 알케닐기, (10) C2-6 알키닐기, (11) C1-6 알킬티오기, (12) C1-6 알콕시카르보닐기, (13) C1-6 알킬설포닐기, (14) C1-6 알킬기(상기 C1-6 알킬기는, 할로겐 원자, 수산기 및 C1-6 알콕시기로 치환될 수 있음), (15) C1-6 알콕시기(상기 C1-6 알콕시기는 1개 내지 3개의 할로겐 원자로 치환될 수 있음), (16) 아미노기(상기 아미노기는, C1-6 알킬기, 포르밀기, C1-6 알카노일기 및 C1-6 알킬설포닐기로 이루어진 군으로부터 선택되는 치환기로 치환될 수 있음), (17) 카르바모일기(상기 카르바모일기는 1개 또는 2개의 C1-6 알킬기로 치환될 수 있음), (18) C1-6 알콕시이미노기, (19) 동일 탄소 원자에 결합된 2개의 C1-3 알킬기가 일체화되어 형성되는 C5-6 사이클로알킬기, 및 (20) 동일 탄소 원자에 결합된 2개의 C1-3 알킬기가 산소 원자 및 상기 탄소 원자와 함께 일체화되어 형성되는 테트라하이드로피라닐기로 이루어진 군이며, Here, substituent group B1 is (1) hydrogen atom, (2) halogen atom, (3) cyano group, (4) hydroxyl group, (5) nitro group, (6) oxo group, (7) carboxy group, (8) C3-8 cycloalkyl group, (9) C2-6 alkenyl group, (10) C2-6 alkynyl group, (11) C1-6 alkylthio group, (12) C1-6 alkoxycarbonyl group, (13) C1-6 alkyl Sulfonyl group, (14) C1-6 alkyl group (The C1-6 alkyl group may be substituted with halogen atom, hydroxyl group and C1-6 alkoxy group), (15) C1-6 alkoxy group (The C1-6 alkoxy group is 1 May be substituted with 3 to 3 halogen atoms), (16) an amino group (where the amino group is a substituent selected from the group consisting of C1-6 alkyl group, formyl group, C1-6 alkanoyl group and C1-6 alkylsulfonyl group) May be substituted), (17) carbamoyl groups (the carbamoyl groups may be substituted with one or two C1-6 alkyl groups), (18) C1-6 alkoxyimino groups, (19) identical carbon atoms Two C1-3 alkyl groups bonded to each other form A C5-6 cycloalkyl group to be formed, and (20) two C1-3 alkyl groups bonded to the same carbon atom are an oxygen atom and a tetrahydropyranyl group formed integrally with the carbon atom,

R3는 수소 원자 또는 메틸기를 나타내고, R 3 represents a hydrogen atom or a methyl group,

R6는 치환기군 A1으로부터 선택되는 치환기를 나타내며,R 6 represents a substituent selected from substituent group A1,

여기서, 치환기군 A1은, (1) 수소 원자, (2) 할로겐 원자, (3) 시아노기, (4) 수산기, (5) 니트로기, (6) 카르복시기, (7) C3-8 사이클로알킬기, (8) C2-6 알케닐기, (9) C2-6 알키닐기, (10) C1-6 알킬티오기, (11) C1-6 알콕시카르보닐기, (12) C1-6 알킬설포닐기, (13) C1-6 알킬기(상기 C1-6 알킬기는, 할로겐 원자, 수산기 및 C1-6 알콕시로 이루어진 군으로부터 선택되는 1개 내지 3개의 치환기로 치환될 수 있음), (14) C1-6 알콕시기(상기 C1-6 알콕시기는 1개 내지 3개의 할로겐 원자로 치환될 수 있음), (15) 아미노기(상기 아미노기는, C1-6 알킬기, 포르밀기, C1-6 알카노일기 및 C1-6 알킬설포닐기로 이루어진 군으로부터 선택되는 치환 기로 치환될 수 있음) 및 (16) 카르바모일기(상기 카르바모일기는 1개 또는 2개의 C1-6 알킬기로 치환될 수 있음)로 이루어진 군임]. Here, substituent group A1 is a (1) hydrogen atom, (2) halogen atom, (3) cyano group, (4) hydroxyl group, (5) nitro group, (6) carboxy group, (7) C3-8 cycloalkyl group, (8) C2-6 alkenyl group, (9) C2-6 alkynyl group, (10) C1-6 alkylthio group, (11) C1-6 alkoxycarbonyl group, (12) C1-6 alkylsulfonyl group, (13) C1-6 alkyl group (The C1-6 alkyl group may be substituted with one to three substituents selected from the group consisting of a halogen atom, a hydroxyl group and C1-6 alkoxy), (14) C1-6 alkoxy group (above C1-6 alkoxy group may be substituted with 1 to 3 halogen atoms), (15) amino group (wherein the amino group is composed of C1-6 alkyl group, formyl group, C1-6 alkanoyl group and C1-6 alkylsulfonyl group) May be substituted with a substituent selected from the group) and (16) a carbamoyl group (wherein the carbamoyl group may be substituted with one or two C 1-6 alkyl groups).

상기 일반식 (I)의 화합물은 5-HT1A 길항 작용 및 결합 작용을 나타내며, 하부 요로 증상, 특히 축뇨 증상의 예방제 또는 치료제로서 유용하다.The compound of general formula (I) exhibits 5-HT 1A antagonism and binding action and is useful as a prophylactic or therapeutic agent for lower urinary tract symptoms, especially urinary tract symptoms.

특히, 상기 일반식 (I)에 포함되는, 하기 식 (i)로 표시되는 화합물인 1-{1-[2-(7-메톡시-2,2-디메틸-4-옥소크로만-8-일)에틸]피페리딘-4-일}-N-메틸-1H-인돌-6-카르복사미드가 우수한 작용을 나타내는 것으로서 기대된다:In particular, 1- {1- [2- (7-methoxy-2,2-dimethyl-4-oxochromen-8- which is a compound represented by the following formula (i) contained in the said General formula (I) Yl) ethyl] piperidin-4-yl} -N-methyl-1H-indole-6-carboxamide is expected to exhibit good action:

Figure 112007086393561-PCT00002
.
Figure 112007086393561-PCT00002
.

그리고, 본 발명은, 상기 식 (i)로 표시되는 화합물 (i)의 제조 방법 및 그의 중간체 화합물을 제공하는 것을 목적으로 한다.And an object of this invention is to provide the manufacturing method of compound (i) represented by said Formula (i), and its intermediate compound.

본 발명자들은 면밀히 연구를 거듭한 결과, 상기 화합물 (i)의 제조 방법을 발견하고, 본 발명을 완성하였다.As a result of careful study, the present inventors found a method for producing compound (i) and completed the present invention.

즉, 본 발명은,That is, the present invention,

(1) 하기 식 (a-6)으로 표시되는 8-(2-하이드록시에틸)-7-메톡시-2,2-디메틸크로만(dimethylchroman)-4-온:(1) 8- (2-hydroxyethyl) -7-methoxy-2,2-dimethylchroman-4-one represented by the following formula (a-6):

Figure 112007086393561-PCT00003
을 산화함으로써 얻어지는 하기 식 (a):
Figure 112007086393561-PCT00003
The following formula (a) obtained by oxidizing:

Figure 112007086393561-PCT00004
로 표시되는 (7-메톡시-2,2-디메틸-4-옥소크로만-8-일)아세트알데하이드와, 하기 식 (b):
Figure 112007086393561-PCT00004
(7-methoxy-2,2-dimethyl-4-oxochromen-8-yl) acetaldehyde represented by the following formula (b):

Figure 112007086393561-PCT00005
로 표시되는 N-메틸-1-(피페리딘-4-일)-1H-인돌-6-카르복사미드를 커플링하는 단계를 포함하는, 하기 식 (i):
Figure 112007086393561-PCT00005
Coupling N-methyl-1- (piperidin-4-yl) -1H-indole-6-carboxamide represented by the following formula (i):

Figure 112007086393561-PCT00006
로 표시되는 1-{1-[2-(7-메톡시-2,2-디메틸-4-옥소크로만-8-일)에틸]피페리딘-4-일}-N-메틸-1H-인돌-6-카르복사미드의 제조 방법,
Figure 112007086393561-PCT00006
1- {1- [2- (7-methoxy-2,2-dimethyl-4-oxochroman-8-yl) ethyl] piperidin-4-yl} -N-methyl-1H- represented by Process for preparing indole-6-carboxamide,

(2) (1)에 있어서, 식 (a-6):(2) In (1), formula (a-6):

Figure 112007086393561-PCT00007
으로 표시되는 8-(2-하이드록시에틸)-7-메톡시-2,2-디메틸크로만-4-온은, 하기 식 (a-5):
Figure 112007086393561-PCT00007
8- (2-hydroxyethyl) -7-methoxy-2,2-dimethylchroman-4-one represented by the following formula (a-5):

Figure 112007086393561-PCT00008
로 표시되는 화합물[식 (a-5)에서, X는 수산기의 보호기를 나타냄]의 보호기를 제거하여 얻어지는 것을 특징으로 하는 제조 방법,
Figure 112007086393561-PCT00008
In the compound represented by the following formula (a-5), X represents a protecting group of a hydroxyl group, which is obtained by removing a protecting group,

(3) (1) 또는 (2)에 있어서, 식 (a-6):(3) In (1) or (2), formula (a-6):

Figure 112007086393561-PCT00009
으로 표시되는 8-(2-하이드록시에틸)-7-메톡시-2,2-디메틸크로만-4-온은, 하기 식 (a-4):
Figure 112007086393561-PCT00009
8- (2-hydroxyethyl) -7-methoxy-2,2-dimethylchroman-4-one represented by the following formula (a-4):

Figure 112007086393561-PCT00010
로 표시되는 화합물[식 (a-4)에서, X는 수산기의 보호기를 나타냄]과 메틸크로톤산을 반응시켜, 하기 식 (a-5):
Figure 112007086393561-PCT00010
In the compound represented by the formula (a (4), X represents a protecting group of a hydroxyl group) and methyl crotonic acid, the following formula (a-5):

Figure 112007086393561-PCT00011
로 표시되는 화합물[식 (a-5)에서, X는 위에서와 동일하게 정의됨]을 얻은 다음, 얻어진 화합물 (a-5)의 보호기를 제거함으로써 얻어지는 것을 특징으로 하는 제조 방법,
Figure 112007086393561-PCT00011
A process for producing a compound represented by the following formula (a-5), wherein X is defined in the same manner as above, and then removing the protecting group of the obtained compound (a-5).

(4) (1) 내지 (3) 중 어느 하나에 있어서, 식 (a-6):(4) The formula (a-6) in any one of (1) to (3):

Figure 112007086393561-PCT00012
으로 표시되는 8-(2-하이드록시에틸)-7-메톡시-2,2-디메틸크로만-4-온은, 하기 식 (a-3):
Figure 112007086393561-PCT00012
8- (2-hydroxyethyl) -7-methoxy-2,2-dimethylchroman-4-one represented by the following formula (a-3):

Figure 112007086393561-PCT00013
으로 표시되는 화합물[식 (a-3)에서, X는 수산기의 보호기를 나타냄]과 산을 반응시켜, 하기 식 (a-4):
Figure 112007086393561-PCT00013
In the compound represented by the following formula (a-3), X represents a protecting group of a hydroxyl group, an acid is reacted with the following formula (a-4):

Figure 112007086393561-PCT00014
로 표시되는 화합물[식 (a-4)에서, X는 위에서와 동일하게 정의됨]을 얻은 다음, 얻어진 화합물 (a-4)와 메틸크로톤산을 반응시켜, 하기 식 (a-5):
Figure 112007086393561-PCT00014
To obtain a compound represented by the formula (a-4), X is the same as defined above, and then reacting the obtained compound (a-4) and methyl crotonic acid, the following formula (a-5):

Figure 112007086393561-PCT00015
로 표시되는 화합물[식 (a-5)에서, X는 위에서와 동일하게 정의됨]을 얻고, 얻어진 화합물 (a-5)의 보호기를 제거함으로써 얻어지는 것을 특징으로 하는 제조 방법,
Figure 112007086393561-PCT00015
A process for producing a compound represented by the formula (a-5), wherein X is defined in the same manner as above) and removing the protecting group of the obtained compound (a-5);

(5) (1) 내지 (4) 중 어느 하나에 있어서, 식 (a-6):(5) The formula (a-6) in any one of (1) to (4):

Figure 112007086393561-PCT00016
으로 표시되는 8-(2-하이드록시에틸)-7-메톡시-2,2-디메틸크로만-4-온은, 하기 식 (a-2):
Figure 112007086393561-PCT00016
8- (2-hydroxyethyl) -7-methoxy-2,2-dimethylchroman-4-one represented by the following formula (a-2):

Figure 112007086393561-PCT00017
로 표시되는 2-[2-(1-에톡시에톡시)-6-메톡시페닐]에탄올의 수산기를 보호하여, 하기 식 (a-3):
Figure 112007086393561-PCT00017
Protecting the hydroxyl group of 2- [2- (1-ethoxyethoxy) -6-methoxyphenyl] ethanol represented by the following formula (a-3):

Figure 112007086393561-PCT00018
으로 표시되는 화합물[식 (a-3)에서, X는 수산기의 보호기를 나타냄]을 얻은 다음, 얻어진 화합물 (a-3)과 산을 반응시켜, 하기 식 (a-4):
Figure 112007086393561-PCT00018
After obtaining the compound represented by Formula (a-3), X represents a protecting group of a hydroxyl group, and then reacting the obtained compound (a-3) with an acid, the following formula (a-4):

Figure 112007086393561-PCT00019
로 표시되는 화합물[식 (a-4)에서, X는 위에서와 동일하게 정의됨]을 얻고, 얻어진 화합물 (a-4)와 메틸크로톤산을 반응시켜, 하기 식 (a-5):
Figure 112007086393561-PCT00019
To obtain a compound represented by the formula (a-4), X is the same as defined above, by reacting the obtained compound (a-4) and methyl crotonic acid, the following formula (a-5):

Figure 112007086393561-PCT00020
로 표시되는 화합물[식 (a-5)에서, X는 위에서와 동일하게 정의됨]을 얻은 후, 얻어진 화합물 (a-5)의 보호기를 제거함으로써 얻어지는 것을 특징으로 하는 제조 방법,
Figure 112007086393561-PCT00020
A process for producing a compound represented by the following formula (a-5), wherein X is defined in the same manner as above, and then removing the protecting group of the obtained compound (a-5).

(6) (1) 내지 (5) 중 어느 하나에 있어서, 식 (a-6):(6) The formula (a-6) in any one of (1) to (5):

Figure 112007086393561-PCT00021
으로 표시되는 8-(2-하이드록시에틸)-7-메톡시-2,2-디메틸크로만-4-온은, 하기 식 (a-1):
Figure 112007086393561-PCT00021
8- (2-hydroxyethyl) -7-methoxy-2,2-dimethylchroman-4-one represented by the following formula (a-1):

Figure 112007086393561-PCT00022
로 표시되는 [2-(1-에톡시에톡시)-6-메톡시페닐]아세트산 에틸을 환원하여, 하기 식 (a-2):
Figure 112007086393561-PCT00022
Ethyl acetate of [2- (1-ethoxyethoxy) -6-methoxyphenyl] acetic acid is reduced to formula (a-2):

Figure 112007086393561-PCT00023
로 표시되는 2-[2-(1-에톡시에톡시)-6-메톡시페닐]에탄올을 얻고, 얻어진 화합물의 수산기를 보호하여, 하기 식 (a-3):
Figure 112007086393561-PCT00023
2- [2- (1-ethoxyethoxy) -6-methoxyphenyl] ethanol represented by the above was obtained, and the hydroxyl group of the obtained compound was protected to give the following formula (a-3):

Figure 112007086393561-PCT00024
으로 표시되는 화합물[식 (a-3)에서, X는 수산기의 보호기를 나타냄]을 얻은 다음, 얻어진 화합물 (a-3)과 산을 반응시켜, 하기 식 (a-4):
Figure 112007086393561-PCT00024
After obtaining the compound represented by Formula (a-3), X represents a protecting group of a hydroxyl group, and then reacting the obtained compound (a-3) with an acid, the following formula (a-4):

Figure 112007086393561-PCT00025
로 표시되는 화합물[식 (a-4)에서, X는 위에서와 동일하게 정의됨]을 얻고, 얻어진 화합물 (a-4)와 메틸크로톤산을 반응시켜, 하기 식 (a-5):
Figure 112007086393561-PCT00025
To obtain a compound represented by the formula (a-4), X is the same as defined above, by reacting the obtained compound (a-4) and methyl crotonic acid, the following formula (a-5):

Figure 112007086393561-PCT00026
로 표시되는 화합물[식 (a-5)에서, X는 위에서와 동일하게 정의됨]을 얻은 후, 얻어진 화합물 (a-5)의 보호기를 제거함으로써 얻어지는 것을 특징으로 하는 제조 방법,
Figure 112007086393561-PCT00026
A process for producing a compound represented by the following formula (a-5), wherein X is defined in the same manner as above, and then removing the protecting group of the obtained compound (a-5).

(7) (1) 내지 (6) 중 어느 하나에 있어서, 식 (a-6):(7) The formula (a-6) in any one of (1) to (6):

Figure 112007086393561-PCT00027
으로 표시되는 8-(2-하이드록시에틸)-7-메톡시-2,2-디메틸크로만-4-온은, 하기 식:
Figure 112007086393561-PCT00027
8- (2-hydroxyethyl) -7-methoxy-2,2-dimethylchroman-4-one represented by the following formula:

로 표시되는 1-(1-에톡시에톡시)-3-메톡시벤젠과 브로모아세트산 에틸을 반응시켜, 하기 식 (a-1): 1- (1-ethoxyethoxy) -3-methoxybenzene and ethyl bromoacetate are reacted with the following formula (a-1):

Figure 112007086393561-PCT00029
로 표시되는 [2-(1-에톡시에톡시)-6-메톡시페닐]아세트산 에틸을 얻고, 얻어진 화합물 (a-1)을 환원하여, 하기 식 (a-2):
Figure 112007086393561-PCT00029
[2- (1-Ethoxyethoxy) -6-methoxyphenyl] ethyl acetate represented by: was obtained, and the obtained compound (a-1) was reduced to give the following formula (a-2):

Figure 112007086393561-PCT00030
로 표시되는 2-[2-(1-에톡시에톡시)-6-메톡시페닐]에탄올을 얻고, 얻어진 화합물 (a-2)의 수산기를 보호하여, 하기 식 (a-3):
Figure 112007086393561-PCT00030
2- [2- (1-ethoxyethoxy) -6-methoxyphenyl] ethanol represented by the above was obtained, and the hydroxyl group of the obtained compound (a-2) was protected to give the following formula (a-3):

Figure 112007086393561-PCT00031
으로 표시되는 화합물[식 (a-3)에서, X는 수산기의 보호기를 나타냄]을 얻은 다음, 얻어진 화합물 (a-3)과 산을 반응시켜, 하기 식 (a-4):
Figure 112007086393561-PCT00031
After obtaining the compound represented by Formula (a-3), X represents a protecting group of a hydroxyl group, and then reacting the obtained compound (a-3) with an acid, the following formula (a-4):

Figure 112007086393561-PCT00032
로 표시되는 화합물[식 (a-4)에서, X는 위에서와 동일하게 정의됨]을 얻고, 얻어진 화합물 (a-4)와 메틸크로톤산을 반응시켜, 하기 식 (a-5):
Figure 112007086393561-PCT00032
To obtain a compound represented by the formula (a-4), X is the same as defined above, by reacting the obtained compound (a-4) and methyl crotonic acid, the following formula (a-5):

Figure 112007086393561-PCT00033
로 표시되는 화합물[식 (a-5)에서, X는 위에서와 동일하게 정의됨]을 얻은 후, 얻어진 화합물 (a-5)의 보호기를 제거함으로써 얻어지는 것을 특징으로 하는 제조 방법,
Figure 112007086393561-PCT00033
A process for producing a compound represented by the following formula (a-5), wherein X is defined in the same manner as above, and then removing the protecting group of the obtained compound (a-5).

(8) (2) 내지 (7) 중 어느 하나에 있어서, X가 벤조일기인 것을 특징으로 하는 제조 방법,(8) The production method according to any one of (2) to (7), wherein X is a benzoyl group,

(9) 하기 식 (II)로 표시되는 화합물:(9) a compound represented by the following formula (II):

Figure 112007086393561-PCT00034
Figure 112007086393561-PCT00034

[식 (II)에서, X1은 수소 원자 또는 수산기의 보호기를 나타냄],[In Formula (II), X 1 represents a hydrogen atom or a protecting group of a hydroxyl group.],

(10) (9)에 있어서, 수산기의 보호기가 벤조일기인 것을 특징으로 하는 화합물,(10) The compound according to (9), wherein the protecting group of the hydroxyl group is a benzoyl group,

(11) 벤조산 2-(7-메톡시-2,2-디메틸-4-옥소크로만-8-일)에틸 또는 8-(2-하이드록시에틸)-7-메톡시-2,2-디메틸크로만-4-온,(11) Benzoic acid 2- (7-methoxy-2,2-dimethyl-4-oxochromen-8-yl) ethyl or 8- (2-hydroxyethyl) -7-methoxy-2,2-dimethyl Croman-4-one,

(12) 하기 식 (c-3):(12) the following formula (c-3):

Figure 112007086393561-PCT00035
으로 표시되는 화합물과 메틸아민을 반응시키는 단계를 포함하는, 하기 식 (i):
Figure 112007086393561-PCT00035
Reaction of the compound and methylamine represented by the following formula (i):

Figure 112007086393561-PCT00036
로 표시되는 1-{1-[2-(7-메톡시-2,2-디메틸-4-옥소크로만-8-일)에틸]피페리딘-4-일}-N-메틸-1H-인돌-6-카르복사미드의 제조 방법,
Figure 112007086393561-PCT00036
1- {1- [2- (7-methoxy-2,2-dimethyl-4-oxochroman-8-yl) ethyl] piperidin-4-yl} -N-methyl-1H- represented by Process for preparing indole-6-carboxamide,

(13) (12)에 있어서, 식 (c-3):(13) In the formula (12), the formula (c-3):

Figure 112007086393561-PCT00037
으로 표시되는 화합물은, 하기 식 (c-2):
Figure 112007086393561-PCT00037
The compound represented by the following formula (c-2):

Figure 112007086393561-PCT00038
로 표시되는 화합물을 가수분해함으로써 얻어지는 것을 특징으로 하는 제조 방법,
Figure 112007086393561-PCT00038
It is obtained by hydrolyzing the compound represented by the manufacturing method,

(14) (12)에 있어서, 식 (c-3):(14) In the formula (12), the formula (c-3):

Figure 112007086393561-PCT00039
으로 표시되는 화합물은, 하기 식 (a):
Figure 112007086393561-PCT00039
The compound represented by the following formula (a):

Figure 112007086393561-PCT00040
로 표시되는 화합물과, 하기 식 (c-1):
Figure 112007086393561-PCT00040
The compound represented by following formula (c-1):

Figure 112007086393561-PCT00041
로 표시되는 화합물 또는 그의 염을 반응시켜, 하기 식 (c-2):
Figure 112007086393561-PCT00041
By reacting the compound or its salt represented by following formula (c-2):

Figure 112007086393561-PCT00042
로 표시되는 화합물을 얻은 다음, 얻어진 화합물을 가수분해함으로써 얻어지는 것을 특징으로 하는 제조 방법,
Figure 112007086393561-PCT00042
A method for producing the compound, which is obtained by hydrolyzing the obtained compound after obtaining the compound represented by

(15) (12)에 있어서, 식 (c-3):(15) In the formula (12), the formula (c-3):

Figure 112007086393561-PCT00043
으로 표시되는 화합물은, 하기 식 (a):
Figure 112007086393561-PCT00043
The compound represented by the following formula (a):

Figure 112007086393561-PCT00044
로 표시되는 화합물과, 하기 식 (b'-4):
Figure 112007086393561-PCT00044
The compound represented by following formula (b'-4):

Figure 112007086393561-PCT00045
로 표시되는 화합물[식 (b'-4)에서, Y는 2급 아민의 보호기를 나타냄]의 보호기를 제거해서 얻어지는 하기 식 (c-1):
Figure 112007086393561-PCT00045
The following formula (c-1) obtained by removing the protecting group of the compound represented by the formula [wherein Y represents a protecting group of a secondary amine] in the formula (b'-4):

Figure 112007086393561-PCT00046
로 표시되는 화합물 또는 그의 염을 반응시켜, 하기 식 (c-2):
Figure 112007086393561-PCT00046
By reacting the compound or its salt represented by following formula (c-2):

Figure 112007086393561-PCT00047
로 표시되는 화합물을 얻은 다음, 얻어진 화합물 (c-2)를 가수분해함으로써 얻어지는 것을 특징으로 하는 제조 방법,
Figure 112007086393561-PCT00047
Obtaining the compound represented by the following, The manufacturing method characterized by obtaining by hydrolyzing the obtained compound (c-2),

(16) (15)에 있어서, Y가 벤질옥시카르보닐인 것을 특징으로 하는 제조 방법에 관한 것이다.(16) The method according to (15), wherein Y is benzyloxycarbonyl.

(발명의 효과)(Effects of the Invention)

본 발명에 따르면, 1-{1-[2-(7-메톡시-2,2-디메틸-4-옥소크로만-8-일)에틸]피페리딘-4-일}-N-메틸-1H-인돌-6-카르복사미드를 공업적으로 유리하게 제조할 수 있다. 또한, 본 발명에 따르면, 이러한 제조에 유리하게 사용되는 제조 중간체를 제공할 수 있다.According to the invention, 1- {1- [2- (7-methoxy-2,2-dimethyl-4-oxochroman-8-yl) ethyl] piperidin-4-yl} -N-methyl- 1H-indole-6-carboxamide can be produced industrially advantageously. Furthermore, according to the present invention, it is possible to provide a production intermediate which is advantageously used for such production.

(본 발명을 실시하기 위한 최선의 형태)Best Mode for Carrying Out the Invention

이하, 본 발명에 따른, 하기 식 (i)로 표시되는 화합물의 제조 방법에 대해 설명한다.Hereinafter, the manufacturing method of the compound represented by following formula (i) which concerns on this invention is demonstrated.

공정 (1)Process (1)

공정 (1)은, 하기 식 (a)로 표시되는 화합물과 하기 식 (b)로 표시되는 화합물을 커플링 반응시켜, 하기 식 (i)로 표시되는 화합물을 얻는 공정이다:Step (1) is a step of coupling-reacting a compound represented by the following formula (a) and a compound represented by the following formula (b) to obtain a compound represented by the following formula (i):

Figure 112007086393561-PCT00048
Figure 112007086393561-PCT00048

공정 (1)에서의 커플링 반응은, 바람직하게는 환원적 아미노화 반응 조건 하에, 즉, 카르보닐 화합물과 아민 화합물의 환원적 아미노화 반응에 통상적으로 이용되는 조건과 같은 조건에서 수행될 수 있다. 본 공정의 환원 반응은 특별히 한정되지는 않지만, 예컨대, 보란(borane), 수소화붕소 착체 화합물 등의 환원제에 의한 환원적 아미노화 반응, 금속 촉매를 사용하는 수소 분위기 하에서의 접촉(接觸) 환원 반응 등을 들 수 있다.The coupling reaction in step (1) may preferably be carried out under reductive amination reaction conditions, i.e. under the same conditions as are commonly used for reductive amination reactions of carbonyl and amine compounds. . Although the reduction reaction in this process is not specifically limited, For example, the reductive amination reaction by reducing agents, such as a borane and a borohydride complex compound, a catalytic reduction reaction in hydrogen atmosphere using a metal catalyst, etc. Can be mentioned.

상기 수소화붕소 착체 화합물을 사용하는 환원적 아미노화 반응을 예시하면, W. S. Emerson, Organic Reactions, 4. 174(1948), C. F. Lane, Synthesis, 135(1975), J. C. Ctowell and S. J. Pedegimas, Synthesis, 127(1974) 및 A. F. Abdel-Magid, K. G. Carson, B. D. Harris, C. A. Marryanoff and R. D. Shah, Journal of Organic Chemistry, 61, 3849(1996) 등의 문헌에 기재된 방법을 들 수 있다. 본 공정에 사용되는 수소화붕소 착체 화합물을 예시하면, 수소화붕소나트륨, 시안화수소붕소나트륨, 트리아세톡시수소화붕소나트륨 등을 들 수 있다. 상기 환원제로서 수소화붕소 착체 화합물을 이용하는 경우, 사용 가능한 용매로서는, 상기 반응을 저해하지 않고, 출발 물질을 어느 정도 용해하는 것이라면 특별히 한정되지 않지만, 구체적으로 예시하면, 메탄올, 에탄올, 테트라하이드로퓨란(tetrahydrofuran), N,N-디메틸포름아미드, 염화메틸렌, 1,2-디클로로에탄 등을 들 수 있다.Illustrative reductive amination reactions using the boron hydride complex compounds include WS Emerson, Organic Reactions, 4. 174 (1948), CF Lane, Synthesis, 135 (1975), JC Ctowell and SJ Pedegimas, Synthesis, 127 ( 1974) and AF Abdel-Magid, KG Carson, BD Harris, CA Marryanoff and RD Shah, Journal of Organic Chemistry, 61, 3849 (1996) and the like. Examples of the boron hydride complex compound used in the present step include sodium borohydride, sodium hydrogen borohydride, sodium triacetoxy borohydride and the like. When the boron hydride complex compound is used as the reducing agent, the solvent that can be used is not particularly limited as long as it does not inhibit the reaction and dissolves the starting material to some extent, but specifically exemplifies methanol, ethanol and tetrahydrofuran. ), N, N-dimethylformamide, methylene chloride, 1,2-dichloroethane and the like.

상기 화합물 (b)는, 상기 화합물 (a)에 대하여 0.8 내지 2.5당량, 바람직하게는 1 내지 1.5 당량의 양으로 사용된다. 본 공정에서 상기 수소화붕소 착체 화합물은, 상기 화합물 (a)에 대하여 1 내지 3 당량, 바람직하게는 1 내지 1.5 당량의 양으로 사용된다. 상기 반응 시간은 특별히 한정되지는 않지만, 통상적으로는 0.5 내지 48시간이며, 바람직하게는 0.5 내지 12시간이다. 상기 반응 온도는 특별히 한정되지는 않지만, 통상적으로 -78℃ 내지 상기 용매의 환류 온도이며, 바람직하게는 빙냉 온도 내지 실온이다.The compound (b) is used in an amount of 0.8 to 2.5 equivalents, preferably 1 to 1.5 equivalents based on the compound (a). In this step, the boron hydride complex compound is used in an amount of 1 to 3 equivalents, preferably 1 to 1.5 equivalents based on the compound (a). Although the said reaction time is not specifically limited, Usually, it is 0.5 to 48 hours, Preferably it is 0.5 to 12 hours. Although the said reaction temperature is not specifically limited, Usually, it is -78 degreeC-reflux temperature of the said solvent, Preferably it is ice-cooling temperature-room temperature.

수소 분위기 하에서의 접촉 환원 반응을 이용하는 경우에 사용되는 용매는, 상기 반응을 저해하지 않는 것이라면 특별히 한정되지는 않지만, 사용 가능한 용매를 예시하면, 메탄올, 에탄올, 테트라하이드로퓨란, 1,4-디옥산 등을 들 수 있다. 상기 반응에 이용되는 금속 촉매를 예시하면, 팔라듐, 산화백금, Raney 니켈 등을 들 수 있다. 상기 반응 시간은 특별히 한정되지는 않지만, 통상적으로 1 내지 48시간이며, 바람직하게는 1 내지 24시간이다. 상기 반응 조건은 특별히 한정되지는 않지만, 상기 반응을 실온 내지 상기 용매의 환류 온도, 및 상압 내지 15 ㎫의 조건에서, 바람직하게는 실온 내지 60℃, 및 상압 내지 0.5 ㎫의 조건에서 수행할 수 있다.The solvent used in the case of using a catalytic reduction reaction under a hydrogen atmosphere is not particularly limited as long as it does not inhibit the reaction. Examples of the solvent that can be used include methanol, ethanol, tetrahydrofuran, 1,4-dioxane, and the like. Can be mentioned. Palladium, platinum oxide, Raney nickel, etc. are mentioned as a metal catalyst used for the said reaction. Although the said reaction time is not specifically limited, Usually, it is 1 to 48 hours, Preferably it is 1 to 24 hours. The reaction conditions are not particularly limited, but the reaction can be carried out at room temperature to the reflux temperature of the solvent, and conditions at normal pressure to 15 MPa, preferably at room temperature to 60 ° C, and at normal pressure to 0.5 MPa. .

상기 화합물 (a)는 하기 공정 (A-1) 내지 공정 (A-6), 및 공정 (A)를 통해 얻어진다.The compound (a) is obtained through the following steps (A-1) to (A-6) and step (A).

공정 (A-1)Process (A-1)

Figure 112007086393561-PCT00049
Figure 112007086393561-PCT00049

공정 (A-1)은, 1-(1-에톡시에톡시)-3-메톡시벤젠과 브로모아세트산 에틸을 반응시켜, 상기 식 (a-1)로 표시되는 화합물을 얻는 공정이다.Step (A-1) is a step of reacting 1- (1-ethoxyethoxy) -3-methoxybenzene with ethyl bromoacetate to obtain a compound represented by the formula (a-1).

본 공정은, 필요한 경우, n-부틸리튬 등의 강염기의 존재 하에서 수행될 수 있다. 본 공정에 사용되는 반응 용매로서는, 상기 반응을 저해하지 않고, 출발 물질을 어느 정도 용해하는 것이라면 특별히 한정되지는 않지만, 상기 반응 용매를 구체적으로 예시하면, 테트라하이드로퓨란, 헵탄, 헥산, 톨루엔, 1,2-디메톡시에탄, 디에틸에테르, 1,2-디클로로에탄 등을 들 수 있다. 상기 반응 온도는, 통상적으로 -78℃ 내지 상기 용매의 환류 온도이며, 바람직하게는 -78℃ 내지 0℃이다. 상기 반응 시간은 특별히 한정되지는 않지만, 통상적으로 1 내지 48시간이며, 바람직하게는 1 내지 24시간이다.This process can be carried out if necessary in the presence of a strong base such as n-butyllithium. The reaction solvent used in this step is not particularly limited as long as it does not inhibit the reaction and dissolves the starting material to some extent. Specific examples of the reaction solvent include tetrahydrofuran, heptane, hexane, toluene, 1 , 2-dimethoxyethane, diethyl ether, 1,2-dichloroethane and the like. The reaction temperature is usually -78 ° C to reflux temperature of the solvent, preferably -78 ° C to 0 ° C. Although the said reaction time is not specifically limited, Usually, it is 1 to 48 hours, Preferably it is 1 to 24 hours.

공정 (A-2)Process (A-2)

Figure 112007086393561-PCT00050
Figure 112007086393561-PCT00050

공정 (A-2)는, 상기 식 (a-1)로 표시되는 화합물을 환원하하여, 상기 식 (a-2)로 표시되는 화합물을 얻는 공정이다.Step (A-2) is a step of reducing the compound represented by the formula (a-1) to obtain a compound represented by the formula (a-2).

공정 (A-2)에서의 에스테르의 환원 반응은, 예컨대, 제4판 실험화학강좌 26(159∼266 페이지) 등에 기재된 환원 반응에 일반적으로 사용되고 있는 조건에서, 또는 상기 조건에 준해서 수행될 수 있다. 상기 반응에 사용되는 환원제를 예시하면, 수소화리튬알루미늄, 수소화붕소리튬, 수소화디이소부틸알루미늄, 수소화비스(2-메톡시에톡시)알루미늄나트륨 등을 들 수 있다. 반응 용매로서는, 상기 반응을 저해하지 않고, 출발 물질을 어느 정도 용해하는 것이라면 특별히 한정되지 않고 사용되며, 사용하기에 바람직한 반응 용매를 구체적으로 예시하면, 테트라하이드로퓨란, 디에틸에테르, 디메톡시에탄, 사이클로펜틸메틸에테르 등의 에테르계 용매; 톨루엔, 자일렌(xylene) 등의 방향족 탄화수소계 용매; 또는 염화메틸렌 등을 들 수 있다. 본 공정에서의 반응 온도는 특별히 한정되지는 않지만, 통상적으로는 -78℃ 내지 상기 용매의 환류 온도이며, 바람직하게는 -78℃ 내지 실온이다. 상기 환원제는, 상기 화합물 (a-1)에 대하여 1 내지 3당량의 양, 바람직하게는 1 내지 1.5 당량의 양으로 사용된다.The reduction reaction of the ester in the step (A-2) can be carried out under the conditions generally used in the reduction reaction described in, for example, the fourth edition of Experimental Chemistry Lecture 26 (pages 159 to 266), or the like. have. Examples of the reducing agent used in the reaction include lithium aluminum hydride, lithium borohydride, diisobutylaluminum hydride, sodium bis (2-methoxyethoxy) aluminum hydride and the like. The reaction solvent is not particularly limited as long as it dissolves the starting material to some extent without inhibiting the above reaction. Specific examples of preferred reaction solvents for use include tetrahydrofuran, diethyl ether, dimethoxyethane, Ether solvents such as cyclopentylmethyl ether; Aromatic hydrocarbon solvents such as toluene and xylene; Or methylene chloride. Although the reaction temperature in this process is not specifically limited, Usually, it is -78 degreeC-reflux temperature of the said solvent, Preferably it is -78 degreeC-room temperature. The reducing agent is used in an amount of 1 to 3 equivalents, preferably 1 to 1.5 equivalents based on the compound (a-1).

공정 (A-3)Process (A-3)

Figure 112007086393561-PCT00051
Figure 112007086393561-PCT00051

(상기 식에서, X는 수산기의 보호기를 나타냄).(Wherein X represents a protecting group of a hydroxyl group).

공정 (A-3)은, 상기 식 (a-2)로 표시되는 화합물의 수산기에 보호기를 도입하여, 상기 식 (a-3)으로 표시되는 화합물을 얻는 공정이다.Step (A-3) is a step of introducing a protecting group into the hydroxyl group of the compound represented by the formula (a-2) to obtain a compound represented by the formula (a-3).

X로 표시되는 수산기의 보호기를 예시하면, 아세틸기 또는 벤조일기 등과 같은 공지된 수산기의 보호기를 들 수 있으며, 벤조일기가 바람직하다. 본 공정에서, 예를 들면, 벤조일기로 보호하는 경우에는, 염화벤조일을, 트리에틸아민 등의 염기 존재 하에, 예컨대, 톨루엔, 자일렌 등의 방향족 탄화수소계 용매, 아세트산 에틸 등의 에스테르계 용매, 디메톡시에탄, 사이클로펜틸메틸에테르 등의 에테르계 용매에서 반응시킴으로써, 목적물을 얻을 수 있다. 염화벤조일은, 상기 화합물 (a-2)에 대하여 1 당량 내지 대과잉량으로 사용될 수 있다. 본 반응에, 예를 들면, N,N,N',N'-테트라메틸에틸렌디아민, 디이소프로필에틸아민, N,N-디메틸아닐린 등을 공존시키는 경우에는 수율의 향상이나 반응 시간의 단축 등과 같은 바람직한 결과를 얻어지는 경우가 있다. 상기 공정에서의 반응 온도는 0 내지 10O℃이고, 바람직하게는 0℃ 내지 실온이다. 본 공정에서의 반응 시간은 특별히 한정되지는 않지만, 통상적으로는 0.5 내지 48시간이며, 바람직하게는 0.5 내지 4시간이다.As a protecting group of the hydroxyl group represented by X, the protecting group of well-known hydroxyl groups, such as an acetyl group or a benzoyl group, is mentioned, A benzoyl group is preferable. In the present step, for example, when protecting with a benzoyl group, benzoyl chloride is used in the presence of a base such as triethylamine, for example, an aromatic hydrocarbon solvent such as toluene, xylene, ester solvent such as ethyl acetate, dimeth The target object can be obtained by making it react with ether solvents, such as methoxyethane and cyclopentyl methyl ether. Benzoyl chloride can be used in the amount of 1 equivalent to excess based on the compound (a-2). In the present reaction, for example, when N, N, N ', N'-tetramethylethylenediamine, diisopropylethylamine, N, N-dimethylaniline and the like coexist, the yield is improved and the reaction time is shortened. The same preferable result may be obtained. The reaction temperature in the said process is 0-10 degreeC, Preferably it is 0 degreeC-room temperature. Although the reaction time in this process is not specifically limited, Usually, it is 0.5 to 48 hours, Preferably it is 0.5 to 4 hours.

공정 (A-4)Process (A-4)

Figure 112007086393561-PCT00052
Figure 112007086393561-PCT00052

(상기 식에서, X는 위에서와 동일하게 정의됨).Wherein X is defined the same as above.

공정 (A-4)는, 상기 식 (a-3)으로 표시되는 화합물과 산을 반응시켜, 상기 식 (a-4)로 표시되는 화합물을 얻는 공정이다.Step (A-4) is a step of reacting the compound represented by the formula (a-3) with an acid to obtain a compound represented by the formula (a-4).

본 공정에 사용되는 산(酸)으로서는, 통상적으로 사용되는 산이라면 어느 것이든 사용할 수 있지만, 염산을 사용하는 것이 바람직하다. 상기 산은, 상기 화합물 (a-3)에 대하여 1 당량 내지 대과잉량으로 사용된다. 본 공정에서 사용되는 반응 용매로서는, 상기 반응을 저해하지 않고, 출발 물질을 어느 정도 용해하는 것이라면 특별히 한정되지는 않지만, 사용 가능한 반응 용매를 구체적으로 예시하면, 톨루엔, 디메톡시에탄, 테트라하이드로퓨란, 물 또는 이들의 혼합 용매 등을 들 수 있다. 본 공정에서의 반응 온도는 0 내지 100℃이며, 바람직하게는 0℃ 내지 실온이다. 반응 시간은 통상적으로 0.5 내지 48시간이고, 바람직하게는 1 내지 4시간이다.As the acid used in this step, any acid can be used as long as it is normally used, but it is preferable to use hydrochloric acid. The acid is used in the amount of 1 equivalent to large excess based on the compound (a-3). The reaction solvent used in this step is not particularly limited as long as it does not inhibit the above reaction and dissolves the starting material to some extent. Specific examples of the reaction solvent that can be used include toluene, dimethoxyethane, tetrahydrofuran, Water or a mixed solvent thereof; The reaction temperature in this process is 0-100 degreeC, Preferably it is 0 degreeC-room temperature. The reaction time is usually 0.5 to 48 hours, preferably 1 to 4 hours.

공정 (A-5)Process (A-5)

Figure 112007086393561-PCT00053
Figure 112007086393561-PCT00053

(상기 식에서, X는 위에서와 동일하게 정의됨).Wherein X is defined the same as above.

공정 (A-5)는, 상기 식 (a-4)로 표시되는 화합물과 메틸크로톤산을 반응시켜, 상기 식 (a-5)로 표시되는 화합물을 얻는 공정이다.Step (A-5) is a step of reacting the compound represented by the formula (a-4) with methyl crotonic acid to obtain the compound represented by the formula (a-5).

본 공정은, 예를 들면, T. Timar 외, "Synthesis of 2,2-Dimethyl-4-Chroma nones", J. Heterocyclic Chem., 37, 1389(2000); J. C. Jaszberenyi 외, "On the Synthesis of Substituted 2,2-Dimethyl-4-Chromanones and Related Compounds", Tetrahedron Letters, 33(20), 2791-2794, 1992; J. C. Jaszberenyi 외, Heterocycles, 38(9), 2099, 1994 등에 기재된 조건과 동등한 조건에서 반응을 수행할 수 있다. 그 외 다른 방법으로서, 상기 화합물 (a-4)와 메틸크로톤산을, 메실산의 존재 하에 반응시킴으로써, 화합물 (a-5)를 얻을 수 있다. 본 공정에서 상기 메틸크로톤산은, 상기 화합물 (a-4)에 대하여 1 당량 내지 대과잉량으로 이용된다. 본 반응은, 필요한 경우, 오산화이인(diphosphorus pentaoxide) 등의 탈수제를 첨가할 수 있다. 본 공정에 사용되는 반응 용매로서는, 상기 반응을 저해하지 않고, 출발 물질을 어느 정도 용해하는 것이라면 특별히 한정되지 않지만, 사용되는 반응 용매를 구체적으로 예시하면, 메탄설폰산 등을 들 수 있다. 본 공정에서의 반응 온도는 실온 내지 100℃이고, 바람직하게는 40 내지 60℃이다. 상기 반응 시간은 특별히 한정되지는 않지만, 통상적으로 0.5 내지 48시간이고, 바람직하게는 1 내지 4시간이다.This process is described, for example, in T. Timar et al., “Synthesis of 2,2-Dimethyl-4-Chroma nones”, J. Heterocyclic Chem., 37, 1389 (2000); J. C. Jaszberenyi et al., “On the Synthesis of Substituted 2,2-Dimethyl-4-Chromanones and Related Compounds”, Tetrahedron Letters, 33 (20), 2791-2794, 1992; The reaction can be carried out under conditions equivalent to those described in J. C. Jaszberenyi et al., Heterocycles, 38 (9), 2099, 1994, and the like. As another method, the compound (a-5) can be obtained by reacting the compound (a-4) and methyl crotonic acid in the presence of mesylic acid. In this step, the methyl crotonic acid is used in the amount of 1 equivalent to large excess based on the compound (a-4). In this reaction, if necessary, a dehydrating agent such as diphosphorus pentaoxide may be added. The reaction solvent used in the present step is not particularly limited as long as the starting material is dissolved to some extent without inhibiting the above reaction. Specific examples of the reaction solvent used include methanesulfonic acid. The reaction temperature in this process is room temperature to 100 degreeC, Preferably it is 40-60 degreeC. Although the said reaction time is not specifically limited, Usually, it is 0.5 to 48 hours, Preferably it is 1 to 4 hours.

공정 (A-6)Process (A-6)

Figure 112007086393561-PCT00054
Figure 112007086393561-PCT00054

(상기 식에서, X는 위에서와 동일하게 정의됨).Wherein X is defined the same as above.

공정 (A-6)은, 상기 식 (a-5)로 표시되는 화합물의 수산기의 보호기를 탈보호하여, 상기 식 (a-6)으로 표시되는 화합물을 얻는 공정이다.Process (A-6) is a process of deprotecting the protecting group of the hydroxyl group of the compound represented by said formula (a-5), and obtaining a compound represented by said formula (a-6).

본 공정의 반응은, 알코올성 수산기의 보호기를 탈보호하는 방법에서 일반적으로 이용되는 조건, 예를 들면, 문헌 T. W. Greene, P. G. M. Wuts, "Protective Groups in Organic Synthesis, Second Edition", John Wiley & Sons, Inc.에 기재된 조건과 같은 조건에서 수행될 수 있다. 예를 들면, 벤조일기 등으로 보호된 알코올성 수산기를, 예컨대, 테트라하이드로퓨란, 메탄올, 에탄올 등의 유기 용매 또는 이들의 혼합 용매 중에서, 수산화나트륨수 등과 반응시킴으로써, 목적물을 얻을 수 있다. 수산화나트륨은, 상기 화합물 (a-5)에 대하여 1 당량 내지 대과잉량으로 사용된다. 본 공정에서의 반응 온도는 0 내지 100℃이며, 바람직하게는 실온 내지 50℃이다. 반응 시간은 특별히 한정되지는 않지만, 통상적으로 0.5 내지 48시간이고, 바람직하게는 1 내지 5시간이다.The reaction of this process is carried out under conditions generally used in the method of deprotecting the protecting group of an alcoholic hydroxyl group, for example, TW Greene, PGM Wuts, "Protective Groups in Organic Synthesis, Second Edition", John Wiley & Sons, Inc. It may be carried out under the same conditions as described in. For example, a target object can be obtained by making alcoholic hydroxyl group protected by the benzoyl group etc. react with sodium hydroxide water etc. in organic solvents, such as tetrahydrofuran, methanol, ethanol, or these mixed solvents, for example. Sodium hydroxide is used in the amount of 1 equivalent to large excess based on the compound (a-5). The reaction temperature in this process is 0-100 degreeC, Preferably it is room temperature-50 degreeC. Although reaction time is not specifically limited, Usually, it is 0.5 to 48 hours, Preferably it is 1 to 5 hours.

공정 (A)Process (A)

Figure 112007086393561-PCT00055
Figure 112007086393561-PCT00055

공정 (A)는, 상기 식 (a-6)으로 표시되는 화합물을 산화하여, 상기 식 (a)로 표시되는 화합물을 얻는 공정이다.Step (A) is a step of oxidizing the compound represented by the formula (a-6) to obtain a compound represented by the formula (a).

당업자에게 공지된 방법에 따라, 알코올 화합물로부터 알데하이드 화합물을 얻을 수 있다. 공지된 산화 방법을 예시하면, Swern 산화, Corey-Kim 산화, Moffatt 산화, PCC 산화, PDC 산화, Dess-Martin 산화, SO3-피리딘 산화, TEMPO 산화 등을 들 수 있다. 본 공정에 사용되는 반응 용매로서는, 상기 반응을 저해하지 않고, 출발 물질을 어느 정도 용해하는 것이라면 특별히 한정되지는 않지만, 사용되는 반응 용매를 예시하면, 디메틸설폭사이드, 테트라하이드로퓨란, 톨루엔, 염화메틸렌, 클로로포름, 아세트산 에틸, 물 또는 이들의 혼합 용매 등을 들 수 있다. 상기 산화제는, 상기 화합물 (a-6)에 대하여 촉매량 내지 대과잉량으로 사용된다. 본 공정에서의 반응 온도는 특별히 한정되는 것은 아니지만, 통상적으로는 -78℃ 내지 상기 용매의 환류 온도이며, 바람직하게는 -5℃ 내지 실온이다. 반응 시간은 특별히 한정되지는 않지만, 통상적으로 1 내지 10시간이고, 바람직하게는 1 내지 5시간이다. 예컨대, TEMPO 산화의 경우에는, 제4판 실험화학강좌 23 유기합성 V 산화 반응, Maruzen Co., Ltd.(369∼403 페이지)에 기재된 방법에 따라 수행될 수 있다. 상기 반응 용매로서는, 반응을 저해하지 않고, 출발 물질을 어느 정도 용해하는 것이라면 특별히 한정되지는 않지만, 예를 들면, 디메틸설폭사이드, 테트라하이드로퓨란, 톨루엔, 염화메틸렌, 클로로포름, 아세트산 에틸, 물 또는 이들의 혼합 용매 등을 들 수 있다. 또한, 2,2,6,6-테트라메틸피페리딘옥사이드-브롬화나트륨의 존재 하에, 산화제, 예를 들면, 탄산수소나트륨 수용액 중의 차아염소산나트륨 등을, 상기 화합물 (a-6)에 대하여 1 당량 이상 사용한다. 상기 산화 반응 온도는 특별히 한정되지는 않지만, 통상적으로 -20℃ 내지 실온이고, 바람직하게는 -5℃ 내지 실온이다. 상기 반응 시간은 특별히 한정되는 것은 아니지만, 통상적으로 1 내지 10시간이며, 바람직하게는 1 내지 5시간이다.According to methods known to those skilled in the art, aldehyde compounds can be obtained from alcohol compounds. Examples of known oxidation methods include Swern oxidation, Corey-Kim oxidation, Moffatt oxidation, PCC oxidation, PDC oxidation, Dess-Martin oxidation, SO 3 -pyridine oxidation, TEMPO oxidation, and the like. The reaction solvent used in this step is not particularly limited as long as it does not inhibit the reaction and dissolves the starting material to some extent. Examples of the reaction solvent used include dimethyl sulfoxide, tetrahydrofuran, toluene and methylene chloride. , Chloroform, ethyl acetate, water or a mixed solvent thereof. The oxidizing agent is used in a catalytic amount to a large excess with respect to the compound (a-6). Although the reaction temperature in this process is not specifically limited, Usually, it is -78 degreeC-reflux temperature of the said solvent, Preferably it is -5 degreeC-room temperature. Although reaction time is not specifically limited, Usually, it is 1 to 10 hours, Preferably it is 1 to 5 hours. For example, in the case of TEMPO oxidation, it can be carried out according to the method described in the fourth edition of Experimental Chemistry Lecture 23 organic synthesis V oxidation reaction, Maruzen Co., Ltd. (p. 369 to 403). The reaction solvent is not particularly limited as long as it does not inhibit the reaction and dissolves the starting material to some extent. For example, dimethyl sulfoxide, tetrahydrofuran, toluene, methylene chloride, chloroform, ethyl acetate, water or these Mixed solvents; and the like. Further, in the presence of 2,2,6,6-tetramethylpiperidine oxide-sodium bromide, an oxidizing agent, for example, sodium hypochlorite in an aqueous sodium hydrogen carbonate solution, etc. Use more than equivalent. Although the said oxidation reaction temperature is not specifically limited, Usually, it is -20 degreeC-room temperature, Preferably it is -5 degreeC-room temperature. Although the said reaction time is not specifically limited, Usually, it is 1 to 10 hours, Preferably it is 1 to 5 hours.

예를 들면, Swern 산화의 경우에는, 제4판 실험화학강좌 23 유기합성 V 산화 반응, Maruzen Co., Ltd.(298∼346 페이지)에 기재된 방법에 따라 수행될 수 있다. 이 때, 상기 반응 용매로서는, 상기 반응을 저해하지 않고, 출발 물질을 어느 정도 용해하는 것이라면 특별히 한정되지는 않지만, 예컨대, 디메틸설폭사이드, 테트라하이드로퓨란, 톨루엔, 염화메틸렌, 클로로포름, 아세트산 에틸, 물 또는 이들의 혼합 용매 등을 들 수 있다. 상기 산화제로서는, 디메틸설폭사이드의 활성화제로서, 예컨대, 염화옥살릴(oxalyl chloride), 무수 트리플루오로아세트산, 무수 아세트산, 사이클로헥실이미드 또는 오산화이인 등을, 상기 화합물 (a-6)에 대하여 2배 몰량 내지 대과잉량으로 사용한다. 상기 반응 온도는 특별히 한정되지는 않지만, 통상적으로는 -70℃ 내지 실온이다. 상기 반응 시간은 특별히 한정되지는 않지만, 통상적으로 3 내지 10시간이며, 바람직하게는 3 내지 5시간이다. 한편, 알데하이드 화합물은, D. P. Kjell 외, "A Nobel, Non aqueous Method for Regeneration of Aldehydes from Bisulfite Adducts". J. 0rganic. Chemistry. 64, 5722-5724(1999)에 기재된 방법에 따라, 아황산수소나트륨 부가물로 변환함으로써, 간편하게 정제될 수 있고, 아울러, 용이하게 재생될 수 있다. 상기 알데하이드 화합물을, 예컨대, 에탄올, 아세트산 에틸, 메탄올 등의 유기 용매 또는 이들의 혼합 용매 중에서, 예를 들면, 아황산수소나트륨 수용액과 반응시킴으로써, 아황산수소나트륨 부가물을 얻을 수 있다. 이 때 사용되는 아황산수소나트륨은, 상기 알데하이드 화합물에 대하여 1 당량 내지 대과잉량으로 사용된다. 상기 반응 온도는 특별히 한정되지는 않지만, 통상적으로 10 내지 40℃이며, 바람직하게는 실온이다.For example, in the case of Swern oxidation, it can be carried out according to the method described in the fourth edition of Experimental Chemistry Lecture 23 organic synthesis V oxidation reaction, Maruzen Co., Ltd. (p. 298 to 346). In this case, the reaction solvent is not particularly limited as long as it does not inhibit the reaction and dissolves the starting material to some extent. For example, dimethyl sulfoxide, tetrahydrofuran, toluene, methylene chloride, chloroform, ethyl acetate, water Or a mixed solvent thereof. Examples of the oxidizing agent include oxalyl chloride, trifluoroacetic anhydride, acetic anhydride, cyclohexylimide, dioxide, or the like, as an activator of dimethyl sulfoxide, with respect to the compound (a-6). It is used in double molar amount or excess amount. Although the said reaction temperature is not specifically limited, Usually, they are -70 degreeC-room temperature. Although the said reaction time is not specifically limited, Usually, it is 3 to 10 hours, Preferably it is 3 to 5 hours. On the other hand, aldehyde compounds are described in D. P. Kjell et al., "A Nobel, Non aqueous Method for Regeneration of Aldehydes from Bisulfite Adducts". J. 0rganic. Chemistry. According to the method described in 64, 5722-5724 (1999), by converting to sodium bisulfite adduct, it can be purified simply and can be easily regenerated. The sodium hydrogen sulfite adduct can be obtained by reacting the aldehyde compound with an aqueous sodium hydrogen sulfite solution, for example, in an organic solvent such as ethanol, ethyl acetate, methanol, or a mixed solvent thereof. Sodium hydrogen sulfite used at this time is used in the amount of 1 equivalent to large excess with respect to the aldehyde compound. Although the said reaction temperature is not specifically limited, Usually, it is 10-40 degreeC, Preferably it is room temperature.

상기 반응 시간은 특별히 한정되는 것은 아니지만, 통상적으로 1 내지 48시간이며, 바람직하게는 12 내지 24시간이다.Although the said reaction time is not specifically limited, Usually, it is 1 to 48 hours, Preferably it is 12 to 24 hours.

이렇게 하여 얻어지는 아황산수소나트륨 부가물을, 예를 들면, 에탄올, 아세트산 에틸, 메탄올 등의 유기 용매 또는 이들의 혼합 용매 중에서, 탄산 칼륨, 탄산 나트륨, 수산화나트륨, 수산화칼륨 등의 염기(수용액)로 처리함으로써, 알데하이드 화합물을 얻을 수 있다. 이 때, 상기 염기는, 상기 아황산수소나트륨 부가물에 대하여 1 당량 내지 대과잉량으로 사용된다. 상기 반응 온도는 특별히 한정되지는 않지만, 통상적으로 10 내지 40℃이며, 바람직하게는 실온이다.The sodium hydrogen sulfite adduct thus obtained is treated with a base (aqueous solution) such as potassium carbonate, sodium carbonate, sodium hydroxide, potassium hydroxide, or the like in an organic solvent such as ethanol, ethyl acetate, methanol, or a mixed solvent thereof. By this, an aldehyde compound can be obtained. At this time, the base is used in the amount of 1 equivalent to excess based on the sodium bisulfite adduct. Although the said reaction temperature is not specifically limited, Usually, it is 10-40 degreeC, Preferably it is room temperature.

상기 반응 시간은 특별히 한정되는 것은 아니지만, 통상적으로는 1 내지 48시간이며, 바람직하게는 12 내지 24시간이다. 상기 화합물 (a)는 정제되어, 또는 정제되지 않은 채로, 상기 화합물 (i)의 제조에 사용될 수 있다.Although the said reaction time is not specifically limited, Usually, it is 1 to 48 hours, Preferably it is 12 to 24 hours. The compound (a) can be used in the preparation of the compound (i), either purified or unpurified.

한편, 상기 공정 (1)에서 사용되는 화합물 (b)는, 예컨대, 하기 공정 (B-1) 내지 (B-6)에 의해 얻어진다.In addition, the compound (b) used at the said process (1) is obtained by the following process (B-1)-(B-6), for example.

공정 (B-1)Process (B-1)

Figure 112007086393561-PCT00056
Figure 112007086393561-PCT00056

공정 (B-1)은, 3-니트로-4-메틸벤조산과 메틸아민을 축합 반응시켜, 상기 식 (b-1)로 표시되는 화합물을 얻는 공정이다.Step (B-1) is a step of condensing 3-nitro-4-methylbenzoic acid and methylamine to obtain a compound represented by the formula (b-1).

본 반응은, 하기 문헌에 기재된 통상적으로 이용되는 조건과 같은 조건에서 수행될 수 있다. 공지된 방법을 예시하면, Rosowsky, A.; Forsch, R. A.; Moran, R. G.; Freisheim, J. H.; J. Med. Chem., 34(1), 227-234(1991), Brzostwska, M.; Brossi, A.; Flippen-Anders on, J. L.; Heterocycles, 32(10), 1969-1972(1991), Romero, D. L.; Morge, R. A.; Biles, C.; Berrios-Pena, N.; May, P. D.; Palmer, J. R.; Johnson, P. D.; Smith, H. W.; Busso, M.; Tan, C.-K.; Vorman, R. L.; Reusser, F.; ALthaus, I. W.; Downey, K. M; So, A. G.; Resnick, L.; Tarpley, W. G., Aristoff, P. A.; J. Med. Chem., 37(7), 999-1014(1994) 등을 들 수 있다.The present reaction can be carried out under the same conditions as commonly used conditions described in the literature. Illustrating known methods, Rosowsky, A .; Forsch, R. A .; Moran, R. G .; Freisheim, J. H .; J. Med. Chem., 34 (1), 227-234 (1991), Brzostwska, M .; Brossi, A .; Flippen-Anders on, J. L .; Heterocycles, 32 (10), 1969-1972 (1991), Romero, D. L .; Morge, R. A .; Biles, C .; Berrios-Pena, N .; May, P. D .; Palmer, J. R .; Johnson, P. D .; Smith, H. W .; Busso, M .; Tan, C.-K .; Vorman, R. L .; Reusser, F .; ALthaus, I. W .; Downey, K. M; So, A. G .; Resnick, L .; Tarpley, W. G., Aristoff, P. A .; J. Med. Chem., 37 (7), 999-1014 (1994), etc. are mentioned.

본 공정에 사용 가능한 축합제를 예시하면, CDI(N,N'-카르보닐디이미다졸), Bop (1H-1,2,3-벤조트리아졸-1-일옥시(트리(디메틸아미노))포스포늄 헥사플루오로포스페이트), WSC (1-에틸-3-(3-디메틸아미노프로필)카르보디이미드ㆍ염산염), DCC (N,N-디사이클로헥실카르보디이미드), 디에틸포스포릴시아나이드 등을 들 수 있다. 또한, 필요한 경우, 상기 3-니트로-4-메틸벤조산에 대하여 1 당량 내지 대과잉량으로 유기 염기, 예컨대, 트리에틸아민 등을 첨가할 수 있다. 본 공정에 사용되는 반응 용매로서는, 상기 반응을 저해하지 않고, 출발 물질을 어느 정도 용해하는 것이라면 특별히 한정되지는 않지만, 구체적으로 예시하면, 테트라하이드로퓨란, 1,4-디옥산, 아세트산 에틸, 아세트산 메틸, 디클로로메탄, 클로로포름, N,N-디메틸포름아미드, 톨루엔, 자일렌 등을 들 수 있다. 상기 반응 온도는 사용하는 원료, 용매 등에 따라 다르며, 특별히 한정되는 것은 아니지만, 빙온(氷溫) 내지 상기 용매의 환류 온도인 것이 바람직하다. 반응 시간은 특별히 한정되지는 않지만, 통상적으로는 0.5 내지 48시간이며, 바람직하게는 0.5 내지 24시간이다. 본 공정에서 얻어지는 (b-1) 화합물은 통상적인 방법에 따라 정제되어, 또는 정제되지 않은 채로, 후속 공정에 사용될 수 있다.Illustrative condensing agents usable in this process include CDI (N, N'-carbonyldiimidazole), Bop (1H-1,2,3-benzotriazol-1-yloxy (tri (dimethylamino)) Phosphonium hexafluorophosphate), WSC (1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride), DCC (N, N-dicyclohexylcarbodiimide), diethylphosphoryl cyanide Etc. can be mentioned. In addition, if necessary, an organic base such as triethylamine, etc. may be added in an amount of 1 equivalent to excessive amount based on the 3-nitro-4-methylbenzoic acid. The reaction solvent used in this step is not particularly limited as long as it does not inhibit the reaction and dissolves the starting material to some extent. Specific examples thereof include tetrahydrofuran, 1,4-dioxane, ethyl acetate, and acetic acid. Methyl, dichloromethane, chloroform, N, N-dimethylformamide, toluene, xylene, etc. are mentioned. The reaction temperature varies depending on the raw materials, solvents, and the like used, and is not particularly limited, but is preferably ice temperature to reflux temperature of the solvent. Although reaction time is not specifically limited, Usually, it is 0.5 to 48 hours, Preferably it is 0.5 to 24 hours. The compound (b-1) obtained in this step can be purified in a conventional manner or used in subsequent steps without being purified.

공정 (B-2)Process (B-2)

Figure 112007086393561-PCT00057
Figure 112007086393561-PCT00057

공정 (B-2)는, 상기 식 (b-1)로 표시되는 화합물과 디메틸포름알데하이드 디메틸아세탈을 반응시켜, 화합물 (b-2)를 얻는 공정이다.Step (B-2) is a step of obtaining compound (b-2) by reacting the compound represented by the formula (b-1) with dimethylformaldehyde dimethylacetal.

본 공정은, 당업자에게 공지된 합성법인, 예컨대, Coe, J. W.; Vetelino, M. G.; Bradlee, M. J.; Tetrahedron Lett., 37(34), 6045-6048(1996) 등에 기재된 조건과 같은 조건에서 반응을 수행할 수 있다. 본 공정에 사용되는 반응 용매로서는, 본 반응을 저해하지 않고, 출발 물질을 어느 정도 용해하는 것이라면 특별히 한정되지는 않지만, 예컨대, 메탄올, 에탄올, 테트라하이드로퓨란, N,N-디메틸포름아미드, 염화메틸렌, 1,2-디클로로에탄 등을 사용할 수 있다. 반응 온도는, 통상적으로 실온 내지 상기 용매의 환류 온도이며, 바람직하게는 실온 내지 10O℃이다. 상기 반응 시간은 특별히 한정되는 것은 아니지만, 통상적으로 1 내지 72시간이며, 바람직하게는 1 내지 48시간이다. 본 공정에서 얻어지는 (b-2) 화합물은 통상적인 방법에 따라 정제되어, 또는 정제되지 않은 채로, 후속 공정에 사용될 수 있다.This process is a synthesis method known to those skilled in the art, such as Coe, J. W .; Vetelino, M. G .; Bradlee, M. J .; The reaction can be carried out under the same conditions as described in Tetrahedron Lett., 37 (34), 6045-6048 (1996) and the like. The reaction solvent used in this step is not particularly limited as long as it does not inhibit the reaction and dissolves the starting material to some extent. For example, methanol, ethanol, tetrahydrofuran, N, N-dimethylformamide, and methylene chloride are used. , 1,2-dichloroethane and the like can be used. The reaction temperature is usually from room temperature to the reflux temperature of the solvent, preferably from room temperature to 100 캜. Although the said reaction time is not specifically limited, Usually, it is 1 to 72 hours, Preferably it is 1 to 48 hours. The compound (b-2) obtained in this step can be purified in a conventional manner or used in subsequent steps without being purified.

공정 (B-3)Process (B-3)

Figure 112007086393561-PCT00058
Figure 112007086393561-PCT00058

공정 (B-3)은, 상기 식 (b-2)로 표시되는 화합물을 아세탈화함으로써, 상기 식 (b-3)으로 표시되는 화합물을 얻는 공정이다.Step (B-3) is a step of obtaining the compound represented by the formula (b-3) by acetalizing the compound represented by the formula (b-2).

본 공정에서의 아세탈화는 당업자에게 공지된 방법에 따라 수행될 수 있지만, 예컨대, Coe, J. W.; Vetelino, M. G.; Bradlee, M. J.; Tetrahedron Lett., 37(34), 6045-6048(1996) 등에 기재된 조건과 같은 조건에서 수행될 수 있다. 상기 아세틸화 반응 온도는 통상적으로 실온 내지 용매의 환류 온도이며, 바람직하게는 실온 내지 10O℃이다. 반응 시간은 특별히 한정되지는 않지만, 통상적으로 1 내지 72시간이며, 바람직하게는 1 내지 48시간이다. 본 공정에서 얻어지는 (b-3)의 화합물은 통상적인 방법에 따라 정제되어, 또는 정제되지 않은 채로 후속 공정에 사용될 수 있다.Acetalization in this process can be performed according to methods known to those skilled in the art, but are described, for example, in Coe, J. W .; Vetelino, M. G .; Bradlee, M. J .; And the conditions described in Tetrahedron Lett., 37 (34), 6045-6048 (1996), and the like. The acetylation reaction temperature is usually from room temperature to the reflux temperature of the solvent, preferably from room temperature to 100 캜. Although reaction time is not specifically limited, Usually, it is 1 to 72 hours, Preferably it is 1 to 48 hours. The compound of (b-3) obtained in this step can be purified according to a conventional method or used in subsequent steps without purification.

공정 (B-4)Process (B-4)

Figure 112007086393561-PCT00059
Figure 112007086393561-PCT00059

공정 (B-4)는, 상기 식 (b-3)으로 표시되는 화합물을 환원하여, 상기 식 (b-4)로 표시되는 화합물을 얻는 공정이다.Step (B-4) is a step of reducing the compound represented by the formula (b-3) to obtain a compound represented by the formula (b-4).

본 공정에서의 환원 반응은 공지된 방법에 따라 수행될 수 있으며, 예컨대, Raney 니켈, 팔라듐, 루테늄, 로듐 또는 백금 등의 귀금속 촉매를 사용하는 접촉 수소화에 의한 환원 반응을 들 수 있다. 이 경우에 바람직한 것은, 예를 들면, 팔라듐 또는 수산화 팔라듐 등을 사용하는 방법을 들 수 있다. 다른 예로서, 염화암모늄을 사용하는 중성 조건에서의 철에 의한 환원 반응 등을 들 수 있다. 본 공정에 사용되는 용매로서는, 상기 반응을 저해하지 않고, 출발 물질을 어느 정도 용해하는 것이라면 특별히 한정되지는 않지만, 예컨대, 메탄올, 에탄올, 테트라하이드로퓨란, N,N-디메틸포름아미드, 염화메틸렌, 1,2-디클로로에탄 등을 사용할 수 있다. 본 공정에서의 반응 조건은 특별히 한정되지는 않지만, 실온 내지 상기 용매의 환류 온도, 및 상압 내지 15 ㎫의 조건에서 수행되며, 바람직하게는 실온 내지 60℃, 및 상압 내지 0.5 ㎫의 조건에서 수행된다. 상기 반응 시간은 특별히 한정되지 않지만, 통상적으로는 1 내지 48시간이며, 바람직하게는 1 내지 24시간이다. 본 공정에서 얻어지는 (b-4)의 화합물은 통상적인 방법에 따라 정제되어, 또는 정제되지 않은 채로 후속 공정에 사용될 수 있다.The reduction reaction in this process can be carried out according to a known method, for example, a reduction reaction by catalytic hydrogenation using a noble metal catalyst such as Raney nickel, palladium, ruthenium, rhodium or platinum. Preferable examples in this case include a method of using palladium, palladium hydroxide or the like. As another example, the reduction reaction with iron in neutral conditions using ammonium chloride, etc. are mentioned. The solvent used in this step is not particularly limited as long as it does not inhibit the above reaction and dissolves the starting material to some extent, but is not particularly limited. For example, methanol, ethanol, tetrahydrofuran, N, N-dimethylformamide, methylene chloride, 1,2-dichloroethane and the like can be used. Although the reaction conditions in this process are not specifically limited, It is performed in the conditions of room temperature to the reflux temperature of the said solvent, and normal pressure-15 Mpa, Preferably it is performed in the conditions of room temperature-60 degreeC, and normal pressure-0.5 Mpa. . Although the said reaction time is not specifically limited, Usually, it is 1 to 48 hours, Preferably it is 1 to 24 hours. The compound of (b-4) obtained in this step can be purified according to a conventional method or used in subsequent steps without being purified.

공정 (B-5)Process (B-5)

Figure 112007086393561-PCT00060
Figure 112007086393561-PCT00060

(상기 식에서, Y는 2급 아민의 보호기를 나타냄).(Wherein Y represents a protecting group of a secondary amine).

공정 (B-5)는, 상기 식 (b-4)로 표시되는 화합물과 상기 식 (b-4')로 표시되는 화합물을 환원적 아미노화 반응시킨 다음, 개환 반응을 수행함으로써, 상기 식 (b-5)로 표시되는 화합물을 얻는 공정이다.Step (B-5) is performed by reductive amination reaction between the compound represented by the formula (b-4) and the compound represented by the formula (b-4 '), followed by a ring-opening reaction, whereby It is a process of obtaining the compound represented by b-5).

Y로 표시되는 2급 아민의 보호기를 예시하면, 공지된 보호기를 들 수 있으며, 구체적으로 예시하면, 벤질옥시카르보닐기, tert-부틸옥시카르보닐기 등을 들 수 있다. 본 공정에서의 환원적 아미노화 반응은 통상적으로 이용되는 조건과 같은 조건에서 수행될 수 있으며, 이러한 환원적 아미노화 반응을 예시하면, 보란, 수소화붕소 착체 화합물 등의 환원제에 의한 환원적 아미노화 반응, 금속 촉매를 사용한 수소 분위기 하에서의 접촉 환원 반응 등을 들 수 있다. 상기 수소화붕소 착체 화합물을 사용한 환원적 아미노화 반응을 예시하면, W. S. Emerson, Organic Reactions, 4, 174(1948), C. F. Lane, Syntheisis, 127(1974), A. F. Abdel-Magid, K. G. Carson, B. D. Harris, C. A. Maryanoff and R. D. Shah, Journal of Organic Chemistry, 61, 3849(1996) 등의 문헌에 기재된 방법을 들 수 있다.As a protecting group of the secondary amine represented by Y, a well-known protecting group is mentioned, Specifically, a benzyloxycarbonyl group, tert- butyloxy carbonyl group, etc. are mentioned. The reductive amination reaction in the present process can be carried out under the same conditions as are commonly used, exemplifying such a reduction amination reaction, reductive amination reaction by a reducing agent such as borane, boron hydride complex compound, etc. And a catalytic reduction reaction in a hydrogen atmosphere using a metal catalyst. Examples of reductive amination reactions using the boron hydride complex compounds include WS Emerson, Organic Reactions, 4, 174 (1948), CF Lane, Syntheisis, 127 (1974), AF Abdel-Magid, KG Carson, BD Harris, The method described in the literature of CA Maryanoff and RD Shah, Journal of Organic Chemistry, 61, 3849 (1996) etc. is mentioned.

상기 수소화붕소 착체 화합물을 예시하면, 수소화붕소나트륨, 시안화수소화붕소나트륨, 트리아세톡시수소화붕소나트륨 등을 들 수 있다. 환원제로서 상기 수소화붕소 착체 화합물을 이용하는 경우, 사용되는 용매로서는, 상기 반응을 저해하지 않고, 출발 물질을 어느 정도 용해하는 것이라면 특별히 한정되지는 않지만, 예컨대, 메탄올, 에탄올, 테트라하이드로퓨란, N,N-디메틸포름아미드, 염화메틸렌, 1,2-디클로로에탄 등을 이용할 수 있다. 본 반응을 산의 공존 하에 수행함으로써, 수율 향상 등과 같은, 보다 바람직한 결과를 얻을 수 있다. 본 반응에 사용되는 산으로서는 특별히 한정되지는 않지만, 바람직한 것을 예시하면, 염산 등의 광산(mineral acid), 아세트산 등의 유기산, 예컨대, 염화아연, 삼불화붕소디에틸에테르 착체, 티타늄(IV) 테트라이소프로폭사이드 등의 루이스 산 등을 들 수 있다. 또한, 상기 산을 용매로서도 이용할 수 있다.Examples of the boron hydride complex compound include sodium borohydride, sodium borohydride cyanide, sodium triacetoxy borohydride and the like. When the boron hydride complex compound is used as the reducing agent, the solvent used is not particularly limited as long as it does not inhibit the reaction and dissolves the starting material to some extent. For example, methanol, ethanol, tetrahydrofuran, N, N -Dimethylformamide, methylene chloride, 1,2-dichloroethane and the like can be used. By carrying out this reaction in the presence of an acid, more preferable results, such as a yield improvement, can be obtained. The acid used in the reaction is not particularly limited, but examples thereof include mineral acids such as hydrochloric acid and organic acids such as acetic acid, such as zinc chloride and boron trifluoride diethyl ether complex, and titanium (IV) tetra. Lewis acids, such as isopropoxide, etc. are mentioned. The acid can also be used as a solvent.

상기 화합물 (b-4')는, 상기 화합물 (b-4)에 대하여 0.8 내지 2.5 당량, 바람직하게는 1 내지 1.5 당량의 양으로 사용된다. 상기 수소화붕소 착체 화합물은, 상기 화합물 (b-4)에 대하여 1 내지 3 당량, 바람직하게는 1 내지 1.5 당량의 양으로 사용된다. 상기 반응 온도는 사용되는 원료, 용매 등에 따라 다르며, 특별히 한정되지는 않지만, 통상적으로 -78℃ 내지 상기 용매의 환류 온도이며, 바람직하게는 빙온 내지 실온이다. 상기 반응 시간은 특별히 한정되지는 않지만, 통상적으로 0.5 내지 48시간이며, 바람직하게는 0.5 내지 12시간이다.The compound (b-4 ') is used in an amount of 0.8 to 2.5 equivalents, preferably 1 to 1.5 equivalents based on the compound (b-4). The boron hydride complex compound is used in an amount of 1 to 3 equivalents, preferably 1 to 1.5 equivalents based on the compound (b-4). The reaction temperature varies depending on the raw materials, solvents, and the like used, and is not particularly limited, but is usually -78 ° C to reflux temperature of the solvent, preferably ice temperature to room temperature. Although the said reaction time is not specifically limited, Usually, it is 0.5 to 48 hours, Preferably it is 0.5 to 12 hours.

수소 분위기 하에서의 접촉 환원 반응을 이용할 때에 사용되는 용매로서는 상기 반응을 저해하지 않는 것이라면, 특별히 한정되지는 않지만, 예컨대, 메탄올, 에탄올, 테트라하이드로퓨란, 1,4-디옥산 등을 들 수 있다. 본 반응에 사용되는 금속 촉매를 예시하면, 팔라듐, 산화 백금, Raney 니켈 등을 들 수 있다. 상기 반응 조건은 특별히 한정되지는 않지만, 실온 내지 상기 용매의 환류 온도, 및 상압 내지 15 ㎫의 조건에서 수행될 수 있고, 바람직하게는 실온 내지 60℃의 온도, 및 상압 내지 0.5 ㎫의 조건에서 수행된다. 상기 반응 시간은 특별히 한정되지는 않지만, 통상적으로 1 내지 48시간이며, 바람직하게는 1 내지 24시간이다.The solvent used when using the catalytic reduction reaction under hydrogen atmosphere is not particularly limited as long as it does not inhibit the reaction. Examples thereof include methanol, ethanol, tetrahydrofuran, 1,4-dioxane and the like. Palladium, platinum oxide, Raney nickel, etc. are mentioned as a metal catalyst used for this reaction. The reaction conditions are not particularly limited, but may be carried out at room temperature to the reflux temperature of the solvent, and conditions of normal pressure to 15 MPa, preferably at a temperature of room temperature to 60 ° C., and normal pressure to 0.5 MPa. do. Although the said reaction time is not specifically limited, Usually, it is 1 to 48 hours, Preferably it is 1 to 24 hours.

본 공정에서의 개환 반응은, 예컨대, Coe, J. W.; Vetelino, M. G.; Bradlee, M. J.; Tetrahedron Lett., 37(34), 6045-6048(1996), Arai, E.; Tokuyama, H.; Linsell, M. S.; Fukuyama, T.; Tetrahedron Lett., 39(1), 71-74(1998), Tishler, A. N, Lanza, T. J.; Tetrahedron Lett., 27(15), 1653(1986), Sakamoto Takao, Kondo Yoshinori, Yamanaka Hiroshi, Chem. Pharm. Bull., Vol. 14, 2362(1986) 등에 기재의 조건과 같은 조건에서 수행될 수 있다.The ring-opening reaction in this step is, for example, Coe, J. W .; Vetelino, M. G .; Bradlee, M. J .; Tetrahedron Lett., 37 (34), 6045-6048 (1996), Arai, E .; Tokuyama, H .; Linsell, M. S .; Fukuyama, T .; Tetrahedron Lett., 39 (1), 71-74 (1998), Tishler, A. N, Lanza, T. J .; Tetrahedron Lett., 27 (15), 1653 (1986), Sakamoto Takao, Kondo Yoshinori, Yamanaka Hiroshi, Chem. Pharm. Bull., Vol. 14, 2362 (1986) and the like can be carried out under the same conditions.

상기 개환 반응에 사용되는 반응 용매로서는, 상기 반응을 저해하지 않고, 출발 물질을 어느 정도 용해하는 것이라면 특별히 한정되지는 않지만, 구체적으로 예시하면, 물, 또는 물과, 예컨대, 메탄올, 에탄올, 테트라하이드로퓨란, 1,4-디옥산, 벤젠, 톨루엔 등의 유기 용매 중에서, 적당한 산을 1 당량 내지 대과잉량으로 사용할 수 있다. 상기 반응에 사용되는 산을 예시하면, 아세트산, 염화수소, 염산, 브롬화수소산, 황산, 아세트산, 트리플루오로아세트산, p-톨루엔설폰산, p-톨루엔설폰산ㆍ피리디늄염, 캠퍼설폰산(camphorsulfonic acid) 등을 들 수 있다. 상기 반응 시간은 특별히 한정되지는 않지만, 통상으로는 1 내지 24시간이며, 바람직하게는 1 내지 24시간이다. 본 공정에서 얻어지는 (b-5)의 화합물은 통상적인 방법에 따라 정제되어, 또는 정제되지 않은 채로 후속 공정에 사용될 수 있다.The reaction solvent used for the ring-opening reaction is not particularly limited as long as it does not inhibit the reaction and dissolves the starting material to some extent. Specific examples thereof include water or water and methanol, ethanol and tetrahydro. In organic solvents, such as furan, 1, 4- dioxane, benzene, toluene, a suitable acid can be used in 1 equivalent-excess. Examples of the acid used in the reaction include acetic acid, hydrogen chloride, hydrochloric acid, hydrobromic acid, sulfuric acid, acetic acid, trifluoroacetic acid, p-toluenesulfonic acid, p-toluenesulfonic acid pyridinium salt, camphorsulfonic acid ), And the like. Although the said reaction time is not specifically limited, Usually, it is 1 to 24 hours, Preferably it is 1 to 24 hours. The compound of (b-5) obtained in this step can be purified according to a conventional method or used in subsequent steps without purification.

공정 (B-6)Process (B-6)

Figure 112007086393561-PCT00061
Figure 112007086393561-PCT00061

(상기 식에서, Y는 위에서와 동일하게 정의됨).(Wherein Y is defined the same as above).

공정 (B-6)은, 상기 식 (b-5)로 표시되는 화합물의 2급 아민의 보호기를 탈보호하여, 상기 식 (b)로 표시되는 화합물을 얻는 공정이다.Step (B-6) is a step of deprotecting the protecting group of the secondary amine of the compound represented by the formula (b-5) to obtain the compound represented by the formula (b).

본 공정의 반응은, 아미노 화합물의 보호기를 탈리하는 데 일반적으로 이용되는 조건, 예를 들면, 문헌 T. W. Greene, P. G. M. Wuts, "Protective Groups in Organic Chemistry, Second Edition", John Wiley & Sons (1991), 304∼405에 기재된 조건과 같은 조건에서 수행될 수 있다. 예를 들면, Y가 벤질옥시카르보닐기로 보호되어 있는 경우에는, 예컨대, 알코올, 테트라하이드로퓨란 등의 용매 중에서, 팔라듐-탄소를 촉매로 사용해서 수소 첨가함으로써 탈보호하여, 화합물 (b)를 얻을 수 있다.The reaction of this process is carried out under conditions that are generally used to desorb the protecting groups of amino compounds, for example, TW Greene, PGM Wuts, "Protective Groups in Organic Chemistry, Second Edition", John Wiley & Sons (1991), It may be carried out under the same conditions as those described in 304 to 405. For example, when Y is protected by a benzyloxycarbonyl group, for example, compound (b) can be obtained by deprotection by hydrogenation using palladium-carbon as a catalyst in a solvent such as alcohol or tetrahydrofuran. have.

본 공정에서 얻어지는 (b) 화합물은 통상적인 방법에 따라 정제되어, 또는 정제되지 않은 채로 후속 공정에 사용될 수 있다.The compound (b) obtained in this step can be purified according to a conventional method or used in a subsequent step without purification.

상기 화합물 (b)는 전술한 제조 방법 외에도, 하기 공정 (B'-1) 내지 공정 (B'-6), 및 상기 공정 (B-6)에 의해서도 얻을 수 있다.The said compound (b) can be obtained also by the following process (B'-1)-a process (B'-6), and the said process (B-6) besides the manufacturing method mentioned above.

Figure 112007086393561-PCT00062
Figure 112007086393561-PCT00062

Figure 112007086393561-PCT00063
Figure 112007086393561-PCT00063

Figure 112007086393561-PCT00064
Figure 112007086393561-PCT00064

공정 (B'-1)Process (B'-1)

공정 (B'-1)은, 3-니트로-4-메틸벤조산과 디메틸포름알데하이드 디메틸아세탈을 반응시켜, 화합물 (b'-1)을 얻는 공정이다. 본 공정은 상기 공정 (B-2)와 같은 조건에서 수행될 수 있다.Step (B'-1) is a step of obtaining compound (b'-1) by reacting 3-nitro-4-methylbenzoic acid with dimethylformaldehyde dimethylacetal. This step can be carried out under the same conditions as the above step (B-2).

공정 (B'-2)Process (B'-2)

공정 (B'-2)는, 화합물 (b'-1)을 아세탈화하여, 화합물 (b'-2)를 얻는 공정이다. 본 공정은 상기 공정 (B-3)과 같은 조건에서 수행될 수 있다.Step (B'-2) is a step of acetalizing compound (b'-1) to obtain compound (b'-2). This step can be carried out under the same conditions as the above step (B-3).

공정 (B'-3)Process (B'-3)

공정 (B'-3)은, 화합물 (b'-2)를 환원하여, 화합물 (b'-3)을 얻는 공정이다. 본 공정은 상기 공정 (B-4)와 같은 조건에서 수행될 수 있다.Step (B'-3) is a step of obtaining compound (b'-3) by reducing compound (b'-2). This step can be carried out under the same conditions as the above step (B-4).

공정 (B'-4)Process (B'-4)

공정 (B'-4)는, 화합물 (b'-3)과 화합물 (b-4')를 반응시켜, 화합물 (b'-4)를 얻는 공정이다. 본 공정은 상기 공정 (B-5)와 같은 조건에서 수행될 수 있다.Step (B'-4) is a step of obtaining compound (b'-4) by reacting compound (b'-3) with compound (b-4 '). The present step can be carried out under the same conditions as the above step (B-5).

공정 (B'-5)Process (B'-5)

공정 (B'-5)는, 화합물 (b'-4)를 가수분해하여, 화합물 (b'-5)을 얻는 공정이다.Step (B'-5) is a step of obtaining compound (b'-5) by hydrolyzing compound (b'-4).

본 공정은, 예를 들면, Mattasa. V. G.; Brown, F. J.; Bernstein, P. R.; Shapiro, H. S.; Maduskuie, T. P. J.; Cronk, L. A.; Vacek, E. P.; Yee, Y. K.; Snyder, D. W.; Krell, R. D.; Lerman, C. L.; Maloney, J. J.; J. Med. Chem., 33(9), 2621-2629(1990)에 기재된 반응 조건과 같은 조건에서 반응을 수행할 수 있다. 구체적으로 예를 들면, 화합물 (b'-4)의 용액에, 예컨대, 수산화나트륨 등의 염기(수용액)를 첨가하고, 몇 시간 내지 1일간 교반한 후, 예컨대, 타르타르산 용액 등의 산으로 처리하여, 화합물 (b'-5)를 얻을 수 있다. 본 공정에 사용되는 반응 용매로서는, 상기 반응을 저해하지 않고, 출발 물질을 어느 정도 용해하는 것이라면 특별히 한정되지는 않지만, 예컨대, 메탄올, 에탄올, 2-프로판올, 테트라하이드로퓨란, 1,4-디옥산, 물 등을 들 수 있다. 본 공정에 사용되는 염기로서는 특별히 한정되지는 않지만, 예컨대, 수산화나트륨, 수산화칼륨, 수산화리튬 등을 사용하는 것이 바람직하다. 상기 염기의 사용량은, 상기 화합물 (b'-4)에 대하여 1 당량 내지 대과잉량이며, 바람직하게는 1 내지 20 당량이다. 본 공정에서의 반응 시간은 특별히 한정되지는 않지만, 통상적으로는 1 내지 24시간이며, 바람직하게는 1 내지 6시간이다. 반응 온도는, 사용하는 원료, 용매 등에 의해 다르며, 특별히 한정되지는 않지만, 통상적으로 -78℃ 내지 상기 용매의 환류 온도이며, 바람직하게는 빙온 내지 실온이다.This process is, for example, Mattasa. V. G .; Brown, F. J .; Bernstein, P. R .; Shapiro, H. S .; Maduskuie, T. P. J .; Cronk, L. A .; Vacek, E. P .; Yee, Y. K .; Snyder, D. W .; Krell, R. D .; Lerman, C. L .; Maloney, J. J .; J. Med. The reaction can be carried out under the same conditions as described in Chem., 33 (9), 2621-2629 (1990). Specifically, for example, a base (aqueous solution) such as sodium hydroxide is added to a solution of the compound (b'-4), stirred for several hours to 1 day, and then treated with an acid such as, for example, a tartaric acid solution. And compound (b'-5) can be obtained. The reaction solvent used in this step is not particularly limited as long as it does not inhibit the above reaction and dissolves the starting material to some extent. For example, methanol, ethanol, 2-propanol, tetrahydrofuran, 1,4-dioxane , Water and the like. Although it does not specifically limit as a base used for this process, For example, it is preferable to use sodium hydroxide, potassium hydroxide, lithium hydroxide, etc. The usage-amount of the said base is 1 equivalent-excess quantity with respect to the said compound (b'-4), Preferably it is 1-20 equivalent. Although the reaction time in this process is not specifically limited, Usually, it is 1 to 24 hours, Preferably it is 1 to 6 hours. The reaction temperature varies depending on the raw materials to be used, the solvent, and the like, and is not particularly limited, but is usually -78 ° C to the reflux temperature of the solvent, preferably ice temperature to room temperature.

본 공정에서 얻어지는 (b'-5)의 화합물은 통상적인 방법에 의해 정제되거나, 또는 정제되지 않은 채로 후속 공정에 사용될 수 있다.The compound of (b'-5) obtained in this step may be purified by a conventional method or used in a subsequent step without purification.

공정 (B'-6)Process (B'-6)

공정(B'-6)은, 화합물 (b'-5)와 메틸아민을 축합 반응시켜, 화합물 (b-5)를 얻는 공정이다. 본 공정은 상기 공정 (B-1)과 같은 조건에서 수행될 수 있다.Step (B'-6) is a step of obtaining a compound (b-5) by condensing the compound (b'-5) and methylamine. This step can be carried out under the same conditions as in step (B-1).

한편, 상기 화합물 (i)은 하기 공정 (C-1) 내지 (C-4)에 의해서도 얻을 수 있다.In addition, the said compound (i) can also be obtained by following process (C-1)-(C-4).

Figure 112007086393561-PCT00065
Figure 112007086393561-PCT00065

Figure 112007086393561-PCT00066
Figure 112007086393561-PCT00066

공정 (C-1)Process (C-1)

공정 (C-1)은, 상기 식 (b'-4)로 표시되는 화합물[식 (b'-4)에서, Y는 2급 민의 보호기를 나타냄]의 2급 아민의 보호기를 탈보호하여, 상기 식 (c-1)로 표시되는 화합물 또는 그의 염을 얻는 공정이다. 상기 화합물의 염은, 공지된 약리학적으로 허용 가능한 염이며, 바람직하게는 염산염이다.Step (C-1) is to deprotect the protecting group of the secondary amine of the compound represented by the formula (b'-4), wherein in the formula (b'-4), Y represents a protecting group of secondary min. It is a process of obtaining the compound or its salt represented by said formula (c-1). Salts of the compounds are known pharmacologically acceptable salts, preferably hydrochloride salts.

본 공정은 상기 공정 (B-6)과 같은 조건에서 수행될 수 있다.The present step can be carried out under the same conditions as the above step (B-6).

공정 (C-2)Process (C-2)

공정 (C-2)는, 상기 식 (c-1)로 표시되는 화합물과 상기 식 (a)로 표시되는 화합물을 커플링하여, 상기 식 (c-2)로 표시되는 화합물을 얻는 공정이다.Step (C-2) is a step of coupling the compound represented by the formula (c-1) and the compound represented by the formula (a) to obtain a compound represented by the formula (c-2).

본 공정은 상기 공정 (1)과 같은 조건에서 수행될 수 있다.This step can be carried out under the same conditions as in step (1).

공정 (C-3)Process (C-3)

공정 (C-3)은, 상기 식 (c-2)로 표시되는 화합물을 가수분해하여, 상기 식 (c-3)으로 표시되는 화합물을 얻는 공정이다.Step (C-3) is a step of obtaining a compound represented by the formula (c-3) by hydrolyzing the compound represented by the formula (c-2).

본 공정은 상기 공정 (B'-5)와 같은 조건에서 수행될 수 있다.This process can be carried out under the same conditions as the above process (B'-5).

공정 (C-4)Process (C-4)

공정 (C-4)는, 상기 식 (c-3)으로 표시되는 화합물과 메틸아민을 축합시켜, 상기 식 (i)로 표시되는 화합물을 얻는 공정이다.Step (C-4) is a step of condensing the compound represented by the formula (c-3) and methylamine to obtain a compound represented by the formula (i).

본 공정은 상기 공정 (B-1)과 같은 조건에서 수행될 수 있다.This step can be carried out under the same conditions as in step (B-1).

이하, 실시예를 들어, 본 발명에 대해 구체적으로 설명하지만, 본 발명이 하기 실시예로 제한되는 것은 아니다. 본 명세서에서, 「실온」이란, 20 내지 30℃의 범위의 온도, 바람직하게는 25℃를 의미한다.Hereinafter, although an Example is given and this invention is demonstrated concretely, this invention is not limited to a following example. In this specification, "room temperature" means the temperature of the range of 20-30 degreeC, Preferably 25 degreeC.

(제조예 1)(Manufacture example 1)

4-(2-디메틸아미노)비닐-3-니트로벤조산 메틸의 합성Synthesis of 4- (2-dimethylamino) vinyl-3-nitrobenzoate methyl

Figure 112007086393561-PCT00067
Figure 112007086393561-PCT00067

질소 분위기 하에, 10 L 용량의 4구 플라스크에 4-메틸-3-니트로벤조산 570.0 g (3.15 몰) 및 디메틸포름아미드(이하, 「DMF」라고 칭함) 3420 mL를 첨가하고, 교반하였다. 그런 다음, 상기 반응액에 N,N-디메틸포름아미드 디메틸아세탈 1334 mL(1197 g, 9.44 몰)을 3회로 나누어서 첨가하였다. 얻어진 반응액을 실온에 서 약 1시간 동안 교반한 후, 상기 반응 용기를 유욕(oil bath)(83℃)에서 가열하였다. 약 15시간 후, HPLC에 의해 반응의 진행을 확인한 다음, 가열을 중단하고, 상기 용기를 빙수욕(ice-water bath)에서 내온(內溫) 28℃까지 냉각하였다.Under a nitrogen atmosphere, 570.0 g (3.15 mol) of 4-methyl-3-nitrobenzoic acid and 3420 mL of dimethylformamide (hereinafter referred to as "DMF") were added to a 10 L four-neck flask and stirred. Then, 1334 mL (1197 g, 9.44 mol) of N, N-dimethylformamide dimethylacetal was added to the reaction mixture in three portions. The reaction solution was stirred at room temperature for about 1 hour, and then the reaction vessel was heated in an oil bath (83 ° C.). After about 15 hours, the progress of the reaction was confirmed by HPLC, and then heating was stopped, and the vessel was cooled to an internal temperature of 28 ° C. in an ice-water bath.

15 L 용량의 4구 플라스크에 물 9120 mL를 투입한 다음, 상기 플라스크를 빙욕 상에서 냉각 및 교반하여, 냉수를 준비하였다. 이 냉수에 상기 반응액을 6분간 주입하였다. 남겨진 반응액을 DMF 100 mL로 세정하여 제거한 다음, 빙수욕을 제거하고, 실온에서 76분간 교반하였다. 석출된 고체를 여과에 의해 수집하고, 남겨진 고체는 물 1.5 L로 세정하여 제거한 다음, 다시 물 1.5 L로 고체를 세정하였다. 이렇게 하여 얻어진 조결정(rough crystal)을 20 L 용량의 스테인리스 용기에 투입한 후, 메탄올 6840 mL를 첨가하고, 얻어진 반응액을 기계적 교반기로 실온에서 65분간 교반하였다. 여과에 의해 결정을 수집한 다음, 메탄올 1140 mL로 세정하였다. 세정된 결정을 40℃에서 감압 건조하여, 적색 고체로서 표기 화합물 668.7 g을 얻었다.9120 mL of water was added to a 15 L four-necked flask, and the flask was cooled and stirred on an ice bath to prepare cold water. The reaction solution was poured into the cold water for 6 minutes. The remaining reaction solution was washed with 100 mL of DMF, then removed, and the ice water bath was removed and stirred at room temperature for 76 minutes. The precipitated solid was collected by filtration, and the remaining solid was removed by washing with 1.5 L of water, and then the solid was washed with 1.5 L of water again. The crude crystal thus obtained was introduced into a 20 L stainless steel vessel, 6840 mL of methanol was added, and the reaction solution was stirred at room temperature for 65 minutes with a mechanical stirrer. The crystals were collected by filtration and then washed with 1140 mL of methanol. The washed crystals were dried at 40 ° C. under reduced pressure to obtain 668.7 g of the title compound as a red solid.

수율: 84.9%Yield 84.9%

1H-NMR(400MHz, CDCl3)δ(ppm): 2.99(s, 6H), 3.90(s, 3H), 5.92(d, J=13.3Hz, 1H), 7.16(d, J=13.3Hz, 1H), 7.47(d, J=8.6Hz, 1H), 7.90(dd, J=8.6, 1.8Hz, 1H), 8.49(d, J=1.8Hz, 1H). 1 H-NMR (400 MHz, CDCl 3 ) δ (ppm): 2.99 (s, 6H), 3.90 (s, 3H), 5.92 (d, J = 13.3 Hz, 1H), 7.16 (d, J = 13.3 Hz, 1H), 7.47 (d, J = 8.6 Hz, 1H), 7.90 (dd, J = 8.6, 1.8 Hz, 1H), 8.49 (d, J = 1.8 Hz, 1H).

(제조예 2)(Manufacture example 2)

4-(2,2-디메톡시에틸)-3-니트로벤조산 메틸의 합성Synthesis of 4- (2,2-dimethoxyethyl) -3-nitrobenzoate methyl

Figure 112007086393561-PCT00068
Figure 112007086393561-PCT00068

질소 분위기 하에, 10 L 용량의 4구 플라스크에 4-(2-디메틸아미노)비닐-3-니트로벤조산 메틸 522 g (2.09 몰)을 투입한 다음, 메탄올 350O mL를 첨가하였다. 그런 다음, 얻어진 용액에, 실온에서 황산/메탄올 혼합액(농축 황산: 266 g, 메탄올: 676 mL)을 13분간 첨가하였다. 상기 반응 용기를 55℃의 유욕에서 가열하고, 내온이 40℃를 초과한 후에는 상기 반응액을 가열 및 교반한 다음, 상기 반응 용기를 빙욕에서 냉각시켰다. 상기 반응액에 트리에틸아민 193.5 mL를 투입한 후, 얻어진 용액을 감압 농축하고, 농축 잔사에 톨루엔 600O mL 및 물 2620 mL를 첨가하였다. 상기 반응액을 부흐너 깔때기가 구비된 Hyflo Super-Cel에 통과시켜 여과한 다음, 상기 부흐너 깔때기를 톨루엔 525 mL로 세정하여, 불용물을 제거하였다. 그 여액(filtrate)을 20 L 용량의 분액 장치에 옮겨 담은 후, 수층을 분액하여 폐기하였다. 유기층은 물 1305 mL로 세정한 후, 감압 농축(욕조 온도 40℃)하여, 표기 화합물을 함유하는 갈색 오일상 물질 625.7 g을 얻었다.Under a nitrogen atmosphere, 522 g (2.09 mol) of methyl 4- (2-dimethylamino) vinyl-3-nitrobenzoate were added to a 10 L four-necked flask, followed by addition of 350O mL of methanol. Then, sulfuric acid / methanol mixture (concentrated sulfuric acid: 266 g, methanol: 676 mL) was added to the obtained solution at room temperature for 13 minutes. The reaction vessel was heated in a 55 ° C oil bath, and after the internal temperature exceeded 40 ° C, the reaction solution was heated and stirred, and then the reaction vessel was cooled in an ice bath. After 193.5 mL of triethylamine was added to the reaction solution, the obtained solution was concentrated under reduced pressure, and 600O mL of toluene and 2620 mL of water were added to the concentrated residue. The reaction solution was filtered by passing through a Hyflo Super-Cel equipped with a Buchner funnel, and then the Buchner funnel was washed with 525 mL of toluene to remove insoluble matters. The filtrate was transferred to a 20 L separator and the aqueous layer was separated and discarded. The organic layer was washed with 1305 mL of water, and then concentrated under reduced pressure (bath temperature of 40 ° C) to give 625.7 g of a brown oily substance containing the title compound.

1H-NMR(CDCl3)δ(ppm): 3.28(d, J=5.3Hz, 2H), 3.45(s, 6H), 3.96(s, 3H), 4.57(t, J=5.3Hz, 1H), 7.51(d, J=8.1Hz, 1H), 8.16(dd, J=8.1, 1.8Hz, 1H), 8.53(d, J=1.8Hz, 1H). 1 H-NMR (CDCl 3 ) δ (ppm): 3.28 (d, J = 5.3 Hz, 2H), 3.45 (s, 6H), 3.96 (s, 3H), 4.57 (t, J = 5.3 Hz, 1H) , 7.51 (d, J = 8.1 Hz, 1H), 8.16 (dd, J = 8.1, 1.8 Hz, 1H), 8.53 (d, J = 1.8 Hz, 1H).

(( 제조예Production Example 3) 3)

3-아미노-4-(2,2-3-amino-4- (2,2- 디메톡시에틸Dimethoxyethyl )벤조산 Benzoic acid 메틸의Methyl 합성 synthesis

Figure 112007086393561-PCT00069
Figure 112007086393561-PCT00069

7 L 용량의 오토클레이브(autoclave) 내에, 4-(2,2-디메톡시에틸)-3-니트로벤조산 메틸(이전 공정의 수율을 100%라고 가정한 경우의 함량: 562 g, 2.09 몰)을 메탄올 300O mL로 세정하여 넣었다. 이 용액에 팔라듐-탄소 56.2 g (10% (50% 함수(含水))를 첨가한 다음, 메탄올 2055 mL를 더 추가하였다. 상기 반응기의 재킷을 통해 냉수를 순환시키고, 수소 압력을 0.1∼0.3 ㎫로 제어하면서(내온 14∼23℃) 반응을 개시하여, 상기 반응액을 2.5시간 동안 교반하였다. 그런 다음, 상기 반응액을 반응기로부터 뽑아내어, 메탄올 320 mL로 씻어냈다. Hyflo Super-Cel로 상기 촉매를 여과하여 제거한 다음, 상기 촉매를 메탄올 1080 mL로 세정하였다. 그 여액을 농축한 결과(욕조 온도 40℃), 결정화된 표기 화합물이 석출되었다. 이 결정에 1,2-디메톡시에탄(이하, 「DME」라고 칭함) 265 mL를 첨가하고, 40℃로 가열하여 용해한 다음, 다시 농축하여, 표기 화합물을 함유하는 갈색 오일상 물질을 얻었다.In a 7 L autoclave, 4- (2,2-dimethoxyethyl) -3-nitrobenzoate (assuming 100% yield of the previous process: 562 g, 2.09 mol) Washed with 300OmL of methanol. To this solution was added 56.2 g (10% (50% hydrous)) of palladium-carbon, followed by the addition of 2055 mL of methanol. The cold water was circulated through the jacket of the reactor and the hydrogen pressure was 0.1-0.3 MPa. The reaction was initiated under controlled control (at 14 to 23 ° C. internal temperature), and the reaction solution was stirred for 2.5 hours, after which the reaction solution was removed from the reactor and washed with 320 mL of methanol. The catalyst was filtered off, and the catalyst was washed with 1080 mL of methanol, and the filtrate was concentrated (bath temperature 40 ° C.) to precipitate the crystallized title compound. 265 mL) was added, heated to 40 ° C. to dissolve, and then concentrated to obtain a brown oily substance containing the title compound.

수득량: 572.4 gYield: 572.4 g

1H-NMR(CDCl3)δ(ppm): 2.91(d, J=5.3Hz, 2H), 3.38(s, 6H), 3.88(s, 3H), 4.17(br, 2H), 4.50(t, J=5.3Hz, 1H), 7.11(d, J=7.6Hz, 1H), 7.3-7.45(m, 2H). 1 H-NMR (CDCl 3 ) δ (ppm): 2.91 (d, J = 5.3 Hz, 2H), 3.38 (s, 6H), 3.88 (s, 3H), 4.17 (br, 2H), 4.50 (t, J = 5.3 Hz, 1H), 7.11 (d, J = 7.6 Hz, 1H), 7.3-7.45 (m, 2H).

(( 제조예Production Example 4) 4)

1-(1-1- (1- 벤질옥시카르보닐피페리딘Benzyloxycarbonylpiperidine -4-일)-1H-인돌-6-카르복시산 -4-yl) -1H-indole-6-carboxylic acid 메틸의Methyl 합성 synthesis

Figure 112007086393561-PCT00070
Figure 112007086393561-PCT00070

질소 분위기 하에, 15 L 용량의 4구 둥근 바닥 플라스크에, 3-아미노-4-(2,2-디메톡시에틸)벤조산 메틸 475 g (1.99 몰)을 투입한 다음, 아세트산 300O mL로 세정하여 넣었다. 얻어진 용액을 교반하면서, 상기 용액에 4-옥소-1-피페리딘카르복시산 벤질 695 g (2.98 몰)을 투입한 후, 아세트산 80O mL로 세정하여 넣었다. 그런 다음, 상기 반응액을 실온에서 1시간 동안 교반한 후, 빙수욕 상에서 냉각하였다. 냉각된 반응액에 트리아세톡시수소화붕소나트륨 631.1 g (2.98 몰)을, 내온을 15℃ 이하로 유지시키면서, 8분할하여 투입한 다음,상기 빙수욕을 수욕으로 변경한 후, 상기 반응액을 약 3시간 동안 교반하였다. 교반된 반응액을 다시 빙수욕에서 냉각한 다음, 물 380O mL를 투입하였다. 미리 100℃로 가열해 둔 유욕에서 상기 반응액을 가온한 다음, 내온이 80℃에 도달한 시점으로부터 6시간 후에 가열을 중단하였다.Under a nitrogen atmosphere, 475 g (1.99 mol) of methyl 3-amino-4- (2,2-dimethoxyethyl) benzoic acid were added to a 15 L four-necked round bottom flask, followed by washing with 300 mL of acetic acid. . While stirring the solution obtained, 695 g (2.98 mol) of benzyl 4-oxo-1-piperidine carboxylic acid was added to the solution, followed by washing with 80 mL of acetic acid. Then, the reaction solution was stirred at room temperature for 1 hour and then cooled on an ice water bath. 631.1 g (2.98 mol) of sodium triacetoxy borohydride was added to the cooled reaction solution while maintaining the internal temperature at 15 ° C. or lower, and then divided into 8 portions, and the ice water bath was changed to a water bath. Stir for 3 hours. The stirred reaction solution was cooled again in an ice water bath, and then 380 mL of water was added thereto. The reaction solution was heated in an oil bath previously heated to 100 ° C., and then heating was stopped 6 hours after the internal temperature reached 80 ° C.

상기 반응액을 20 L 용량의 분액 장치에 옮겨 넣고, 톨루엔 5938 mL 및 물 2969 mL를 첨가하고, 교반한 후, 수층을 폐기하였다. 유기층을, 각각 4453 mL 및 2969 mL의 0.5N 수산화나트륨 수용액으로, 2969 mL의 5% 식염수로 2회, 그리고 물 2969 mL로 차례로 세정하였다.The reaction solution was transferred to a 20 L separator, 5938 mL of toluene and 2969 mL of water were added, stirred, and the aqueous layer was discarded. The organic layer was washed with 4453 mL and 2969 mL of 0.5N aqueous sodium hydroxide solution, twice with 2969 mL of 5% brine and then with 2969 mL of water.

유기층을 농축하여(욕조 온도 40℃), 표기 화합물을 함유하는 갈색 오일상 물질 1025.1 g을 얻었다.The organic layer was concentrated (bath temperature 40 ° C.) to give 1025.1 g of a brown oily substance containing the title compound.

이 오일상 물질 1017.1 g에 메탄올 1017 mL를 첨가하여 용해한 다음, 실온에서 표기 화합물의 종결정 80O ㎎을 투입하였다. 상기 용액을 약 17시간 동안 교반한 후, 상기 결정을 여과에 의해 수집하여, 50O mL의 메탄올로 세정하였다. 세정된 결정을 40℃에서 약 2.5시간 동안 감압 농축하여, 옅은 황색 결정으로서 표기 화합물 622.2 g 얻었다.1017 mL of methanol was added to 1017.1 g of this oily substance to dissolve it, and 80 mg of seed crystals of the title compound were added at room temperature. After the solution was stirred for about 17 hours, the crystals were collected by filtration and washed with 50OmL of methanol. The washed crystals were concentrated under reduced pressure at 40 ° C. for about 2.5 hours to give 622.2 g of the title compound as pale yellow crystals.

수율: 79.3%Yield: 79.3%

1H-NMR(CDCl3)δ(ppm): 1.80-2.05(m, 2H), 2.05-2.23(m, 2H), 2.92-3.15(m, 2H), 3.96(s, 3H), 4.30-4.60(m, 3H), 5.18(s, 2H), 6.58(dd, J=0.4, 2.8Hz, 1H), 7.30-7.45(m, 6H), 7.64(dd, J=0.4, 8.4Hz, 1H), 7.80(dd, J=1.6, 8.4Hz, 1H), 8.14(s, 1H). 1 H-NMR (CDCl 3 ) δ (ppm): 1.80-2.05 (m, 2H), 2.05-2.23 (m, 2H), 2.92-3.15 (m, 2H), 3.96 (s, 3H), 4.30-4.60 (m, 3H), 5.18 (s, 2H), 6.58 (dd, J = 0.4, 2.8 Hz, 1H), 7.30-7.45 (m, 6H), 7.64 (dd, J = 0.4, 8.4 Hz, 1H), 7.80 (dd, J = 1.6, 8.4 Hz, 1H), 8.14 (s, 1H).

(( 제조예Production Example 5) 5)

1-(1-1- (1- 벤질옥시카르보닐피페리딘Benzyloxycarbonylpiperidine -4-일)-1H-인돌-6-카르복시산의 합성Synthesis of -4-yl) -1H-indole-6-carboxylic acid

Figure 112007086393561-PCT00071
Figure 112007086393561-PCT00071

20 L 용량의 4구 둥근 바닥 플라스크에 1-(1-벤질옥시카르보닐피페리딘-4-일)-1H-인돌-6-카르복시산 메틸 617.0 g (1.57 몰), DME 2036 mL, 및 디메틸설폭사 이드 4072 mL를 차례로 투입한 다음, 얻어진 물질을 빙수욕에서 냉각시키면서 교반하였다. 내온이 10℃에 도달하면, 상기 용액에 8% 수산화나트륨 수용액 864.7 g (1.10 몰당량; 수산화나트륨 74.4 g을 수돗물 790 mL에 용해한 것)을 7분간 적하하였다. 적하 종료 후, 상기 빙수욕을 수욕(24.5℃∼22.3℃)으로 교체하여, 상기 반응액을 내온 20℃∼22℃의 범위에서 4시간 10분간 계속 교반하였다.In a 20 L four-necked round bottom flask, 617.0 g (1.57 mol) of 1- (1-benzyloxycarbonylpiperidin-4-yl) -1H-indole-6-carboxylic acid, 2036 mL of DME, and dimethyl sulfide 4072 mL of the slide side was added sequentially, and the obtained material was stirred while cooling in an ice water bath. When the internal temperature reached 10 ° C, 864.7 g (1.10 molar equivalents; 74.4 g of sodium hydroxide dissolved in 790 mL of tap water) of 8% aqueous sodium hydroxide solution was added dropwise to the solution for 7 minutes. After completion of the dropwise addition, the ice water bath was replaced with a water bath (24.5 ° C to 22.3 ° C), and the reaction solution was continuously stirred for 4 hours and 10 minutes in an internal temperature range of 20 ° C to 22 ° C.

그런 다음, 상기 반응액을 균등하게 2분할하여(3.62 L×2), 각각을 동일한 방식으로 후처리하였다. 상기 반응액 3.62 L를 빙수욕에서 냉각하고, 수돗물 2314 mL를 17분간 첨가한 후, 아세트산 에틸 1543 mL를 첨가하였다. 내온이 10℃ 이하가 되면, 상기 반응액에 2N 염산 420 mL를 첨가하여, 수층의 pH를 7로 조정하였다. 이 용액을 20 L 용량의 분액 장치에 옮겨 담은 다음, 수돗물 2314 mL 및 아세트산 에틸 1543 mL를 첨가하고, 수층을 폐기하였다.Then, the reaction solution was divided equally into two parts (3.62 L × 2), and each was worked up in the same manner. 3.62 L of the reaction solution was cooled in an ice water bath, 2314 mL of tap water was added for 17 minutes, and then 1543 mL of ethyl acetate was added. When internal temperature became 10 degrees C or less, 420 mL of 2N hydrochloric acid was added to the said reaction liquid, and the pH of the aqueous layer was adjusted to 7. The solution was transferred to a 20 L separator, and then 2314 mL of tap water and 1543 mL of ethyl acetate were added and the aqueous layer was discarded.

2분할하여 처리된 유기층을 모아서, 5% 식염수 3085 g 및 수돗물 3085 mL를 사용하여 차례로 세정하였다. 상기 유기층을 감압 농축하기 시작하자, 결정이 석출되었기 때문에, 농축을 중지하고, 테트라하이드로퓨란 200 mL를 첨가하여 용액을 형성하고, 이 용액을 HPLC에 의해 정량함으로써 수득량을 산출하였다. 상기 유기층을 감압 농축한 다음, 톨루엔 2468 mL (2회의 공비 조작에 사용된 총량)을 사용하여, 감압 하에 2회의 공비 조작을 수행하여, 황백색 고체와 액체의 혼합물 1333.6 g을 얻었다.The organic layer treated by dividing was collected, washed sequentially with 3085 g of 5% saline and 3085 mL of tap water. When the organic layer was concentrated under reduced pressure, since crystals precipitated, the concentration was stopped, 200 mL of tetrahydrofuran was added to form a solution, and the yield was calculated by quantifying the solution by HPLC. The organic layer was concentrated under reduced pressure, and then subjected to two azeotropic operations under reduced pressure using 2468 mL of toluene (total amount used for two azeotropic operations) to obtain 1333.6 g of a mixture of an off-white solid and a liquid.

표기 화합물 함유량: 566.1 g, 수율: 95.2%Marked compound content: 566.1 g, yield: 95.2%

1H-NMR(CDCCl3)δ(ppm): 1.80-2.04(m, 2H), 2.06-2.21(m, 2H), 2.94-3.16(m, 2H), 4.30-4.58(m, 3H), 5.19(s, 2H), 6.60(dd, J=0.8, 3.6Hz, 1H), 7.30-7.44(m, 6H), 7.68(dd, J=0.8, 8.4Hz, 1H), 7.88(dd, J=1.6, 8.4Hz, 1H), 8.22(s, 1H). 1 H-NMR (CDCCl 3 ) δ (ppm): 1.80-2.04 (m, 2H), 2.06-2.21 (m, 2H), 2.94-3.16 (m, 2H), 4.30-4.58 (m, 3H), 5.19 (s, 2H), 6.60 (dd, J = 0.8, 3.6 Hz, 1H), 7.30-7.44 (m, 6H), 7.68 (dd, J = 0.8, 8.4 Hz, 1H), 7.88 (dd, J = 1.6 , 8.4 Hz, 1H), 8.22 (s, 1H).

(제조예 6)(Manufacture example 6)

1-(1-벤질옥시카르보닐피페리딘-4-일)-N-메틸-1H-인돌-6-카르복사미드의 합성Synthesis of 1- (1-benzyloxycarbonylpiperidin-4-yl) -N-methyl-1H-indole-6-carboxamide

Figure 112007086393561-PCT00072
Figure 112007086393561-PCT00072

질소 기류 하에, 15 L 용량의 4구 둥근 바닥 플라스크에 1-(1-벤질옥시카르보닐피페리딘-4-일)-1H-인돌-6-카르복시산 1333.6 g (함유량: 566.1 g, 1.50 mmol) 및 테트라하이드로퓨란 5950 mL를 투입한 다음, 실온에서 교반하였다. 얻어진 용액에 N,N'-카르보닐디이미다졸(이하, 「CDI」라 칭함 ) 339.5 g을 투입하고, 약 1시간 후에 CDI 17.4 g을 추가 투입하였다. 그로부터 약 1시간 후에, 상기 반응액을 빙수욕에서 냉각하고, 내온이 10℃ 이하가 된 시점에 40% 메틸아민 수용액 407 mL를 12분간 적하한 다음, 얻어진 반응액을 동일 온도에서 약 1.5시간 교반하였다.1333.6 g of 1- (1-benzyloxycarbonylpiperidin-4-yl) -1H-indole-6-carboxylic acid (content: 566.1 g, 1.50 mmol) in a 15 L four-neck round bottom flask under nitrogen stream 5950 mL of tetrahydrofuran was added thereto, followed by stirring at room temperature. 339.5 g of N, N'-carbonyldiimidazole (hereinafter referred to as "CDI") was added to the obtained solution, and about 1 hour, 17.4 g of CDI was further added. After about 1 hour, the reaction solution was cooled in an ice water bath, 407 mL of a 40% aqueous methylamine solution was added dropwise for 12 minutes when the internal temperature became 10 ° C or lower, and the reaction solution was stirred at the same temperature for about 1.5 hours. It was.

그런 다음, 상기 반응액을 균등하게 2분할하여(유기층=3740 mL×2, 수층=92 mL×2), 각각을 동일한 방식으로 후처리하였다. 한쪽 반응액(유기층=3740 mL, 수층=92 mL)을 20 L 용량의 분액 장치에 옮겨 담은 후, 아세트산 에틸 5950 mL 및 수 돗물 2975 mL를 차례로 첨가하고, 분액하였다. 유기층에 2N의 염산 540 mL를 첨가해서 수층의 pH를 3으로 조정한 후, 분액하였다. 상기 유기층을, 10% 식염수 2975 g, 5% 식염수 2975 g 및 수돗물 1488 mL로 차례로 세정하였다.Then, the reaction solution was divided equally into two parts (organic layer = 3740 mL × 2, aqueous layer = 92 mL × 2), and each was worked up in the same manner. One reaction solution (organic layer = 3740 mL, aqueous layer = 92 mL) was transferred to a 20 L separator, and then 5950 mL of ethyl acetate and 2975 mL of tap water were added sequentially, followed by separating. 540 mL of 2N hydrochloric acid was added to the organic layer, the pH of the aqueous layer was adjusted to 3, and the solution was separated. The organic layer was washed sequentially with 2975 g of 10% saline, 2975 g of 5% saline and 1488 mL of tap water.

2분할하여 처리된 유기층을 모아서, 유기층 14921.6 g 중의 표기 화합물량을 정량하였다.The organic layer treated by dividing into 2 was collected, and the amount of the title compound in 14921.6 g of the organic layer was quantified.

HPLC 정량 시의 함유량: 561.2 g, 수율: 95.9%HPLC quantitation content: 561.2 g, yield: 95.9%

1H-NMR(CDCl3)δ(ppm): 1.93(brs, 2H), 2.04-2.18(m, 2H), 3.02(brs, 2H), 4.26-4.60(m,3H), 5.18(s, 2H), 6.58(dd, J=0.8, 3.2Hz, 1H), 7.28-7.44(m, 7H), 7.65(dd, J=0.4, 8.4Hz, 1H), 8.10(s, 1H). 1 H-NMR (CDCl 3 ) δ (ppm): 1.93 (brs, 2H), 2.04-2.18 (m, 2H), 3.02 (brs, 2H), 4.26-4.60 (m, 3H), 5.18 (s, 2H ), 6.58 (dd, J = 0.8, 3.2 Hz, 1H), 7.28-7.44 (m, 7H), 7.65 (dd, J = 0.4, 8.4 Hz, 1H), 8.10 (s, 1H).

상기 유기층 중 12774.0 g에 톨루엔 1270 mL를 첨가한 다음, 감압 농축(욕조 온도 40℃)하고, 얻어진 농축물에 다시 톨루엔 1270 mL를 첨가한 후, 농축함으로써, 황갈색 오일상 물질 986.5 g을 얻었다. 수득한 물질을 하기 제조예 7에서 이용하였다.1270 mL of toluene was added to 12774.0 g of the organic layer, followed by concentration under reduced pressure (bath temperature of 40 ° C.), and 1270 mL of toluene was further added to the obtained concentrate, followed by concentration, to give 986.5 g of a tan oily substance. The obtained material was used in Preparation Example 7 below.

(제조예 7)(Manufacture example 7)

N-메틸-1-(피페리딘-4-일)-1H-인돌-6-카르복사미드의 합성Synthesis of N-methyl-1- (piperidin-4-yl) -1H-indole-6-carboxamide

Figure 112007086393561-PCT00073
Figure 112007086393561-PCT00073

1-(1-벤질옥시카르보닐피페리딘-4-일)-N-메틸-1H-인돌-6-카르복사미드의 톨 루엔 용액 985.5 g (함유량: 489.3 g, 1.25 mmol)에 테트라하이드로퓨란 2447 mL를 첨가하여 용해한 다음, 얻어진 용액을 7 L의 오토클레이브에 넣었다. 그런 다음, 상기 반응 용기에 메탄올 2447 mL 및 10% 팔라듐-탄소 49 g (50% 함수)을 차례로 투입하였다. 상기 반응 용기 내부를 질소로 2회 치환한 후, 수소로 2회 치환하였다. 수소 압력을 0.1 ㎫ 내지 0.2 ㎫로 제어하면서, 상기 반응액을 약 2시간 동안 교반하였다. 그런 다음, 가압을 해제하고, 오토클레이브의 내부를 질소 치환한 후, 오토클레이브를 열고, 상기 반응 용기의 바닥으로부터 상기 반응액을 배출하였다. 상기 오토클레이브 내부를 메탄올/테트라하이드로퓨란(1/1)의 혼합액으로 세정한 다음, 상기 반응액과 상기 세정액을 합하고, 여과에 의해 상기 촉매를 수집한 후, 여재(filtration cake)를 메탄올/테트라하이드로퓨란(1/1)으로 세정하였다. 그 여액을 감압 농축하여, 갈색 용액 830.5 g을 얻었다.Tetrahydrofuran in 985.5 g (content: 489.3 g, 1.25 mmol) of toluene solution of 1- (1-benzyloxycarbonylpiperidin-4-yl) -N-methyl-1H-indole-6-carboxamide 2447 mL was added to dissolve and the resulting solution was placed in a 7 L autoclave. Then, 2447 mL of methanol and 49 g of 10% palladium-carbon (50% hydrous) were sequentially added to the reaction vessel. The inside of the reaction vessel was replaced with nitrogen twice, and then twice with hydrogen. The reaction solution was stirred for about 2 hours while controlling the hydrogen pressure to 0.1 MPa to 0.2 MPa. Then, the pressure was released, the interior of the autoclave was nitrogen-substituted, the autoclave was opened, and the reaction solution was discharged from the bottom of the reaction vessel. After washing the inside of the autoclave with a mixed solution of methanol / tetrahydrofuran (1/1), combining the reaction solution and the washing solution, collecting the catalyst by filtration, and filtering the filtration cake with methanol / tetra. Washed with hydrofuran (1/1). The filtrate was concentrated under reduced pressure to obtain 830.5 g of a brown solution.

함유량: 345.6 g, 수율: 98.0% (1-(1-벤질옥시카르보닐피페리딘-4-일)-1H-인돌-6-카르복시산 메틸로부터의 통산 수율)Content: 345.6 g, Yield: 98.0% (calculated yield from 1- (1-benzyloxycarbonylpiperidin-4-yl) -1H-indole-6-methyl carboxylate)

상기 갈색 용액 799.7 g (함유량: 332.8 g)에 DME 1468 mL를 첨가하고, 농축한 다음(욕조 온도 40℃), 다시 DME 1468 mL를 첨가하고, 농축하여, 담황색 고체와 갈색 용액의 혼합물 677.0 g을 얻었다.1468 mL of DME was added to 799.7 g (content: 332.8 g) of the brown solution, concentrated (bath temperature 40 ° C.), and then 1468 mL of DME was added and concentrated to give 677.0 g of a mixture of a pale yellow solid and a brown solution. Got it.

1H-NMR(CDCl3)δ(ppm): 1.88-2.02(m, 2H), 2.06-2.16(m, 2H), 2.80-2.92(m, 2H), 3.22-3.32(m, 2H), 4.46(tt, J=4.0, 12.0Hz, 1H), 6.58(dd, J=0.8, 3.2Hz, 1H), 7.36-7.44(m, 2H), 7.65(d, J=8.4Hz, 1H), 8.11(s, 1H). 1 H-NMR (CDCl 3 ) δ (ppm): 1.88-2.02 (m, 2H), 2.06-2.16 (m, 2H), 2.80-2.92 (m, 2H), 3.22-3.32 (m, 2H), 4.46 (tt, J = 4.0, 12.0 Hz, 1H), 6.58 (dd, J = 0.8, 3.2 Hz, 1H), 7.36-7.44 (m, 2H), 7.65 (d, J = 8.4 Hz, 1H), 8.11 ( s, 1 H).

(제조예 8)(Manufacture example 8)

N-메틸-4-메틸-3-니트로벤즈아미드의 합성Synthesis of N-methyl-4-methyl-3-nitrobenzamide

Figure 112007086393561-PCT00074
Figure 112007086393561-PCT00074

3-니트로-4-메틸벤조산 1.83 g (1O mmol)을 테트라하이드로퓨란 18.3 mL에 용해한 다음, 질소 분위기 하, 실온에서, 이 용액에 CDI 2.43 g (15 mmol)을 투입하였다. 이렇게 하여 얻어진 반응액을 실온에서 1.5 시간 교반한 다음, 빙수욕에서 냉각시킨 후, 상기 반응액에 40% 메틸아민 수용액 2.33 g (30 mmol)을 적하하였다. 상기 반응액을 15분간 빙수욕으로 냉각하면서 교반하고, 실온에서 2.5시간 동안 교반하였다.1.83 g (10 mmol) of 3-nitro-4-methylbenzoic acid were dissolved in 18.3 mL of tetrahydrofuran, and then 2.43 g (15 mmol) of CDI was added to this solution at room temperature under a nitrogen atmosphere. The reaction solution thus obtained was stirred at room temperature for 1.5 hours, and then cooled in an ice water bath, followed by dropping 2.33 g (30 mmol) of 40% aqueous methylamine solution. The reaction solution was stirred with cooling in an ice water bath for 15 minutes and stirred at room temperature for 2.5 hours.

그런 다음, 상기 반응액을 아세트산 에틸로 희석한 후, 5% NaHCO3 수용액에 주입한 다음, 아세트산 에틸로 추출하였다. 유기층을 0.1N의 염산, 5% 탄산수소나트륨 수용액, 5% 염화나트륨 수용액 및 물로 차례로 세정한 다음, 무수 황산 마그네슘으로 건조한 후, 여과에 의해 분리한 다음, 감압 농축하여, 표기 화합물 1.75g을 백색 결정으로서 얻었다.Then, the reaction solution was diluted with ethyl acetate, poured into a 5% aqueous NaHCO 3 solution, and extracted with ethyl acetate. The organic layer was washed successively with 0.1 N hydrochloric acid, 5% aqueous sodium hydrogen carbonate solution, 5% aqueous sodium chloride solution and water, dried over anhydrous magnesium sulfate, separated by filtration, and then concentrated under reduced pressure to give 1.75 g of the title compound as white crystals. Obtained as.

수율: 90.1%Yield: 90.1%

1H-NMR(400MHz, CDCl3)δ(ppm): 2.66(s, 3H), 3.05(d, J=4.8Hz, 3H), 6.20(brs, 1H), 7.44(d, J=8.4Hz, 1H), 7.95(dd, J=2.0, 8.4Hz, 1H), 8.34(d, J=2.0Hz, 1H) 1 H-NMR (400 MHz, CDCl 3 ) δ (ppm): 2.66 (s, 3H), 3.05 (d, J = 4.8 Hz, 3H), 6.20 (brs, 1H), 7.44 (d, J = 8.4 Hz, 1H), 7.95 (dd, J = 2.0, 8.4 Hz, 1H), 8.34 (d, J = 2.0 Hz, 1H)

ESI-MS: m/z 217(M+Na)+ ESI-MS: m / z 217 (M + Na) +

(제조예 9)(Manufacture example 9)

4-(2-디메틸아미노비닐)-N-메틸-3-니트로벤즈아미드의 합성Synthesis of 4- (2-dimethylaminovinyl) -N-methyl-3-nitrobenzamide

Figure 112007086393561-PCT00075
Figure 112007086393561-PCT00075

N-메틸-4-메틸-3-니트로벤즈아미드 1.65 g (8.49 mmol)을 DMF 9.9 mL에 용해한 다음, 질소 분위기 하, 실온에서, 이 용액에 N,N-디메틸포름아미드 디메틸아세탈 6.49 g (50.90 mmol)을 적하한 후, 얻어진 반응액을 80℃에서 46시간 가열 및 교반하였다.1.65 g (8.49 mmol) of N-methyl-4-methyl-3-nitrobenzamide was dissolved in 9.9 mL of DMF, and then 6.49 g (50.90) of N, N-dimethylformamide dimethylacetal in this solution at room temperature under a nitrogen atmosphere. mmol) was added dropwise, and the obtained reaction solution was heated and stirred at 80 ° C for 46 hours.

그런 다음, 상기 반응액을 감압 농축한 후, 잔사를 플래시 컬럼 크로마토그래피(flash column chromatography)에 의해 정제(Merck, Silica Gel 60, 230∼400 메쉬; 아세트산 에틸:헵탄, 1:1→2:1)하였다. 목적물을 함유하는 분획을 모아서, 감압 농축한 후, 잔사를 플래시 컬럼 크로마토그래피에 의해 정제(Fuji silysia, NH-Silica Gel; 아세트산 에틸:헵탄=1:1)하였다. 그런 다음, 목적물을 함유하는 분획을 모아서, 감압 농축함으로써, 암적색 결정으로서 표기 화합물 800.2 ㎎을 얻었다.Then, the reaction solution was concentrated under reduced pressure, and the residue was then purified by flash column chromatography (Merck, Silica Gel 60, 230 to 400 mesh; ethyl acetate: heptane, 1: 1 → 2: 1). ) Fractions containing the desired product were collected, concentrated under reduced pressure, and the residue was purified by flash column chromatography (Fuji silysia, NH-Silica Gel; ethyl acetate: heptane = 1: 1). Then, the fractions containing the target product were collected and concentrated under reduced pressure to obtain 800.2 mg of the title compound as dark red crystals.

수율: 37.8%Yield: 37.8%

1H-NMR(400MHz, CDCl3)δ(ppm): 2.97(s, 6H), 3.01(d, J=4.8Hz, 3H), 5.94(d, J=13.2Hz, 1H), 6.18(brs, 1H), 7.12(d, J=13.2Hz, 1H), 7.49(d, J=8.4Hz, 1H), 7.78(dd, J=2.0, 8.4Hz, 1H), 8.22(d, J=2.0Hz, 1H) 1 H-NMR (400 MHz, CDCl 3 ) δ (ppm): 2.97 (s, 6H), 3.01 (d, J = 4.8 Hz, 3H), 5.94 (d, J = 13.2 Hz, 1H), 6.18 (brs, 1H), 7.12 (d, J = 13.2 Hz, 1H), 7.49 (d, J = 8.4 Hz, 1H), 7.78 (dd, J = 2.0, 8.4 Hz, 1H), 8.22 (d, J = 2.0 Hz, 1H)

ESI-MS: m/z 272(M+Na)+ ESI-MS: m / z 272 (M + Na) +

(제조예 10)(Manufacture example 10)

4-(2,2-디메톡시에틸)-N-메틸-3-니트로벤즈아미드의 합성Synthesis of 4- (2,2-dimethoxyethyl) -N-methyl-3-nitrobenzamide

Figure 112007086393561-PCT00076
Figure 112007086393561-PCT00076

제조예 9에서 얻은 4-(2-디메틸아미노비닐)-N-메틸-3-니트로벤즈아미드 100.0 ㎎ (0.40 mmol)를 0.5 mL의 메탄올에 용해한 다음, 실온에서 이 용액에 황산 53.8 ㎎/메탄올 0.5 mL를 첨가한 후, 55℃에서 5시간 동안 가열 및 교반하였다.100.0 mg (0.40 mmol) of 4- (2-dimethylaminovinyl) -N-methyl-3-nitrobenzamide obtained in Preparation Example 9 was dissolved in 0.5 mL of methanol, and then 53.8 mg / methanol 0.5 sulfuric acid was added to this solution at room temperature. After adding mL, it was heated and stirred at 55 ° C. for 5 hours.

그런 다음, 얻어진 반응액을 빙수욕에서 냉각한 다음, 상기 반응액에 트리에틸아민 243 ㎎ (2.40 mmol)을 첨가한 후, 감압 농축하였다. 잔사에 물과 톨루엔을 첨가하고, 톨루엔으로 추출하였다. 얻어진 유기층을 무수 황산 나트륨으로 건조한 다음, 여과에 의해 분리한 다음, 감압 농축하여, 등적색(orange-red) 오일상 물질로서 표기 화합물 93.5 ㎎을 얻었다.Then, the obtained reaction solution was cooled in an ice water bath, and then, 243 mg (2.40 mmol) of triethylamine was added to the reaction solution, and the resultant was concentrated under reduced pressure. Water and toluene were added to the residue, and extracted with toluene. The resulting organic layer was dried over anhydrous sodium sulfate, separated by filtration, and then concentrated under reduced pressure to obtain 93.5 mg of the title compound as an orange-red oily substance.

수율: 86.9%Yield: 86.9%

1H-NMR(400MHz, CDCl3)δ(ppm): 3.04(d, J=4.8Hz, 3H), 3.27(d, J=5.2Hz, 2H), 3.35(s, 6H), 4.56(t, J=5.2Hz, 1H), 6.26(brs, 1H), 7.50(d, J=8.0Hz, 1H), 7.93(dd, J=2.0, 8.0Hz, 1H), 8.26(d, J=2.0Hz, 1H) 1 H-NMR (400 MHz, CDCl 3 ) δ (ppm): 3.04 (d, J = 4.8 Hz, 3H), 3.27 (d, J = 5.2 Hz, 2H), 3.35 (s, 6H), 4.56 (t, J = 5.2 Hz, 1H), 6.26 (brs, 1H), 7.50 (d, J = 8.0 Hz, 1H), 7.93 (dd, J = 2.0, 8.0 Hz, 1H), 8.26 (d, J = 2.0 Hz, 1H)

ESI-MS: m/z 291(M+Na)+ ESI-MS: m / z 291 (M + Na) +

(제조예 11)(Manufacture example 11)

3-아미노-4-(2,2-디메톡시에틸)-N-메틸벤즈아미드의 합성Synthesis of 3-amino-4- (2,2-dimethoxyethyl) -N-methylbenzamide

Figure 112007086393561-PCT00077
Figure 112007086393561-PCT00077

제조예 10에서 얻은 4-(2,2-디메톡시에틸)-N-메틸-3-니트로벤즈아미드 93.5 ㎎ (0.35 mmol)의 2 mL 메탄올 용액에 10% 팔라듐-탄소 1O ㎎을 첨가한 다음, 상온 상압에서 수소 첨가하였다.10 mg of palladium-carbon 10 mg was added to a solution of 93.5 mg (0.35 mmol) of 4- (2,2-dimethoxyethyl) -N-methyl-3-nitrobenzamide obtained in Preparation Example 10, Hydrogenation was performed at room temperature and atmospheric pressure.

상기 반응 종료 후, Hyflo Super-Cel을 이용하여, 여과에 의해 상기 촉매를 분리한 다음, 여액을 감압 농축하여, 담갈색 오일상 물질로서 표기 화합물 83.4 ㎎을 얻었다.After completion of the reaction, the catalyst was separated by filtration using Hyflo Super-Cel, and then the filtrate was concentrated under reduced pressure to obtain 83.4 mg of the title compound as a pale brown oily substance.

수율: 100%Yield: 100%

1H-NMR(400MHz, CDCl3)δ(ppm): 2.88(d, J=5.2Hz, 2H), 2.98(d, J=4.8Hz, 3H), 3.37(s, 6H), 4.18(brs, 2H), 4.49(t, J=5.2Hz, 1H), 6.09(brs, 1H), 7.00(dd, J=1.6, 8.0Hz, 1H), 7.08(d, J=8.0Hz, 1H), 7.14(d, J=1.6Hz, 1H) 1 H-NMR (400 MHz, CDCl 3 ) δ (ppm): 2.88 (d, J = 5.2 Hz, 2H), 2.98 (d, J = 4.8 Hz, 3H), 3.37 (s, 6H), 4.18 (brs, 2H), 4.49 (t, J = 5.2 Hz, 1H), 6.09 (brs, 1H), 7.00 (dd, J = 1.6, 8.0 Hz, 1H), 7.08 (d, J = 8.0 Hz, 1H), 7.14 ( d, J = 1.6 Hz, 1H)

ESI-MS: m/z 261(M+Na)+ ESI-MS: m / z 261 (M + Na) +

(제조예 12)(Manufacture example 12)

1-(1-벤질옥시카르보닐피페리딘-4-일)-N-메틸-1H-인돌-6-카르복사미드의 합성Synthesis of 1- (1-benzyloxycarbonylpiperidin-4-yl) -N-methyl-1H-indole-6-carboxamide

Figure 112007086393561-PCT00078
Figure 112007086393561-PCT00078

제조예 11에서 얻은 3-아미노-4-(2,2-디메톡시에틸)-N-메틸벤즈아미드 83.4 ㎎ (0.35 mmol)을 아세트산 1.7 mL에 용해한 다음, 실온에서, 이 용액에 4-옥소-1-피페리딘카르복시산 벤질 123 ㎎ (0.52 mmol)을 첨가하고, 얻어진 반응액을 질소 분위기 하, 실온에서 교반하였다. 1시간 후, 상기 반응액을 냉수욕에서 냉각한 다음, 상기 반응액에 STAB(트리아세톡시수소화붕소나트륨) 117 ㎎ (0.52 mmol)을 투입하고, 얻어진 반응액을 실온에서 1시간 20분간 교반하였다. 그런 다음, 상기 반응액을 냉수욕에서 냉각한 후, 상기 반응액에 물 1.7 mL를 적하한 다음, 100℃에서 5시간 가열 및 교반하였다.83.4 mg (0.35 mmol) of 3-amino-4- (2,2-dimethoxyethyl) -N-methylbenzamide obtained in Preparation Example 11 was dissolved in 1.7 mL of acetic acid, and then 4-oxo- was added to the solution at room temperature. 123 mg (0.52 mmol) of 1-piperidinecarboxylic acid benzyl was added, and the obtained reaction solution was stirred at room temperature under a nitrogen atmosphere. After 1 hour, the reaction solution was cooled in a cold water bath, and then 117 mg (0.52 mmol) of STAB (sodium triacetoxyborohydride) was added to the reaction solution, and the reaction solution was stirred at room temperature for 1 hour and 20 minutes. Then, after cooling the reaction solution in a cold water bath, 1.7 mL of water was added dropwise to the reaction solution, and then heated and stirred at 100 ° C for 5 hours.

상기 반응액에 톨루엔을 첨가하고, 추출하였다. 여기서, 1-(1-벤질옥시카르보닐피페리딘-4-일)-N-메틸-1H-인돌-6-카르복사미드가 석출되었기 때문에, 수층에 아세트산 에틸을 첨가하여 1-(1-벤질옥시카르보닐피페리딘-4-일)-N-메틸-1H-인돌-6-카르복사미드를 용해한 다음, 5N의 수산화 나트륨 용액으로 중화한 후, 아세트산 에틸로 추출하였다. 유기층을 무수 황산 마그네슘으로 건조하고, 여과에 의해 분리한 다음, 감압 농축하고, 그 잔사를 플래시 컬럼 크로마토그래피에 의해 정제(Merck, Silica Gel 60, 230∼400 메쉬; 아세트산 에틸:헵탄=2:1)하여, 무색 오일상 물질로서, 1-(1-벤질옥시카르보닐피페리딘-4-일)-N-메틸-1H-인돌-6-카르복사미드 114.9 ㎎을 얻었다.Toluene was added to the reaction solution and extracted. Here, since 1- (1-benzyloxycarbonylpiperidin-4-yl) -N-methyl-1H-indole-6-carboxamide was precipitated, ethyl acetate was added to the aqueous layer and 1- (1- Benzyloxycarbonylpiperidin-4-yl) -N-methyl-1H-indole-6-carboxamide was dissolved, neutralized with 5N sodium hydroxide solution, and extracted with ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate, separated by filtration, concentrated under reduced pressure, and the residue was purified by flash column chromatography (Merck, Silica Gel 60, 230-400 mesh; ethyl acetate: heptane = 2: 1). 114.9 mg of 1- (1-benzyloxycarbonylpiperidin-4-yl) -N-methyl-1H-indole-6-carboxamide was obtained as a colorless oily substance.

이렇게 하여 얻어진 오일상 물질을 톨루엔 0.12 mL에 용해한 다음, 실온에서 교반하면서, 상기 용액에 사이클로펜틸 메틸 에테르 0.96 mL를 적하하였다. 얻어진 용액을 50℃에서 가열 및 교반하고, 1-(1-벤질옥시카르보닐피페리딘-4-일)-N-메틸-1H-인돌-6-카르복사미드의 종결정을 첨가하였다. 그런 다음, 상기 반응액을 50℃로 가열 및 교반하면서, 상기 반응액에 헵탄 0.24 mL를 적하한 다음, 50℃에서 10분간 가열 및 교반하였다. 얻어진 반응액을 10℃/15분의 속도로 실온까지 서냉한 다음, 1O℃에서 1시간 동안 교반하였다. 석출된 결정을 여과에 의해 수집하였으며, 이로써, 백색 결정으로서, 1-(1-벤질옥시카르보닐피페리딘-4-일)-N-메틸-1H-인돌-6-카르복사미드 99.3 ㎎을 얻었다.The oily substance thus obtained was dissolved in 0.12 mL of toluene, and then 0.96 mL of cyclopentyl methyl ether was added dropwise to the solution while stirring at room temperature. The obtained solution was heated and stirred at 50 ° C., and seed crystals of 1- (1-benzyloxycarbonylpiperidin-4-yl) -N-methyl-1H-indole-6-carboxamide were added. Then, while heating and stirring the reaction solution at 50 ° C, 0.24 mL of heptane was added dropwise to the reaction solution, and then heated and stirred at 50 ° C for 10 minutes. The obtained reaction solution was slowly cooled to room temperature at a rate of 10 ° C./15 minutes, and then stirred at 10 ° C. for 1 hour. The precipitated crystals were collected by filtration, thereby yielding 99.3 mg of 1- (1-benzyloxycarbonylpiperidin-4-yl) -N-methyl-1H-indole-6-carboxamide as white crystals. Got it.

수율: 72.7%Yield: 72.7%

1H-NMR (400MHz, CDCl3)δ(ppm): 1.83-2.02(br, 2H), 2.04-2.16(br, 2H), 2.94-3.10(br, 2H), 3.06(d, J=4.8Hz, 3H), 4.30-4.58(m, 3H), 5.17(s, 2H), 6.24(brs, 1H), 6.56(d, J=3.2Hz, 1H), 7.28(d, J=3.2Hz, 1H), 7.31-7.41(m, 6H), 7.62(d, J=8.4Hz, 1H), 8.05(s, 1H) 1 H-NMR (400 MHz, CDCl 3 ) δ (ppm): 1.83-2.02 (br, 2H), 2.04-2.16 (br, 2H), 2.94-3.10 (br, 2H), 3.06 (d, J = 4.8 Hz , 3H), 4.30-4.58 (m, 3H), 5.17 (s, 2H), 6.24 (brs, 1H), 6.56 (d, J = 3.2 Hz, 1H), 7.28 (d, J = 3.2 Hz, 1H) , 7.31-7.41 (m, 6H), 7.62 (d, J = 8.4 Hz, 1H), 8.05 (s, 1H)

ESI-MS: m/z 414(M+Na)+ ESI-MS: m / z 414 (M + Na) +

(제조예 13)(Manufacture example 13)

1-(1-에톡시에톡시)-3-메톡시벤젠의 합성Synthesis of 1- (1-ethoxyethoxy) -3-methoxybenzene

Figure 112007086393561-PCT00079
Figure 112007086393561-PCT00079

질소 분위기 하, 15 L 용량의 4구 둥근 바닥 플라스크에 테트라하이드로퓨란 260O mL 및 3-메톡시페놀 650.4 g (5.24 몰)을 첨가하였다. 그런 다음, 이 테트라하이드로퓨란 용액에 피리디늄 p-톨루엔설포네이트 65.8 g (0.26 몰)을 첨가하고, 교반을 개시하였다. 얻어진 혼합물을, 8℃의 온도로 설정한 항온조에서 냉각시킨 다음, 에틸 비닐 에테르 760.1 g (10.54 몰)을 약 1.5시간 동안 적하하였다. 그런 다음, 얻어진 반응액을 동일 온도에서 2.7시간 동안 교반한 후, 상기 항온조의 온도를 15℃로 설정하였다. 내온이 14℃를 초과하는 시점으로부터 약 2시간 더 교반하였다. 상기 항온조의 온도를 8℃로 설정하고, 내온이 거의 10℃가 된 시점으로부터, 상기 반응액에 8% 탄산수소나트륨 수용액 715.2 g (탄산수소나트륨 57.2 g을 수돗물 658 mL에 용해하여 제조한 것)을 10분간 적하하였다. 상기 반응액을 20 L 용량의 분액 깔때기에 옮겨 담은 후, 수돗물 1040 mL를 추가하고, 톨루엔 4550 mL를 첨가하여 추출한 후, 얻어진 유기층을 수돗물 130O mL 및 650 mL로 2회 세정하 였다. 세정된 유기층을 내온 40℃에서 감압 농축하여, 표기 화합물을 함유하는 담황색 오일상 물질을 얻었다.To a 15 L four-necked round bottom flask under nitrogen atmosphere was added 260 mL of tetrahydrofuran and 650.4 g (5.24 mol) of 3-methoxyphenol. Then, 65.8 g (0.26 mol) of pyridinium p-toluenesulfonate was added to this tetrahydrofuran solution, and stirring was started. The resulting mixture was cooled in a thermostat set at a temperature of 8 ° C. and then 760.1 g (10.54 mol) of ethyl vinyl ether was added dropwise for about 1.5 hours. Then, after the obtained reaction solution was stirred at the same temperature for 2.7 hours, the temperature of the thermostat was set to 15 ℃. It stirred about 2 hours from the time when internal temperature exceeded 14 degreeC. The temperature of the thermostat was set to 8 ° C., and 715.2 g of an aqueous 8% sodium bicarbonate solution was prepared by dissolving 57.2 g of sodium bicarbonate in 658 mL of tap water at the time when the internal temperature reached almost 10 ° C. Was added dropwise for 10 minutes. The reaction solution was transferred to a 20 L separatory funnel, 1040 mL of tap water was added, 4550 mL of toluene was added and extracted, and the organic layer was washed twice with 130 mL of tap water and 650 mL. The washed organic layer was concentrated under reduced pressure at 40 ° C. to obtain a pale yellow oily substance containing the title compound.

수득량: 1213.5 g, 함량: 1019.3 g, 수율: 99.1%Yield: 1213.5 g, Content: 1019.3 g, Yield: 99.1%

1H-NMR(400MHz, CDCl3)δ(ppm): 1.21(t, J=6.8Hz, 3H), 1.50(d, J=5.2Hz, 3H), 3.50-3.60(m, 2H), 3.79(s, 3H), 5.38(q, J=5.2Hz, 1H), 6.50-6.66(m, 3H), 7.13-7.20(m, 1H). 1 H-NMR (400 MHz, CDCl 3 ) δ (ppm): 1.21 (t, J = 6.8 Hz, 3H), 1.50 (d, J = 5.2 Hz, 3H), 3.50-3.60 (m, 2H), 3.79 ( s, 3H), 5.38 (q, J = 5.2 Hz, 1H), 6.50-6.66 (m, 3H), 7.13-7.20 (m, 1H).

(실시예 1)(Example 1)

[2-(1-에톡시에톡시)-6-메톡시페닐]아세트산 에틸의 합성Synthesis of [2- (1-ethoxyethoxy) -6-methoxyphenyl] ethyl acetate

Figure 112007086393561-PCT00080
Figure 112007086393561-PCT00080

질소 분위기 하에, 20 L 용량의 반응 장치에 1-(1-에톡시에톡시)-3-메톡시벤젠 854.0 g (함량: 717.4 g, 3.656 몰)을 투입하고, 테트라하이드로퓨란 7174 mL로 세정한 후, 얻어진 용액을 교반하였다. 상기 반응 장치의 재킷에 4℃의 온도로 설정된 냉각액을 순환시키고, 상기 반응액에 n-부틸리튬 1156 g (4.414 몰)[2.71 M, n-헥산 용액]을 41분간 적하한 다음, 상기 반응 용액을 동일 온도에서 약 1.5시간 동안 교반하였다. 냉각액 온도를 -20℃로 설정하고, 일단 내온이 -10℃ 이하가 된 것이 확인되면, 상기 반응액에 요오드화구리(I) 417.8 g (2.19 몰)을 3회로 나누어 첨가한 다음, 상기 반응액을 동일 온도에서 약 14시간 교반하였다. 상기 냉각액 설정 온도를 -90℃로 변경하고, 상기 반응액에 브로모아세트산 에틸 702.1 g (4.20 몰)을 26분간 적하한 후, 테트라하이드로퓨란 10 mL로 세정하였다. 적하 종료 후, 얻어진 반응액을 44분간 교반하고, 상기 냉각액 온도 설정을 -35℃로 변경한 다음, 상기 반응액을 약 1.8시간 더 교반하였다. 상기 냉각액 온도 설정을 -20℃로 변경하고, 내온이 -20℃를 초과하면, 상기 용액을 1시간 교반한 다음, HPLC에 의해 상기 반응의 진행을 확인하였다. 동일 온도에서 상기 반응액에 28% 암모니아수 1435 mL를 약 30분간 첨가하고, 상기 냉각액 온도를 25℃로 변경하였다. 상기 반응액에 톨루엔 7174 mL를 첨가하여 추출하고, 유기층을 28% 암모니아수 1440 mL 및 수돗물(1435 mL×3)로 차례로 세정하였다. 얻어진 유기층에 N,N-디이소프로필에틸아민 127 mL(0.73 몰)을 첨가한 후, 감압 농축하여, 표기 화합물을 함유하는 옅은 오렌지색 오일상 물질을 얻었다.In a nitrogen atmosphere, 854.0 g (content: 717.4 g, 3.656 mol) of 1- (1-ethoxyethoxy) -3-methoxybenzene was added to a 20-L reactor and washed with 7174 mL of tetrahydrofuran. Then, the obtained solution was stirred. After circulating a coolant set at a temperature of 4 ° C. in the jacket of the reactor, 1156 g (4.414 mol) [2.71 M, n-hexane solution] of n-butyllithium was added dropwise to the reaction solution for 41 minutes, and then the reaction solution was added. Was stirred at the same temperature for about 1.5 hours. When the coolant temperature was set to -20 ° C and the internal temperature was found to be -10 ° C or lower, 417.8 g (2.19 mol) of copper (I) iodide was added to the reaction solution in three portions, and then the reaction solution was added. It stirred about 14 hours at the same temperature. The coolant set temperature was changed to −90 ° C., and 702.1 g (4.20 mol) of ethyl bromoacetate was added dropwise to the reaction solution for 26 minutes, followed by washing with 10 mL of tetrahydrofuran. After completion of the dropwise addition, the obtained reaction solution was stirred for 44 minutes, the coolant temperature setting was changed to -35 ° C, and the reaction solution was further stirred for about 1.8 hours. The coolant temperature setting was changed to −20 ° C., and when the internal temperature exceeded −20 ° C., the solution was stirred for 1 hour, and then the progress of the reaction was confirmed by HPLC. At the same temperature, 1435 mL of 28% aqueous ammonia was added to the reaction solution for about 30 minutes, and the coolant temperature was changed to 25 ° C. 7174 mL of toluene was added to the reaction solution, and the organic layer was washed with 1440 mL of 28% ammonia water and tap water (1435 mL × 3). 127 mL (0.73 mol) of N, N-diisopropylethylamine was added to the obtained organic layer, and it concentrated under reduced pressure, and the pale orange oily substance containing the title compound was obtained.

수득량: 1122.3 g, 함량: 990.7 g, 수율: 96.0%Yield: 1122.3 g, content: 990.7 g, yield: 96.0%

1H-NMR(400MHz, CDCl3)δ(ppm): 1.19(t, J=7.2Hz, 3H), 1.24(d, J=7.2Hz, 3H), 1.47(d, J=5.2Hz, 3H), 3.46-3.56(m, 1H), 3.66-3.82(m, 3H), 3.80(s, 3H), 4.14(q, J=7.2Hz, 2H), 5.39(q, J=5.2Hz, 1H), 6.57(d, J=8.4Hz, 1H), 6.70(d, J=8.8Hz, 1H), 7.17(dd, J=8.8, 8.4Hz, 1H). 1 H-NMR (400 MHz, CDCl 3 ) δ (ppm): 1.19 (t, J = 7.2 Hz, 3H), 1.24 (d, J = 7.2 Hz, 3H), 1.47 (d, J = 5.2 Hz, 3H) , 3.46-3.56 (m, 1H), 3.66-3.82 (m, 3H), 3.80 (s, 3H), 4.14 (q, J = 7.2 Hz, 2H), 5.39 (q, J = 5.2 Hz, 1H), 6.57 (d, J = 8.4 Hz, 1H), 6.70 (d, J = 8.8 Hz, 1H), 7.17 (dd, J = 8.8, 8.4 Hz, 1H).

(실시예 2)(Example 2)

2-[1-에톡시에톡시]-6-메톡시페닐]에탄올의 합성Synthesis of 2- [1-ethoxyethoxy] -6-methoxyphenyl] ethanol

Figure 112007086393561-PCT00081
Figure 112007086393561-PCT00081

질소 분위기 하에, 15 L 용량의 4구 둥근 바닥 플라스크에, [2-(1-에톡시에톡시)-6-메톡시페닐]아세트산 에틸 248.8 g (함량: 213.0 g, 0.754 몰) 및 동일 화합물 561.6 g (함량: 495.7 g, 1.756 몰), 톨루엔(8504 mL) 및 DME(2126 mL)를 차례로 첨가한 다음, 교반을 개시하고, 상기 반응 용기를 빙냉하였다. 이 용액에 수소화 비스(2-메톡시에톡시)알루미늄 나트륨 1403.7 g (65% 톨루엔 용액, 1.8 몰당량)을 50분간 적하하였다. 적하 종료 후 즉시, 빙수욕을 수욕(water bath)으로 변경하고, 상기 반응액을 2.5시간 교반하였다. 그런 다음, 상기 수욕을 빙수욕으로 변경하고, 상기 반응액에 8%(w/w) 수산화나트륨 수용액(93.0% 수산화나트륨 430 g에 물 4570 mL를 첨가하여 제조함) 약 1.5 L를 47분간 적하하였다. 얻어진 반응액을 20 L 분액 깔때기에 옮긴 다음, 앞서 제조한 수산화나트륨 수용액의 나머지를 전량 첨가하고, 수층을 폐기하였다. 유기층을 수돗물(1417 mL×2회, 709 mL×1회)로 3회 세정한 후, 40℃에서 감압 농축하여, 농축 잔사에게 포함된 표기 화합물을 정량하였다.Under a nitrogen atmosphere, 248.8 g of [2- (1-ethoxyethoxy) -6-methoxyphenyl] ethyl acetate (content: 213.0 g, 0.754 mol) and the same compound 561.6 were placed in a 15 L four-neck round bottom flask. g (content: 495.7 g, 1.756 mol), toluene (8504 mL) and DME (2126 mL) were added in sequence, then stirring was initiated and the reaction vessel was ice cooled. 1403.7 g (65% toluene solution, 1.8 molar equivalents) of sodium hydrogenated bis (2-methoxyethoxy) aluminum was dripped at this solution for 50 minutes. Immediately after completion of the dropping, the ice water bath was changed to a water bath, and the reaction solution was stirred for 2.5 hours. Then, the water bath was changed to an ice water bath, and about 1.5 L of 8% (w / w) aqueous sodium hydroxide solution (prepared by adding 4570 mL of water to 430 g of 93.0% sodium hydroxide) was added dropwise to the reaction solution for 47 minutes. It was. The resulting reaction solution was transferred to a 20 L separatory funnel, and then the total amount of the rest of the aqueous sodium hydroxide solution prepared above was added, and the aqueous layer was discarded. The organic layer was washed three times with tap water (1417 mL × 2 times, 709 mL × 1 times), and then concentrated under reduced pressure at 40 ° C. to quantify the title compound contained in the concentrated residue.

농축 잔사 중량: 1042.0 g, 함량: 563.3 gConcentrated residue weight: 1042.0 g, Content: 563.3 g

1H-NMR(400MHz, CDCl3)δ(ppm): 1.20(t, J=7.2Hz, 3H), 1.50(d, J=5.6Hz, 3H), 3.00(t, J=6.8Hz, 2H), 3.48-3.58(m, 1H), 3.68-3.90(m, 3H), 3.82(s, 3H), 5.42(q, J=5.6Hz, 1H), 6.58(d, J=8.0Hz, 1H), 6.70(d, J=8.4Hz, 1H), 7.13(dd, J=8.4, 8.0Hz, 1H). 1 H-NMR (400 MHz, CDCl 3 ) δ (ppm): 1.20 (t, J = 7.2 Hz, 3H), 1.50 (d, J = 5.6 Hz, 3H), 3.00 (t, J = 6.8 Hz, 2H) , 3.48-3.58 (m, 1H), 3.68-3.90 (m, 3H), 3.82 (s, 3H), 5.42 (q, J = 5.6 Hz, 1H), 6.58 (d, J = 8.0 Hz, 1H), 6.70 (d, J = 8.4 Hz, 1 H), 7.13 (dd, J = 8.4, 8.0 Hz, 1 H).

(실시예 3)(Example 3)

벤조산 2-[2-(1-에톡시에톡시)-6-메톡시페닐]에틸의 합성Synthesis of Benzoic Acid 2- [2- (1-ethoxyethoxy) -6-methoxyphenyl] ethyl

Figure 112007086393561-PCT00082
Figure 112007086393561-PCT00082

실시예 2에서 얻은 유기층 잔사 1042.0 g을, 질소 분위기 하에 15L 용량의 4구 둥근 바닥 플라스크에 옮겨 담은 후, 톨루엔 8102 mL, DME 2025 mL, 트리에틸아민 304.8 g 및 N,N,N,N-테트라메틸에틸렌디아민 29.2 g을 차례로 첨가하였다. 그런 다음, 얻어진 용액을 빙냉하에 교반하면서, 상기 용액에 염화벤조일 388.1 g (2.761 몰)을 40분간 적하하였다. 상기 반응액을 동일 온도에서 10분간 교반한 다음, 상기 빙욕을 수욕으로 변경한 후, 2.8시간 더 교반하였다. 상기 반응액을 20 L 용량의 분액 깔때기에 옮겨 담은 후, 각각 3544 mL 및 709 mL의 수돗물로 2회 세정하였다. 얻어진 유기층 10.84 L 중의 표기 화합물을 정량하였다.1042.0 g of the organic layer residue obtained in Example 2 was transferred to a 15 L four-necked round bottom flask under nitrogen atmosphere, and then 8102 mL of toluene, 2025 mL of DME, 304.8 g of triethylamine and N, N, N, N-tetra 29.2 g of methylethylenediamine were added sequentially. Then, 388.1 g (2.761 mol) of benzoyl chloride was added dropwise to the solution over 40 minutes while the obtained solution was stirred under ice cooling. The reaction solution was stirred at the same temperature for 10 minutes, and then the ice bath was changed to a water bath, followed by further stirring for 2.8 hours. The reaction solution was transferred to a 20 L separatory funnel and washed twice with 3544 mL and 709 mL of tap water, respectively. The title compound in 10.84 L of the obtained organic layer was quantified.

함량: 745.0 gContent: 745.0 g

1H-NMR(400MHz, CDCl3)δ(ppm): 1.18(t, J=7.2Hz, 3H), 1.48(d, J=5.2Hz, 3H), 3.17(t, J=7.2Hz, 2H), 3.45-3.56(m, 1H), 3.66-3.80(m, 1H), 3.76(s, 3H), 4.45(t, J=7.2Hz, 2H), 5.41(q, J=5.2Hz, 1H), 6.55(d, J=8.4Hz, 1H), 6.71(d, J=8.0Hz, 1H), 7.13(dd, J=8.4, 8.0Hz, 1H), 7.36-7.44(m, 2H), 7.50-7.56(m, 1H), 7.98-8.06(m, 2H). 1 H-NMR (400 MHz, CDCl 3 ) δ (ppm): 1.18 (t, J = 7.2 Hz, 3H), 1.48 (d, J = 5.2 Hz, 3H), 3.17 (t, J = 7.2 Hz, 2H) , 3.45-3.56 (m, 1H), 3.66-3.80 (m, 1H), 3.76 (s, 3H), 4.45 (t, J = 7.2 Hz, 2H), 5.41 (q, J = 5.2 Hz, 1H), 6.55 (d, J = 8.4 Hz, 1H), 6.71 (d, J = 8.0 Hz, 1H), 7.13 (dd, J = 8.4, 8.0 Hz, 1H), 7.36-7.44 (m, 2H), 7.50-7.56 (m, 1 H), 7.98-8.06 (m, 2 H).

(실시예 4)(Example 4)

벤조산 2-(2-하이드록시-6-메톡시페닐)에틸의 합성Synthesis of Benzoic Acid 2- (2-hydroxy-6-methoxyphenyl) ethyl

Figure 112007086393561-PCT00083
Figure 112007086393561-PCT00083

실시예 3에서 얻은 유기층을 15 L 용량의 4구 둥근 바닥 플라스크에 옮긴 다음, 테트라하이드로퓨란 2126 mL를 첨가하고, 얻어진 용액을 빙수욕에서 냉각하면서, 교반하였다. 그런 다음, 5N 염산 1417 mL를 23분간 적하한 후, 얻어진 반응액을 동일 온도에서 약 1시간 교반한 다음, 욕조의 냉수를 제거한 후, 2.5시간 동안 계속 교반하였다. 이렇게 하여 얻어진 반응액을 20 L 용량의 분액 깔때기에 옮기고, 수층을 폐기하였다. 유기층을 8% 탄산수소나트륨 수용액(탄산수소나트륨 170 g에 물 1956 mL를 첨가하여 조정함) 및 수돗물(709 mL×2)로 2회 세정하였다. 세정된 유기층을 욕조 온도 40℃에서 감압 농축하여, 슬러리 1463.0 g을 얻었다.The organic layer obtained in Example 3 was transferred to a 15 L four-necked round bottom flask, then 2126 mL of tetrahydrofuran was added, and the resulting solution was stirred while cooling in an ice water bath. Then, 1417 mL of 5N hydrochloric acid was added dropwise for 23 minutes, and the reaction solution was stirred at the same temperature for about 1 hour, and then the cold water of the bath was removed, followed by stirring for 2.5 hours. The reaction solution thus obtained was transferred to a 20 L separatory funnel, and the aqueous layer was discarded. The organic layer was washed twice with an aqueous 8% sodium bicarbonate solution (adjusted by adding 1956 mL of water to 170 g of sodium bicarbonate) and tap water (709 mL × 2). The washed organic layer was concentrated under reduced pressure at a bath temperature of 40 ° C. to obtain 1463.0 g of a slurry.

얻어진 슬러리를 10 L 용량의 4구 둥근 바닥 플라스크 내에서 테트라하이드로퓨란 709 mL로 세정하였다. 그런 다음, 교반하면서, 툴루엔-헵탄 혼합액(1:8) 5670 mL를 약 2.5시간 동안 적하한 후, 실온에서 약 14시간 동안 교반하였다. 석출된 결정을 여과에 의해 수집한 다음, 수집된 결정을 톨루엔-헵탄 혼합액(1:8) 708 mL로 세정하였다. 그런 다음, 40℃의 욕조 온도에서, 감압 하에 약 4.5시간 동안 건조하여, 표기 화합물을 백색 결정으로서 얻었다.The resulting slurry was washed with 709 mL of tetrahydrofuran in a 10 L four-necked round bottom flask. Then, while stirring, 5670 mL of the toluene-heptane mixture (1: 8) was added dropwise for about 2.5 hours, followed by stirring at room temperature for about 14 hours. The precipitated crystals were collected by filtration, and then the collected crystals were washed with 708 mL of toluene-heptane mixture (1: 8). Then, at a bath temperature of 40 ° C., it was dried for about 4.5 hours under reduced pressure to obtain the title compound as white crystals.

수득량: 535.9 g, 수율: 78.4%Yield: 535.9 g, yield: 78.4%

1H-NMR(400MHz, CDCl3)δ(ppm): 3.15(t, J=7.2Hz, 2H), 3.79(s, 3H), 4.45(t, J=7.2Hz, 2H), 5.86(s, 1H), 6.48(d, J=8.4Hz, 1H), 6.53(d, J=8.4Hz, 1H), 7.09(dd, J=8.4, 8.4Hz, 1H), 7.44(dd, J=7.6, 7.6Hz, 2H), 7.56(dd, J=7.6, 7.6Hz, 1H), 8.04(d, J=7.6Hz, 1H). 1 H-NMR (400 MHz, CDCl 3 ) δ (ppm): 3.15 (t, J = 7.2 Hz, 2H), 3.79 (s, 3H), 4.45 (t, J = 7.2 Hz, 2H), 5.86 (s, 1H), 6.48 (d, J = 8.4 Hz, 1H), 6.53 (d, J = 8.4 Hz, 1H), 7.09 (dd, J = 8.4, 8.4 Hz, 1H), 7.44 (dd, J = 7.6, 7.6 Hz, 2H), 7.56 (dd, J = 7.6, 7.6 Hz, 1H), 8.04 (d, J = 7.6 Hz, 1H).

(실시예 5)(Example 5)

벤조산 2-(7-메톡시-2,2-디메틸-4-옥소크로만-8-일)에틸의 합성Synthesis of Benzoic Acid 2- (7-methoxy-2,2-dimethyl-4-oxochroman-8-yl) ethyl

Figure 112007086393561-PCT00084
Figure 112007086393561-PCT00084

10 L 용량의 4구 둥근 바닥 플라스크에, 3-메틸크로톤산 202.2 g (2.020 몰) 및 메탄설폰산 2 L를 첨가한 다음, 질소 기류 하에, 50℃의 수욕 상에서 교반하였다. 얻어진 용액에, 실시예 4에서 얻은 벤조산 2-(2-하이드록시-6-메톡시페닐)에틸 500.0 g (1.836 몰)을 투입하였다. 그런 다음, 상기 반응 혼합물을 동일 온도 에서 1.8시간 동안 교반한 후, 빙냉하였다. 상기 반응 용액에 톨루엔 2.5 L를 주입한 다음, 수돗물 5 L를 약 1시간 동안 적하하였다. 내용물을 20 L 용량의 분액 장치에 옮기고, 분액하여, 수층을 폐기하였다. 유기층을 수돗물(5 L×3)로 3회 세정한 다음, 욕조 온도 40℃에서 감압 농축하여, 표기 화합물 846.1 g을 얻었다.To a 10 L four-necked round bottom flask, 202.2 g (2.020 mol) of 3-methylcrotonic acid and 2 L of methanesulfonic acid were added, followed by stirring on a water bath at 50 ° C. under a stream of nitrogen. 500.0 g (1.836 mol) of the benzoic acid 2- (2-hydroxy-6-methoxyphenyl) ethyl obtained in Example 4 were added to the obtained solution. Then, the reaction mixture was stirred at the same temperature for 1.8 hours and then ice-cooled. 2.5 L of toluene was injected into the reaction solution, and then 5 L of tap water was added dropwise for about 1 hour. The contents were transferred to a 20 L separator, and separated to discard the aqueous layer. The organic layer was washed three times with tap water (5 L × 3), and then concentrated under reduced pressure at a bath temperature of 40 ° C. to obtain 846.1 g of the title compound.

1H-NMR(400MHz, CDCl3)δ(ppm): 1.39(s, 6H), 2.62(s, 2H), 3.13(t, J=6.8Hz, 2H), 3.82(s, 3H), 4.45(t, J=6.8Hz, 2H), 6.57(d, J=8.8Hz, 1H), 7.38-7.45(m, 2H), 7.51-7.57(m, 1H), 7.82(d, J=8.8Hz, 1H), 7.98-8.04(m, 2H). 1 H-NMR (400 MHz, CDCl 3 ) δ (ppm): 1.39 (s, 6H), 2.62 (s, 2H), 3.13 (t, J = 6.8 Hz, 2H), 3.82 (s, 3H), 4.45 ( t, J = 6.8 Hz, 2H), 6.57 (d, J = 8.8 Hz, 1H), 7.38-7.45 (m, 2H), 7.51-7.57 (m, 1H), 7.82 (d, J = 8.8 Hz, 1H ), 7.98-8.04 (m, 2 H).

(실시예 6)(Example 6)

8-(2-하이드록시에틸)-7-메톡시-2,2-디메틸크로만-4-온의 합성Synthesis of 8- (2-hydroxyethyl) -7-methoxy-2,2-dimethylchroman-4-one

Figure 112007086393561-PCT00085
Figure 112007086393561-PCT00085

상기 실시예 5에서 얻은 오일상 물질 844.9 g을 2.5 L의 테트라하이드로퓨란에 용해하여, 20 L 용량의 4구 둥근 바닥 플라스크에 옮겼다. 이 테트라하이드로퓨란 용액에 메탄올 2.5 L를 첨가한 다음, 얻어진 용액을 물(수온: 22℃)로 냉각 한 후, 교반 하에 8%(w/w) 수산화나트륨 수용액[수산화 나트륨(93.0%) 158 g에 물 1678 mL를 첨가하여 제조]을 18분간 적하하였다. 적하 종료 후, 상기 수욕을 제거하고, 상기 반응액을 실온에서 약 3.5 시간 동안 교반하였다. 그런 다음, 상기 반 응액에 약 1시간 동안 수돗물 10 L를 적하하였다. 반응 용기를 빙냉한 후, 1O℃ 이하의 내온에서 상기 반응액을 약 1시간 동안 교반하였다. 석출된 결정을 여과에 의해 수집하여, 수돗물 2 L 및 메탄올-수돗물 혼합물(1:4, 400 mL/1600 mL)로 차례로 세정하였다. 그런 다음, 상기 결정의 무게가 일정해질 때까지, 상기 결정을 40℃에서 감압 건조하여, 미정제 표기 화합물 374.7 g을 옅은 황백색 고체로서 얻었다.844.9 g of the oily material obtained in Example 5 was dissolved in 2.5 L of tetrahydrofuran and transferred to a 20 L four-neck round bottom flask. 2.5 L of methanol was added to this tetrahydrofuran solution, and the resulting solution was cooled with water (water temperature: 22 ° C), followed by stirring 158 g of an aqueous 8% (w / w) sodium hydroxide solution [sodium hydroxide (93.0%)]. Was prepared by adding 1678 mL of water to the mixture for 18 minutes. After completion of the dropwise addition, the water bath was removed, and the reaction solution was stirred at room temperature for about 3.5 hours. Then, 10 L of tap water was added dropwise to the reaction solution for about 1 hour. After the reaction vessel was ice-cooled, the reaction solution was stirred at about 100 ° C. or lower for about 1 hour. The precipitated crystals were collected by filtration and washed sequentially with 2 L of tap water and methanol-tap water mixture (1: 4, 400 mL / 1600 mL). Then, the crystals were dried under reduced pressure at 40 ° C. until the weight of the crystals became constant, to obtain 374.7 g of the crude title compound as a pale yellow-white solid.

수득량: 374.7 g, 함량: 305.8 g, 수율: 66.6%Yield: 374.7 g, content: 305.8 g, yield: 66.6%

15 L 용량의 4구 둥근 바닥 플라스크에, 상기 미정제 표기 화합물 374.7 g (함량: 305.8 g) 및 아세트산 에틸 2 L를 투입한 다음, 80℃로 가열한 수욕에서 가열 교반을 개시하였다. 얻어진 현탁액에 아세트산 에틸 4.116 L를 추가한 다음, 욕조 온도 설정을 75℃로 변경하였다. 상기 결정이 용해되었음을 확인한 후, 상기 수욕의 온도를 서서히 낮춘 다음, 45.3℃의 내온에서 종결정을 투입하였다. 종결정 투입 6분 후에 결정의 석출이 관찰되었다. 상기 수욕의 온도를 더 낮춘 다음, 30℃ 이하의 내온에서 상기 현탁액에 헵탄 6.116 L를 약 1시간 동안 첨가하고, 동일 온도에서 상기 반응액을 약 13시간 동안 교반하였다. 상기 현탁액을 빙냉한 다음, 약 4시간 교반한 후, 부흐너 깔때기로 여과하여 결정을 수집한 다음, 수집된 결정을 아세트산 에틸-헵탄(1:2) 혼합액 918 mL로 세정하였다. 그런 다음, 상기 결정을 40℃ 수욕 상에서 약 3시간 감압 건조하고, 실온에서 약 14시간 감압 건조함으로써, 표기 화합물을 회백색 고체로서 수득하였다.To a 15 L four-necked round bottom flask, 374.7 g (content: 305.8 g) of the crude titled compound and 2 L of ethyl acetate were added thereto, and then the stirring was started in a water bath heated to 80 ° C. 4.116 L of ethyl acetate was added to the obtained suspension, and the bath temperature setting was changed to 75 ° C. After confirming that the crystals were dissolved, the temperature of the water bath was gradually lowered, and seed crystals were added at an internal temperature of 45.3 ° C. Precipitation of crystals was observed 6 minutes after seed crystal addition. After lowering the temperature of the water bath, 6.116 L of heptane was added to the suspension at an internal temperature of 30 ° C. or lower for about 1 hour, and the reaction solution was stirred for about 13 hours at the same temperature. The suspension was cooled on ice, stirred for about 4 hours, filtered through a Buchner funnel to collect crystals, and the collected crystals were then washed with 918 mL of an ethyl-heptane (1: 2) mixture. The crystals were then dried under reduced pressure for about 3 hours on a 40 ° C. water bath and dried under reduced pressure for about 14 hours at room temperature to give the title compound as an off-white solid.

수득량: 294.5 g, 함량: 275.4 g, 수율: 90.1%Yield: 294.5 g, Content: 275.4 g, Yield: 90.1%

1H-NMR(400MHz, CDCl3)δ(ppm): 1.45(s, 6H), 2.68(s, 2H), 2.96(t, J=6.8Hz, 2H), 3.73-3.80(m, 2H), 3.89(s, 3H), 6.59(d, J=8.8Hz, 1H), 7.81(d, J=8.8Hz, 1H). 1 H-NMR (400 MHz, CDCl 3 ) δ (ppm): 1.45 (s, 6H), 2.68 (s, 2H), 2.96 (t, J = 6.8 Hz, 2H), 3.73-3.80 (m, 2H), 3.89 (s, 3H), 6.59 (d, J = 8.8 Hz, 1H), 7.81 (d, J = 8.8 Hz, 1H).

(실시예 7)(Example 7)

8-(2-하이드록시에틸)-7-메톡시-2,2-디메틸크로만4-온의 합성(재결정)Synthesis (Recrystallization) of 8- (2-hydroxyethyl) -7-methoxy-2,2-dimethylchroman4-one

10O mL 용량의 4구 둥근 바닥 플라스크에, 미정제 표기 화합물 3.71 g (함량: 3.0 g) 및 메틸이소부틸케톤 45 mL를 투입한 다음, 82℃로 가열한 유욕에서 가열 및 교반하여, 용액을 형성하였다. 이 용액을 서냉하고, 내온 59℃에서 종결정을 투입하였다. 30분마다 유욕의 온도 설정을 5℃씩 낮추어 서냉하고, 내온 26.7℃에서 헵탄 30 mL를 약 1시간 동안 적하하였다. 18분 경과 후, 상기 현탁액을 냉수로 냉각하고, 1시간 50분 후에 여과에 의해 결정을 얻었다. 얻어진 결정을, 메틸 이소부틸 케톤-헵탄 혼합액(3:2) 3 mL로 세정한 후, 40℃의 수욕 상에서 약 1시간 동안 감압 건조하여, 표기 화합물을 백색 고체로서 얻었다.To a 100 mL four-necked round bottom flask, 3.71 g (content: 3.0 g) of crude title compound and 45 mL of methyl isobutyl ketone were added, followed by heating and stirring in an oil bath heated to 82 ° C. to form a solution. It was. The solution was slowly cooled, and seed crystals were added at an inner temperature of 59 ° C. Every 30 minutes, the temperature setting of the oil bath was lowered by 5 ° C., and 30 mL of heptane was added dropwise for about 1 hour at an internal temperature of 26.7 ° C. After 18 minutes, the suspension was cooled with cold water and crystals were obtained by filtration after 1 hour and 50 minutes. The obtained crystals were washed with 3 mL of methyl isobutyl ketone-heptane mixed solution (3: 2), and then dried under reduced pressure for about 1 hour on a 40 DEG C water bath to obtain the title compound as a white solid.

수득량: 2.72 g, 함량: 2.64 g, 수율: 87.8%Yield: 2.72 g, content: 2.64 g, yield: 87.8%

(실시예 8)(Example 8)

(7-메톡시-2,2-디메틸-4-옥소크로만-8-일)아세트알데하이드의 합성Synthesis of (7-methoxy-2,2-dimethyl-4-oxochromen-8-yl) acetaldehyde

Figure 112007086393561-PCT00086
Figure 112007086393561-PCT00086

15 L 용량의 4구 둥근 바닥 플라스크에 8-(2-하이드록시에틸)-7-메톡시-2,2-디메틸크로만-4-온 248.3 g (함량: 232.7 g, 0.930 몰) 및 동일 화합물 294.0 g (함량: 274.9 g, 1.098 몰), 아세트산 에틸 7614 mL를 투입하여 교반하였다. 그런 다음, -4℃로 온도 설정된 냉욕을 사용하여, 이 현탁액의 냉각을 개시한 후, 브롬화나트륨 161.9 g (1.574 몰), 수돗물 508 mL 및 2,2,6,6-테트라메틸피페리딘 옥사이드 3.17 g (20.28 mmol)을 차례로 투입하였다. 내온이 0℃에 도달한 후, 상기 플라스크 내에 차아염소산 나트륨 용액 5.536 몰과 7%(w/w) 탄산수소나트륨 수용액 2538 g의 혼합액을 약 2시간 동안 적하하였다. 적하 종료 후, 상기 냉각욕의 온도를 0℃로 변경하고, 상기 반응액을 45분간 계속 교반하였다. 상기 반응액을 20 L 용량의 분액 깔때기에 옮기고, 수층을 폐기하였다. 유기층을 10% 염화나트륨 수용액 2030 g 및 수돗물 2030 mL로 차례로 세정하였다. 세정된 유기층을 감압 농축(40℃)하여, 슬러리 743.7 g을 얻었다. 상기 슬러리에 DME 500 mL를 첨가하여 용액을 형성하고, 얻어진 용액을 감압 농축(40℃)한 후, 석출된 결정에 다시 DME 500 mL를 첨가하여 용해하였다. 이 용액을 5 L 용량의 4구 둥근 바닥 플라스크에 옮긴 다음, 40℃의 수욕에서 가열하였다. 상기 반응액에 DME 515 mL를 첨가한 후, 183 rpm에서 교반한 다음, 수돗물 약 50O mL를 투입하고, 4분 후에 빙수욕에서 냉각을 개시하였다. 상기 반응액에 종결정을 첨가한 후, 약 1시간 교반한 다음, 수돗물 약 515 mL를 약 30분간 첨가하였다. 그런 다음, 상기 반응액을 1.3시간 더 교반한 후, 헵탄 1523 mL를 약 1시간 동안 투입하고, 얻어진 용액을 동일 온도에서 약 1시간 이상 교반하였다. 석출된 결정을 여과에 의해 수집한 후, DME/수돗물/헵 탄의 혼합액(약 600 mL, DME/수돗물/헵탄=1/1/1.5의 비율로 혼합한 것을 사용)으로 세정한 다음, 상기 결정의 무게가 거의 일정량이 될 때까지, 감압 건조(욕조 온도 40℃)하여, 표기 화합물을 황백색 고체로서 얻었다.248.3 g (content: 232.7 g, 0.930 mol) of 8- (2-hydroxyethyl) -7-methoxy-2,2-dimethylchroman-4-one in a 15 L four-necked round bottom flask 294.0 g (content: 274.9 g, 1.098 mol) and 7614 mL of ethyl acetate were added and stirred. The cooling of this suspension was then initiated using a cold bath set at −4 ° C., followed by 161.9 g (1.574 moles) of sodium bromide, 508 mL of tap water and 2,2,6,6-tetramethylpiperidine oxide 3.17 g (20.28 mmol) were added sequentially. After the internal temperature reached 0 ° C., a mixture of 5.536 mol of sodium hypochlorite solution and 2538 g of a 7% (w / w) sodium hydrogen carbonate solution was added dropwise into the flask for about 2 hours. After completion of the dropwise addition, the temperature of the cooling bath was changed to 0 ° C, and the reaction solution was continuously stirred for 45 minutes. The reaction solution was transferred to a 20 L separatory funnel and the aqueous layer was discarded. The organic layer was washed sequentially with 2030 g of 10% aqueous sodium chloride solution and 2030 mL of tap water. The washed organic layer was concentrated under reduced pressure (40 ° C) to give 743.7 g of a slurry. 500 mL of DME was added to the slurry to form a solution. The resulting solution was concentrated under reduced pressure (40 ° C.), and 500 mL of DME was further added to the precipitated crystals to dissolve it. The solution was transferred to a 5 L four-necked round bottom flask and heated in a 40 ° C. water bath. After adding 515 mL of DME to the reaction solution, the mixture was stirred at 183 rpm, about 50 mL of tap water was added thereto, and 4 minutes later, cooling was started in an ice water bath. After adding seed crystals to the reaction solution, the mixture was stirred for about 1 hour, and then about 515 mL of tap water was added for about 30 minutes. Then, the reaction solution was further stirred for 1.3 hours, 1523 mL of heptane was added for about 1 hour, and the resulting solution was stirred for about 1 hour or more at the same temperature. The precipitated crystals were collected by filtration, washed with a mixed solution of DME / tap water / heptane (about 600 mL, mixed at a ratio of DME / tap water / heptane = 1/1 / 1.5), and then the crystals It dried under reduced pressure (bath temperature 40 degreeC) until the weight of nearly became a fixed amount, and the title compound was obtained as an off-white solid.

수득량: 478.0 g, 함량: 413.9 g, 수율: 82.2%Yield: 478.0 g, Content: 413.9 g, Yield: 82.2%

1H-NMR(600MHz, DMSO-d6)δ(ppm): 1.34(s, 6H), 2.70(s, 2H), 3.63(s, 2H), 3.83(s, 3H), 6.80(d, J=9.0Hz, 1H), 7.72(d, J=9.0Hz, 1H), 9.58(s, 1H). 1 H-NMR (600 MHz, DMSO-d 6 ) δ (ppm): 1.34 (s, 6H), 2.70 (s, 2H), 3.63 (s, 2H), 3.83 (s, 3H), 6.80 (d, J = 9.0 Hz, 1H), 7.72 (d, J = 9.0 Hz, 1H), 9.58 (s, 1H).

(실시예 9)(Example 9)

(7-메톡시-2,2-디메틸-4-옥소크로만-8-일)아세트알데하이드의 합성Synthesis of (7-methoxy-2,2-dimethyl-4-oxochromen-8-yl) acetaldehyde

Figure 112007086393561-PCT00087
Figure 112007086393561-PCT00087

20O mL 용량의 4구 둥근 바닥 플라스크에 (7-메톡시-2,2-디메틸-4-옥소크로만-8-일)아세트알데하이드 6.54 g (함량: 6.0 g), 에탄올 54 mL 및 아세트산 에틸 6 mL를 첨가하여, 얻어진 반응액을 실온에서 교반하였다. 교반된 반응액에 아황산수소나트륨 수용액(2.51 g을 물 6 mL에 용해한 것)을 20분간 적하하였다. 그런 다음, 아세트산 에틸 60 mL를 1.5시간 동안 적하하고, 실온 상태에서 상기 반응액을 철야 교반하였다. 석출된 결정을 여과에 의해 수집한 다음, 수집된 결정을 에탄올/아세트산 에틸(1/1) 혼합액(12 mL)으로 세정하여, 표기 화합물의 아황산수소나트륨 부가체 8.14 g을 얻었다.In a 20-neck, four-necked round-bottom flask (7-methoxy-2,2-dimethyl-4-oxochromen-8-yl), 6.54 g acetaldehyde (6.0 g), 54 mL ethanol and 6 ethyl acetate mL was added and the resulting reaction solution was stirred at room temperature. An aqueous sodium hydrogen sulfite solution (2.51 g dissolved in 6 mL of water) was added dropwise to the stirred reaction solution for 20 minutes. Then, 60 mL of ethyl acetate was added dropwise for 1.5 hours, and the reaction solution was stirred overnight at room temperature. The precipitated crystals were collected by filtration, and then the collected crystals were washed with an ethanol / ethyl acetate (1/1) mixture (12 mL) to obtain 8.14 g of sodium hydrogen sulfite adduct of the title compound.

표기 화합물의 아황산수소나트륨 부가체Sodium hydrogen sulfite adduct of the title compound

1H-NMR(600MHz, DMSO-d6)δ(ppm): 1.35(s, 3H), 1.36(s, 3H), 2.66(s, 2H), 2.88(dd, J=13.0, 3.0Hz, 1H), 3.00(dd, J=13.0, 11.0Hz, 1H), 3.81(s, 3H), 4.18(ddd, J=11.0, 6.0, 3.0Hz, 1H), 4.35(d, J=6.0Hz, 1H), 6.69(d, J=9.0Hz, 1H), 7.60(d, J=9.0Hz, 1H) 1 H-NMR (600 MHz, DMSO-d 6 ) δ (ppm): 1.35 (s, 3H), 1.36 (s, 3H), 2.66 (s, 2H), 2.88 (dd, J = 13.0, 3.0 Hz, 1H ), 3.00 (dd, J = 13.0, 11.0 Hz, 1H), 3.81 (s, 3H), 4.18 (ddd, J = 11.0, 6.0, 3.0 Hz, 1H), 4.35 (d, J = 6.0 Hz, 1H) , 6.69 (d, J = 9.0 Hz, 1H), 7.60 (d, J = 9.0 Hz, 1H)

30O mL 용량의 4구 둥근 바닥 플라스크에, 표기 화합물의 아황산수소나트륨 부가체 6.0 g 및 아세트산 에틸 120 mL를 첨가하여 교반하였다. 이 현탁액에 10% 탄산칼륨 수용액 30 g을 첨가한 후, 얻어진 반응액을 실온에서 2시간 이상 교반하였다. 유기층을 분리하고, 상기 유기층을 10% 식염수 및 수돗물(2회)로 차례로 세정하였다. 세정된 유기층에 톨루엔 12 mL를 첨가하고, 감압 농축한 후, 감압 건조하여, 담황색 고체로서 표기 화합물 3.49 g을 얻었다.To a 30-necked four-necked round bottom flask, 6.0 g of sodium bisulfite adduct of the title compound and 120 mL of ethyl acetate were added and stirred. After adding 30 g of 10% aqueous potassium carbonate solution to the suspension, the obtained reaction solution was stirred at room temperature for 2 hours or more. The organic layer was separated and the organic layer was washed sequentially with 10% saline and tap water (twice). Toluene 12 mL was added to the washed organic layer, concentrated under reduced pressure, and dried under reduced pressure to obtain 3.49 g of the title compound as a pale yellow solid.

(실시예 10)(Example 10)

1-{1-[2-(7-메톡시-2,2-디메틸-4-옥소크로만-8-일)에틸]피페리딘-4-일}-N-메틸-1H-인돌-6-카르복사미드의 합성1- {1- [2- (7-methoxy-2,2-dimethyl-4-oxochromen-8-yl) ethyl] piperidin-4-yl} -N-methyl-1H-indole-6 Synthesis of Carboxamide

Figure 112007086393561-PCT00088
Figure 112007086393561-PCT00088

질소 기류 하, 15 L 용량의 4구 둥근 바닥 플라스크에, 제조예 7에서 합성한 N-메틸-1-(피페리딘-4-일)-1H-인돌-6-카르복사미드 677.0 g (함유량: 332.8 g, 1.293 mmol) 및 테트라하이드로퓨란 2,00O mL를 첨가하였다. 또한, 이 현탁액에, 실시예 8에서 얻은 (7-메톡시-2,2-디메틸-4-옥소크로만-8-일)아세트알데하이드 426.4 g (함유량: 369.2 g, 1.15 당량), 테트라하이드로퓨란 1328 mL 및 아세트산 148 mL(2.0 몰당량)를 차례로 투입한 다음, 실온에서 원료의 용해를 확인한 시점으로부터 상기 반응액을 1시간 동안 교반하였다. 그런 다음, 빙수욕에서 상기 반응액을 1O℃ 이하로 냉각한 후, 상기 반응액에 트리아세톡시수소화붕소나트륨(356.3 g, 1.3 몰당량)을 4분할하여 투입하였다. 전량 투입 종료 시점으로부터 약 10분 후, 상기 빙수욕을 수욕(21.9℃)으로 교체하고, 온도 제어하면서 교반하였다. 약 1시간 후, 상기 반응액을 샘플링하여, HPLC 분석에 의해 반응의 종료를 확인하였다. 상기 반응 용기를 빙수욕으로 냉각한 다음, 약 10℃에서 상기 반응액에 아세트산 에틸 4500 mL를 첨가하였다. 그런 다음, 상기 반응액에 1N 수산화나트륨 수용액 5200 mL를 36분간 투입하였다.677.0 g of N-methyl-1- (piperidin-4-yl) -1H-indole-6-carboxamide synthesized in Production Example 7 in a four-necked round bottom flask having a capacity of 15 L under nitrogen stream : 332.8 g, 1.293 mmol) and 2,00 mL of tetrahydrofuran were added. Furthermore, to this suspension, 426.4 g of (7-methoxy-2,2-dimethyl-4-oxochromen-8-yl) acetaldehyde obtained in Example 8 (content: 369.2 g, 1.15 equiv) and tetrahydrofuran 1328 mL and acetic acid 148 mL (2.0 molar equivalents) were added sequentially, and the reaction solution was stirred for 1 hour from the time point when dissolution of the raw material was confirmed at room temperature. Then, the reaction solution was cooled to 10 ° C. or lower in an ice water bath, and sodium triacetoxy borohydride (356.3 g, 1.3 molar equivalents) was added to the reaction solution in 4 portions. After about 10 minutes from the end of the total amount addition, the ice water bath was replaced with a water bath (21.9 ° C.) and stirred under temperature control. After about 1 hour, the reaction solution was sampled to confirm the end of the reaction by HPLC analysis. The reaction vessel was cooled in an ice water bath, and then 4500 mL of ethyl acetate was added to the reaction solution at about 10 ° C. Then, 5200 mL of 1N aqueous sodium hydroxide solution was added to the reaction solution for 36 minutes.

상기 반응액을 20 L 용량의 분액 장치에 옮기고, 아세트산 에틸 2156 mL로 세정한 다음, 유기층을 분리하였다. 얻어진 유기층을 7% 탄산수소나트륨 수용액 1000 g, 5% 식염수(3328 g 및 1000 g: 2회) 및 수돗물 3328 mL로 차례로 세정하였다.The reaction solution was transferred to a 20 L separator, washed with 2156 mL of ethyl acetate, and the organic layer was separated. The obtained organic layer was washed with 1000 g of 7% aqueous sodium hydrogen carbonate solution, 5% brine (3328 g and 1000 g twice) and 3328 mL of tap water.

상기 유기층을 감압 농축한 다음, 에탄올 1664 mL를 첨가한 후, 농축한 다음, 얻어진 용액 1902.6 g을 정량하였다. 표기 화합물의 함유량은 581.1 g, 수율은 91.8%, HPLC 순도는 92.5%이었다.The organic layer was concentrated under reduced pressure, 1664 mL of ethanol was added, concentrated, and 1902.6 g of the resulting solution was quantified. The content of the title compound was 581.1 g, the yield was 91.8%, and the HPLC purity was 92.5%.

상기 농축물에 에탄올 1664 mL를 첨가하여 용해한 다음, 활성탄 57.0 g을 투 입한 후, 약 1시간 동안 교반하였다. 상기 활성탄을 Hyflo Super-Cel을 이용해서 여과하여 제거한 다음, 에탄올 400 mL로 세정하였다. 그 여액을 감압 농축(내온 40℃)하여, 갈색 오일상 물질로서 표기 화합물 1461.8 g을 얻었다. 함유량: 552.5 g, HPLC 순도: 92.5%1664 mL of ethanol was added to the concentrate to dissolve it, and 57.0 g of activated carbon was added thereto, followed by stirring for about 1 hour. The activated carbon was removed by filtration using Hyflo Super-Cel, and then washed with 400 mL of ethanol. The filtrate was concentrated under reduced pressure (internal temperature 40 ° C) to obtain 1461.8 g of the titled compound as a brown oily substance. Content: 552.5 g, HPLC Purity: 92.5%

(실시예 11)(Example 11)

1-피페리딘-4-일-1H-인돌-6-카르복시산 메틸 염산염의 합성Synthesis of 1-piperidin-4-yl-1H-indole-6-carboxylic acid methyl hydrochloride

Figure 112007086393561-PCT00089
Figure 112007086393561-PCT00089

1-(1-벤질옥시카르보닐피페리딘-4-일)-1H-인돌-6-카르복시산 메틸 27.5 g을 메탄올 68.75 mL 및 테트라하이드로퓨란 68.75 mL에 용해하고, 10% 팔라듐-탄소(약 50% 함수품) 1.1 g의 존재 하에, 0.3 ㎫의 수소 분위기에서 약 7.5 시간 교반하였다. 상기 촉매를 여과에 의해 제거한 다음, 상기 용매를 증류에 의해 제거하여, 혼합물 16.69 g을 얻었다. 이 혼합물 중 6.96 g을 사용하여, 2-프로판올 77 mL에 용해한 다음, 빙냉 하에 농축 염산 2.73 mL를 서서히 첨가하였다. 석출된 결정을 여과에 의해 수집하고, 수집된 결정을 2-프로판올로 세정하였다. 상기 결정을 감압 건조한 후, 표기 화합물 5.89 g을 얻었다.27.5 g of 1- (1-benzyloxycarbonylpiperidin-4-yl) -1H-indole-6-carboxylic acid methyl are dissolved in 68.75 mL of methanol and 68.75 mL of tetrahydrofuran and 10% palladium-carbon (about 50 % Water) agitation was performed for about 7.5 hours in a hydrogen atmosphere of 0.3 MPa in the presence of 1.1 g. The catalyst was removed by filtration and then the solvent was removed by distillation to give 16.69 g of the mixture. Using 6.96 g of this mixture, it was dissolved in 77 mL of 2-propanol and then slowly added 2.73 mL of concentrated hydrochloric acid under ice-cooling. The precipitated crystals were collected by filtration, and the collected crystals were washed with 2-propanol. After drying the crystals under reduced pressure, 5.89 g of the title compound were obtained.

1H-NMR(400MHz, DMSO-d6)δ(ppm): 2.00-2.30(m, 4H), 3.05-3.25(m, 2H), 3.30-3.50(m, 2H), 3.85(s, 3H), 4.80-5.00(m, 1H), 6.61(d, J=3.1Hz, 1H), 7.61(d, J=3.1Hz, 1H), 7.60-7.70(m, 2H), 8.26(s, 1H). 1 H-NMR (400 MHz, DMSO-d 6 ) δ (ppm): 2.00-2.30 (m, 4H), 3.05-3.25 (m, 2H), 3.30-3.50 (m, 2H), 3.85 (s, 3H) , 4.80-5.00 (m, 1H), 6.61 (d, J = 3.1 Hz, 1H), 7.61 (d, J = 3.1 Hz, 1H), 7.60-7.70 (m, 2H), 8.26 (s, 1H).

(실시예 12)(Example 12)

1-{1-[2-(7-메톡시-2,2-디메틸-4-옥소크로만-8-일)에틸]피페리딘-4-일}-1H-인돌-6-카르복시산 메틸의 합성Of 1- {1- [2- (7-methoxy-2,2-dimethyl-4-oxochroman-8-yl) ethyl] piperidin-4-yl} -1H-indole-6-carboxylic acid methyl synthesis

Figure 112007086393561-PCT00090
Figure 112007086393561-PCT00090

1-피페리딘-4-일-1H-인돌-6-카르복시산 메틸 염산염 2.92 g 및 (7-메톡시-2,2-디메틸-4-옥소크로만-8-일)아세트알데하이드 2.92 g에, 테트라하이드로퓨란 58.4 mL 및 아세트산 14.6 mL를 첨가한 다음, 40℃로 가열한 후, 이 반응액을 약 3시간 동안 교반하였다. 상기 반응액을 빙수욕에서 냉각한 후, 상기 반응액에 트리아세톡시수소화붕소나트륨 2.52 g을 3회로 나누어 첨가하였다. 얻어진 반응액을 실온으로 되돌리고, 30분 후에 반응의 진행을 확인하였다. 상기 반응액을 다시 빙수욕에서 냉각한 다음, 톨루엔 87 mL 및 물 29 mL를 첨가하고, 수층을 폐기하였다. 상기 유기층을 1N 수산화나트륨 수용액 49 mL, 69 mL 및 30 mL로 차례로 세정한 후, 5% 식염수 29 mL, 14 mL, 그리고 물 14 mL로 세정하였다. 상기 용매를 증류에 의해 제거함으로써, 미정제 표제 화합물 4.80 g을 얻었다.2.92 g of 1-piperidin-4-yl-1H-indole-6-carboxylic acid methyl hydrochloride and 2.92 g of (7-methoxy-2,2-dimethyl-4-oxochromen-8-yl) acetaldehyde, 58.4 mL of tetrahydrofuran and 14.6 mL of acetic acid were added, then heated to 40 ° C., and the reaction solution was stirred for about 3 hours. After cooling the reaction solution in an ice water bath, 2.52 g of sodium triacetoxy borohydride was added to the reaction solution in three portions. The obtained reaction liquid was returned to room temperature, and progress of reaction was confirmed after 30 minutes. The reaction solution was again cooled in an ice water bath, then 87 mL of toluene and 29 mL of water were added, and the aqueous layer was discarded. The organic layer was washed sequentially with 49 mL, 69 mL, and 30 mL of 1N aqueous sodium hydroxide solution, followed by 29 mL of 5% saline solution, 14 mL, and 14 mL of water. By removing the solvent by distillation, 4.80 g of crude title compound was obtained.

1H-NMR(400MHz, CDCl3)δ(ppm): 1.47(s, 6H), 2.10-2.20(m, 4H), 2.25-2.40(m, 2H), 2.50-2.60(m, 2H), 2.69(s, 2H), 2.85-2.95(m, 2H), 3.20-3.35(m, 2H), 3.90(s, 3H), 3.96(s, 3H), 4.30-4.45(m, 1H), 6.50-6.60(m, 1H), 6.59(d, J=8.8Hz, 1H), 7.42(d, J=3.1Hz, 1H), 7.64(d, J=8.4Hz, 1H), 7.79(dd, J=8.40, 1.50Hz, 1H), 7.80(d, J=8.8Hz, 1H), 8.16(s, 1H). 1 H-NMR (400 MHz, CDCl 3 ) δ (ppm): 1.47 (s, 6H), 2.10-2.20 (m, 4H), 2.25-2.40 (m, 2H), 2.50-2.60 (m, 2H), 2.69 (s, 2H), 2.85-2.95 (m, 2H), 3.20-3.35 (m, 2H), 3.90 (s, 3H), 3.96 (s, 3H), 4.30-4.45 (m, 1H), 6.50-6.60 (m, 1H), 6.59 (d, J = 8.8 Hz, 1H), 7.42 (d, J = 3.1 Hz, 1H), 7.64 (d, J = 8.4 Hz, 1H), 7.79 (dd, J = 8.40, 1.50 Hz, 1H), 7.80 (d, J = 8.8 Hz, 1H), 8.16 (s, 1H).

(실시예 13)(Example 13)

1-{1-[2-(7-메톡시-2,2-디메틸-4-옥소크로만-8-일)에틸]피페리딘-4-일}-1H-인돌-6-카르복시산의 합성Synthesis of 1- {1- [2- (7-methoxy-2,2-dimethyl-4-oxochromen-8-yl) ethyl] piperidin-4-yl} -1H-indole-6-carboxylic acid

Figure 112007086393561-PCT00091
Figure 112007086393561-PCT00091

1-{1-[2-(7-메톡시-2,2-디메틸-4-옥소크로만-8-일)에틸]피페리딘-4-일}-1H-인돌-6-카르복시산 메틸의 상기 미정제 생성물 3.5 g을 테트라하이드로퓨란 28.0 mL에 용해하고, 얻어진 용액에 1N 수산화나트륨 수용액 14 mL를 첨가하였다. 얻어진 반응액에 메탄올 14 mL를 첨가한 다음, 40℃로 가열하고, 30분 교반하였다. 그런 다음, 테트라하이드로퓨란 7 mL 및 메탄올 3.5 mL를 추가한 다음, 2시간 동안 교반하고, 동일 온도에서 약 16시간 더 교반하였다. 상기 반응액을 빙수욕에서 냉각시킨 다음, 1N 염산 12.2 mL 및 1N 수산화나트륨 0.5 mL를 첨가하여, pH를 7로 조정하자, 결정이 석출되었다. 이 슬러리에 물 10 mL를 더 첨가한 다음, 여과에 의해 상기 결정을 수집하고, 수집된 결정을 2-프로판올과 물의 혼합액(5:1) 21 mL로 세정하였다. 세정된 결정을 감압 건조하여, 표기 화합물 2.45 g을 얻었다.Of 1- {1- [2- (7-methoxy-2,2-dimethyl-4-oxochroman-8-yl) ethyl] piperidin-4-yl} -1H-indole-6-carboxylic acid methyl 3.5 g of the crude product was dissolved in 28.0 mL of tetrahydrofuran, and 14 mL of 1N aqueous sodium hydroxide solution was added to the resulting solution. To the obtained reaction solution, 14 mL of methanol was added, heated to 40 ° C., and stirred for 30 minutes. Then, 7 mL of tetrahydrofuran and 3.5 mL of methanol were added, followed by stirring for 2 hours, and further stirring at the same temperature for about 16 hours. The reaction solution was cooled in an ice water bath, and then 12.2 mL of 1N hydrochloric acid and 0.5 mL of 1N sodium hydroxide were added to adjust the pH to 7 to precipitate crystals. To the slurry was further added 10 mL of water, and then the crystals were collected by filtration, and the collected crystals were washed with 21 mL of a mixture of 2-propanol and water (5: 1). The washed crystals were dried under a reduced pressure to obtain 2.45 g of the title compound.

1H-NMR(400MHz, DMSO-d6)δ(ppm): 1.39(s, 6H), 1.90-2.10(m ,4H), 2.20-2.35(m, 2H), 2.40-2.50(m, 2H), 2.70(s, 2H), 2.70-2.80(m, 2H), 3.05-3.15(m, 2H), 3.85(s, 3H), 4.40-4.55(m, 1H), 6.53(dJ=3.4Hz, 1H), 6.73(d, J=8.8Hz, 1H), 7.57(d, J=8.0Hz, 1H), 7.61(dd, J=8.0, 1.2Hz, 1H), 7.63(d, J=8.8Hz ,1H), 7.72(d ,J=3.4Hz, 1H), 8.15(s, 1H). 1 H-NMR (400 MHz, DMSO-d 6 ) δ (ppm): 1.39 (s, 6H), 1.90-2.10 (m, 4H), 2.20-2.35 (m, 2H), 2.40-2.50 (m, 2H) , 2.70 (s, 2H), 2.70-2.80 (m, 2H), 3.05-3.15 (m, 2H), 3.85 (s, 3H), 4.40-4.55 (m, 1H), 6.53 (dJ = 3.4Hz, 1H ), 6.73 (d, J = 8.8 Hz, 1H), 7.57 (d, J = 8.0 Hz, 1H), 7.61 (dd, J = 8.0, 1.2 Hz, 1H), 7.63 (d, J = 8.8 Hz, 1H ), 7.72 (d, J = 3.4 Hz, 1 H), 8.15 (s, 1 H).

(실시예 14)(Example 14)

1-{1-[2-(7-메톡시-2,2-디메틸-4-옥소크로만-8-일)에틸]피페리딘-4-일}-1H-인돌-6-카르복시산 메틸의 합성Of 1- {1- [2- (7-methoxy-2,2-dimethyl-4-oxochroman-8-yl) ethyl] piperidin-4-yl} -1H-indole-6-carboxylic acid methyl synthesis

Figure 112007086393561-PCT00092
Figure 112007086393561-PCT00092

1-피페리딘-4-일-1H-인돌-6-카르복시산 메틸 2.80 g 및 (7-메톡시-2,2-디메틸-4-옥소크로만-8-일)아세트알데하이드 3.16 g에, DME 28 mL, 테트라하이드로퓨란 14 mL 및 아세트산 1.24 mL를 첨가하였다. 결정이 석출되었지만, 상기 반응액을 그대로 1시간 동안 교반하였다. 그런 다음, 상기 반응액을 빙수욕에서 냉각시킨 후, 상기 반응액에 트리아세톡시수소화붕소나트륨 2.75 g을 3회로 나누어 첨가하였다. 상기 반응액을 실온으로 되돌린 다음, 테트라하이드로퓨란 3 mL를 추가하고, 약 1.5 시간 후에 반응의 진행을 확인하였다. 상기 반응액을 다시 빙수욕에서 냉각시킨 다음, 톨루엔 68 mL 및 물 29 mL를 첨가하고, 청징 여과(淸澄濾過)한 후, 톨루엔 30 mL를 첨가하고, 수층을 폐기하였다. 유기층을, 1N 수산화나트륨 수용액 29 mL, 5% 식염수 29 mL×2회 및 물 29 mL로 세정하였다. 용매를 증류에 의해 제거하여, 미정제 표제 화합물 5.62 g을 얻었다.2.80 g of 1-piperidin-4-yl-1H-indol-6-carboxylic acid and 3.16 g of (7-methoxy-2,2-dimethyl-4-oxochromen-8-yl) acetaldehyde, DME 28 mL, tetrahydrofuran 14 mL and acetic acid 1.24 mL were added. Crystals precipitated, but the reaction solution was stirred for 1 hour. Then, the reaction solution was cooled in an ice water bath, and then 2.75 g of sodium triacetoxyborohydride was added to the reaction solution in three portions. After returning the reaction solution to room temperature, 3 mL of tetrahydrofuran was added, and the progress of the reaction was observed after about 1.5 hours. The reaction solution was cooled again in an ice-water bath, and then 68 mL of toluene and 29 mL of water were added, and after clarification filtration, 30 mL of toluene was added, and the aqueous layer was discarded. The organic layer was washed with 29 mL of 1N aqueous sodium hydroxide solution, 29 mL of 5% saline solution, and 29 mL of water. The solvent was removed by distillation to give 5.62 g of crude title compound.

(실시예 15)(Example 15)

1-{1-[2-(7-메톡시-2,2-디메틸-4-옥소크로만-8-일)에틸]피페리딘-4-일}-1H-인돌-6-카르복시산의 합성Synthesis of 1- {1- [2- (7-methoxy-2,2-dimethyl-4-oxochromen-8-yl) ethyl] piperidin-4-yl} -1H-indole-6-carboxylic acid

Figure 112007086393561-PCT00093
Figure 112007086393561-PCT00093

1-{1-[2-(7-메톡시-2,2-디메틸-4-옥소크로만-8-일)에틸]피페리딘-4-일}-1H-인돌-6-카르복시산 메틸의 미정제 생성물 4.0 g을 테트라하이드로퓨란 40.0 mL에 용해한 다음, 얻어진 용액에 1N 수산화나트륨 수용액 16 mL를 첨가하였다. 그런 다음, 메탄올 20 mL를 첨가하여 상기 반응액의 분층(分層)을 제거한 후, 상기 반응액을 40℃에서 약 20.5시간 동안 교반하였다. 교반된 반응액을 빙수욕에서 냉각한 다음, 1N 염산 15 mL를 첨가하여, pH 7로 조정하자, 결정이 석출되었다. 이 슬러 리에 물 1O mL를 더 첨가하고, 상기 결정을 여과에 의해 수집한 다음, 수집된 결정을 2-프로판올/물 (1/5, 24 mL)로 세정하였다. 세정된 결정을 감압 건조하여, 표기 화합물 3.34 g을 얻었다.Of 1- {1- [2- (7-methoxy-2,2-dimethyl-4-oxochroman-8-yl) ethyl] piperidin-4-yl} -1H-indole-6-carboxylic acid methyl 4.0 g of crude product was dissolved in 40.0 mL of tetrahydrofuran, and then 16 mL of 1N aqueous sodium hydroxide solution was added to the resulting solution. Then, 20 mL of methanol was added to remove the partition of the reaction solution, and the reaction solution was stirred at 40 ° C. for about 20.5 hours. The stirred reaction solution was cooled in an ice-water bath, and then 15 mL of 1N hydrochloric acid was added to adjust the pH to 7 to precipitate crystals. 100 mL of water was added to this slurry, and the crystals were collected by filtration, and then the collected crystals were washed with 2-propanol / water (1/5, 24 mL). The washed crystals were dried under a reduced pressure to obtain 3.34 g of the title compound.

(실시예 16)(Example 16)

1-{1-[2-(7-메톡시-2,2-디메틸-4-옥소크로만-8-일)에틸]피페리딘-4-일}-N-메틸-1H-인돌-6-카르복사미드의 합성1- {1- [2- (7-methoxy-2,2-dimethyl-4-oxochromen-8-yl) ethyl] piperidin-4-yl} -N-methyl-1H-indole-6 Synthesis of Carboxamide

Figure 112007086393561-PCT00094
Figure 112007086393561-PCT00094

1-{1-[2-(7-메톡시-2,2-디메틸-4-옥소크로만-8-일)에틸]피페리딘-4-일}-1H-인돌-6-카르복시산 1.0 g을 에탄올 25 mL에 용해한 다음, 얻어진 용액에 1,1'-카르보닐디이미다졸 851 ㎎을 첨가한 후, 상기 반응액을 40℃에서 2시간 교반하였다. 그런 다음, 상기 반응액을 빙수욕에서 냉각시킨 다음, 상기 반응액에 40% 메틸아민 수용액 1.81 mL를 첨가한 후, 50분간 교반하였다. 교반된 반응액에 아세트산 에틸 40 mL 및 물 20 mL를 첨가하고, 유기층을 분리하였다. 얻어진 유기층에 10% 식염수 20 mL를 첨가하여 세정한 다음, 1N 염산수 8.5 mL를 첨가하여 pH 7로 조정하고, 수층을 폐기하고, 상기 유기층을 물 10 mL로 세정하였다. 얻어진 유기층을 감압 농축한 후, 1-프로판올 3 mL를 첨가한 다음, 재농축하여, 표기 화합물을 얻었다.1.0 g of 1- {1- [2- (7-methoxy-2,2-dimethyl-4-oxochromen-8-yl) ethyl] piperidin-4-yl} -1H-indole-6-carboxylic acid Was dissolved in 25 mL of ethanol, and 851 mg of 1,1'-carbonyldiimidazole was added to the resulting solution, and the reaction solution was stirred at 40 ° C for 2 hours. Then, the reaction solution was cooled in an ice water bath, and then 1.81 mL of 40% aqueous methylamine solution was added to the reaction solution, followed by stirring for 50 minutes. 40 mL of ethyl acetate and 20 mL of water were added to the stirred reaction solution, and the organic layer was separated. 20 mL of 10% saline was added to the obtained organic layer, followed by washing. Then, 8.5 mL of 1N hydrochloric acid was added to adjust pH to 7. The aqueous layer was discarded, and the organic layer was washed with 10 mL of water. The obtained organic layer was concentrated under reduced pressure, and then 3 mL of 1-propanol was added and then concentrated again to obtain the title compound.

실시예 6의 화합물은 하기의 참고예에 따라서도 제조될 수 있다.The compound of Example 6 may also be prepared according to the following reference example.

(참고예 1)(Reference Example 1)

2,6-디아세톡시톨루엔의 합성Synthesis of 2,6-diacetoxytoluene

Figure 112007086393561-PCT00095
Figure 112007086393561-PCT00095

빙수욕 상에서 교반되고 있는, 2,6-디하이드록시톨루엔 6.2 g (50 mmol) 및 탄산칼륨 27.6 g (20O mmol)의 아세토니트릴 62 mL 현탁액에, 무수 아세트산 15.0 mL (16.3 g, 160 mmol)을 3분간 적하하였다. 27분 후, 교반을 멈추고, 이 반응액을 실온에서 하룻밤 동안 방치한 다음, 여과한 후, 여액에 톨루엔 10O mL 및 물 50 mL를 첨가하여, 분액 깔때기에서 교반 및 정치(靜置)시켰다. 수층을 폐기하고, 유기층을 물 25 mL로 2회 세정한 다음, 상기 용매를 증류에 의해 제거함으로써, 표기 화합물 10.3 g을 얻었다.15.0 mL (16.3 g, 160 mmol) of acetic anhydride was added to a 62 mL suspension of 6.2 g (50 mmol) of 2,6-dihydroxytoluene and 27.6 g (20O mmol) of acetonitrile, which was stirred on an ice water bath. 3 minutes was dripped. After 27 minutes, stirring was stopped, and the reaction solution was allowed to stand at room temperature overnight, and then filtered, and then, 10 mL of toluene and 50 mL of water were added to the filtrate, followed by stirring and standing in a separating funnel. The aqueous layer was discarded, the organic layer was washed twice with 25 mL of water, and then the solvent was removed by distillation to give 10.3 g of the title compound.

1H-NMR(400MHz, CDCl3)δ(ppm): 2.00(s, 3H), 2.33(s, 6H), 6.95(d, J=8.1Hz, 2H), 7.24(t, J=8.3Hz, 1H) 1 H-NMR (400 MHz, CDCl 3 ) δ (ppm): 2.00 (s, 3H), 2.33 (s, 6H), 6.95 (d, J = 8.1 Hz, 2H), 7.24 (t, J = 8.3 Hz, 1H)

(참고예 2)(Reference Example 2)

2-아세톡시-6-하이드록시톨루엔의 합성Synthesis of 2-acetoxy-6-hydroxytoluene

Figure 112007086393561-PCT00096
Figure 112007086393561-PCT00096

2,6-디아세톡시톨루엔 8.22 g (39.5 mmol)을 에틸렌글리콜 디메틸 에테르 82 mL에 용해한 다음, 얻어진 용액에 수소화붕소나트륨 14.9 g (395 mmol)을 첨가하고, 60℃의 수욕 상에서 9시간 44분간 가열 및 교반하였다. 상기 반응액을 실온에서 하룻밤 방치한 다음, 상기 반응액을, 빙수욕 상에서 교반되고 있는 톨루엔 100 mL과 물 100 mL의 혼합액에 투입하여 5분간 교반한 후, 분액 깔때기에 옮겨 넣고, 정치하였다. 분액된 수층을 톨루엔 50 mL로 추출하고, 모아 둔 유기층을 물 50 mL로 2회 세정한 후, 상기 용매를 증류에 의해 제거하여, 표기 화합물 5.01 g을 얻었다.After dissolving 8.22 g (39.5 mmol) of 2,6-diacetoxytoluene in 82 mL of ethylene glycol dimethyl ether, 14.9 g (395 mmol) of sodium borohydride was added to the obtained solution, and the mixture was heated for 9 hours and 44 minutes in a 60 ° C water bath. Heated and stirred. After leaving the reaction solution at room temperature overnight, the reaction solution was added to a mixed solution of 100 mL of toluene and 100 mL of water stirred on an ice water bath, stirred for 5 minutes, then transferred to a separatory funnel and left to stand. The separated aqueous layer was extracted with 50 mL of toluene, the collected organic layer was washed twice with 50 mL of water, and then the solvent was removed by distillation to obtain 5.01 g of the title compound.

1H-NMR(400MHz, CDCl3)δ(ppm): 2.04(s, 3H), 2.34(s, 3H), 6.63(d, J=8.8Hz, 1H), 6.65(d, J=8.3Hz, 1H), 7.05(t, J=8.3Hz, 1H). 1 H-NMR (400 MHz, CDCl 3 ) δ (ppm): 2.04 (s, 3H), 2.34 (s, 3H), 6.63 (d, J = 8.8 Hz, 1H), 6.65 (d, J = 8.3 Hz, 1H), 7.05 (t, J = 8.3 Hz, 1H).

(참고예 3)(Reference Example 3)

2-아세톡시-6-메톡시톨루엔의 합성Synthesis of 2-acetoxy-6-methoxytoluene

Figure 112007086393561-PCT00097
Figure 112007086393561-PCT00097

2-아세톡시-6-하이드록시톨루엔 5.01 g (30.0 mmol)의 아세토니트릴 50 mL 용액에, 탄산 칼륨 12.44 g (90.0 mmol) 및 요오드화메틸 12.77 g (90.0 mmol)을 첨가한 다음, 90℃의 유욕 상에서 96분간 가열 및 교반하였다. 그 반응액을 실온에서 약 3시간 방치한 다음, 상기 반응액을, 빙수욕 상에서 교반되고 있는 톨루엔 10O mL와 물 10O mL의 혼합액에 투입하여, 2분간 교반한 후, 분액 깔때기에 옮겨 넣고, 정치하였다. 수층을 분액하여 폐기하고, 유기층을 1규정의 수산화칼륨 수용액 20 mL, 그리고 물 20 mL로 3회 세정한 후, 상기 용매를 증류에 의해 제거하여, 표기 화합물 4.69 g을 얻었다.To a 50 mL solution of 5.01 g (30.0 mmol) of acetonitrile of 2-acetoxy-6-hydroxytoluene, 12.44 g (90.0 mmol) of potassium carbonate and 12.77 g (90.0 mmol) of methyl iodide were added, followed by an oil bath at 90 ° C. Heated and stirred for 96 min. The reaction solution was allowed to stand at room temperature for about 3 hours, and then the reaction solution was added to a mixed solution of 100 mL of toluene and 10 mL of water stirred on an ice water bath, stirred for 2 minutes, then transferred to a separatory funnel, and left standing. It was. The aqueous layer was separated and discarded, and the organic layer was washed three times with 20 mL of a prescribed aqueous potassium hydroxide solution and 20 mL of water, and then the solvent was removed by distillation to obtain 4.69 g of the title compound.

1H-NMR(400MHz, CDCl3)δ(ppm): 2.03(s, 3H), 2.32(s, 3H), 3.84(s, 3H), 6.65(d, J=8.0Hz, 1H), 6.74(d, J=8.1Hz, 1H), 7.16(t, J=8.3Hz, 1H). 1 H-NMR (400 MHz, CDCl 3 ) δ (ppm): 2.03 (s, 3H), 2.32 (s, 3H), 3.84 (s, 3H), 6.65 (d, J = 8.0 Hz, 1H), 6.74 ( d, J = 8.1 Hz, 1H), 7.16 (t, J = 8.3 Hz, 1H).

(참고예 4)(Reference Example 4)

2-하이드록시-6-메톡시톨루엔의 합성Synthesis of 2-hydroxy-6-methoxytoluene

Figure 112007086393561-PCT00098
Figure 112007086393561-PCT00098

2-아세톡시-6-메톡시톨루엔 4.69 g (26.0 mmol)의 에탄올 360 mL 용액에, 농축 황산 18.0 mL의 물 90 mL 용액을 첨가한 다음, 120℃의 유욕 상에서 36분간 가열 및 교반하였다. 이 반응액을 실온에서 하룻밤 방치한 다음, 분액 깔때기에 옮겨 넣은 후, 50 mL 및 20 mL의 톨루엔으로 추출하고, 유기층을 모아서, 물 30 mL, 5% 탄산수소나트륨 수용액 30 mL, 그 다음에 물 30 mL로 2회 세정한 후, 상기 용매를 증류에 의해 제거함으로써, 표기 화합물 3.15 g을 얻었다.To a 360 mL solution of 4.69 g (26.0 mmol) of 2-acetoxy-6-methoxytoluene, a 90 mL solution of 18.0 mL of concentrated sulfuric acid was added, followed by heating and stirring for 36 minutes on a 120 ° C. oil bath. The reaction solution was left at room temperature overnight, then transferred to a separatory funnel, extracted with 50 mL and 20 mL of toluene, the organic layers were collected, 30 mL of water, 30 mL of 5% aqueous sodium bicarbonate solution, and then water After washing twice with 30 mL, the solvent was removed by distillation to obtain 3.15 g of the title compound.

1H-NMR(400MHz, CDCl3)δ(ppm): 2.12(s, 3H), 3.82(s, 3H), 4.71(s, 1H), 6.45(d, J=8.3Hz, 1H), 6.48(d, J=8.8Hz, 1H), 7.03(t, J=8.3Hz, 1H). 1 H-NMR (400 MHz, CDCl 3 ) δ (ppm): 2.12 (s, 3H), 3.82 (s, 3H), 4.71 (s, 1H), 6.45 (d, J = 8.3 Hz, 1H), 6.48 ( d, J = 8.8 Hz, 1H), 7.03 (t, J = 8.3 Hz, 1H).

(참고예 5)(Reference Example 5)

2-(N,N-디에틸카르바모일옥시)-6-메톡시톨루엔의 합성Synthesis of 2- (N, N-diethylcarbamoyloxy) -6-methoxytoluene

Figure 112007086393561-PCT00099
Figure 112007086393561-PCT00099

2-하이드록시-6-메톡시톨루엔 3.15 g (22.8 mmol)의 아세토니트릴 16 mL 용액에, 탄산 칼륨 3.50 g (25.1 mmol), 디에틸카르바모일 클로라이드 3.4 g (25.1 mmol)을 첨가한 다음, 얻어진 반응액을 100℃의 유욕 상에서 59분간 가열 및 교반하였다. 그런 다음, 디에틸카르바모일 클로라이드 0.6 g (4.4 mmol)을 추가하고, 얻어진 반응액을 38분간 더 가열한 후, 이 반응액을 빙수욕 상에서 교반하면서, 톨루엔 30 mL 및 물 30 mL를 투입하여 20분간 교반한 다음, 분액 깔때기에 옮겨 넣고, 정치시켰다. 수층을 분액 폐기하고, 유기층을 2규정의 수산화칼륨 수용액 1O mL, 이어서 물 1O mL로 2회 세정한 다음, 상기 용매를 증류에 의해 제거함으로써, 미정제 표기 화합물 5.58 g을 얻었다. 상기 화합물이 고화되었기 때문에, 이 중 일부는 종결정으로서 얻었다.To a 16 mL solution of 3.15 g (22.8 mmol) of acetonitrile of 2-hydroxy-6-methoxytoluene, 3.50 g (25.1 mmol) of potassium carbonate and 3.4 g (25.1 mmol) of diethylcarbamoyl chloride were added, The obtained reaction liquid was heated and stirred for 59 minutes on a 100 degreeC oil bath. Then, 0.6 g (4.4 mmol) of diethylcarbamoyl chloride was added, and the obtained reaction solution was further heated for 38 minutes, and then 30 mL of toluene and 30 mL of water were added while stirring the reaction solution in an ice water bath. After stirring for 20 minutes, the mixture was transferred to a separating funnel and allowed to stand. The aqueous layer was separated and discarded, and the organic layer was washed twice with 10 mL of aqueous potassium hydroxide aqueous solution followed by 10 mL of water, and then the solvent was removed by distillation to obtain 5.58 g of the crude title compound. Since the compound was solidified, some of this was obtained as seed crystals.

상기 미정제 표기 화합물 5.58 g을 50℃의 수욕 상에서 가열 및 교반하여, 에탄올 14.5 mL 및 물 8.9 mL에 용해한 다음, 실온에서 자연 냉각을 개시하였다. 상기 용액의 온도가 35℃가 될 때까지 종결정을 투입하고, 석출 개시를 확인하여, 수욕 및 빙수욕에서 냉각시켰다. 상기 혼합물을 빙수욕 상에서 약 1시간 교반하고, 상기 결정화 혼합물 온도가 2.2℃일 때, 여과에 의해 결정을 수집한 다음, 50% 함수(含水) 에탄올 8 mL로 세정하였다. 세정된 결정을 감압 건조(30℃, 90분)하 여, 표기 화합물 3.89 g을 얻었다.5.58 g of the crude title compound were heated and stirred in a water bath at 50 ° C., dissolved in 14.5 mL of ethanol and 8.9 mL of water, and then natural cooling was initiated at room temperature. Seed crystals were added until the temperature of the solution reached 35 ° C, and the start of precipitation was confirmed and cooled in a water bath and an ice water bath. The mixture was stirred for about 1 hour on an ice water bath and when the crystallization mixture temperature was 2.2 ° C., crystals were collected by filtration and then washed with 8 mL of 50% hydrous ethanol. The washed crystals were dried under reduced pressure (30 ° C., 90 minutes) to obtain 3.89 g of the title compound.

1H-NMR(400MHz, CDCl3)δ(ppm): 1.24(m, 6H), 2.05(s, 3H), 3.43(m, 4H), 3.85(s, 3H), 6.71(d, J=8.3Hz, 1H), 6.71(d, J=8.1Hz, 1H), 7.13(t, J=8.3Hz, 1H). 1 H-NMR (400 MHz, CDCl 3 ) δ (ppm): 1.24 (m, 6H), 2.05 (s, 3H), 3.43 (m, 4H), 3.85 (s, 3H), 6.71 (d, J = 8.3 Hz, 1H), 6.71 (d, J = 8.1 Hz, 1H), 7.13 (t, J = 8.3 Hz, 1H).

(참고예 6)(Reference Example 6)

N,N-디에틸-(2-하이드록시-6-메톡시페닐)아세트아미드의 합성Synthesis of N, N-diethyl- (2-hydroxy-6-methoxyphenyl) acetamide

Figure 112007086393561-PCT00100
Figure 112007086393561-PCT00100

리튬 디이소프로필아미드 5.0 mL (2M/테트라하이드로퓨란-에틸벤젠, 10 mmol)를 드라이 아이스-에탄올 냉매 상에서 교반 및 냉각한 다음, 2-(N,N-디에틸카르바모일옥시)-6-메톡시톨루엔 0.95 g (4.0 mmol)의 테트라하이드로퓨란 8.0 mL 용액을 16분간 적하하였다. 1분 후, 실온에서 가온(加溫)을 개시하고, 상기 혼합물을 47분간 교반한 후, 하룻밤 동안 정치시켰다. 그런 다음, 톨루엔 10 mL 및 물 10 mL를 첨가하여, 4분간 교반한 후, 얻어진 혼합물을 분액 깔때기에 옮겨 넣고, 정치시켰다. 수층을 분액 채취하고, 수집된 수층과, 유기층으로부터 2규정 수산화 칼륨 수용액으로 2회(각 5.0 mL씩) 추출한 수층을 합하였다. 이 수층을 톨루엔 10 mL로 세정한 다음, 톨루엔 1O mL를 투입하고, 얻어진 혼합물을 교반하면서, 2규정 염산 수용액 20 mL를 첨가한 후, 분액 깔때기에 옮겨 넣고, 정치시켰다. 유기층을 분액 채취하고, 수집된 유기층과, 수층으로부터 톨루엔 5 mL로 추출한 유기층을 합하였다. 이 유기층을 물 5 mL로 2회 세정한 다음, 감압 농축하여, 표기 화합물 0.81 g을 얻었다.5.0 mL of lithium diisopropylamide (2M / tetrahydrofuran-ethylbenzene, 10 mmol) was stirred and cooled over a dry ice-ethanol refrigerant, followed by 2- (N, N-diethylcarbamoyloxy) -6- A solution of 8.0 mL of 0.95 g (4.0 mmol) tetrahydrofuran of methoxytoluene was added dropwise for 16 minutes. After 1 minute, warming was started at room temperature, and the mixture was stirred for 47 minutes, and then allowed to stand overnight. Then, 10 mL of toluene and 10 mL of water were added and stirred for 4 minutes, after which the resulting mixture was transferred to a separating funnel and allowed to stand. The aqueous layer was separated, and the collected aqueous layer was combined with the aqueous layer extracted twice (5.0 mL each) with 2 nd aqueous potassium hydroxide solution from the organic layer. After wash | cleaning this aqueous layer with 10 mL of toluene, 10 mL of toluene was thrown in, and the obtained mixture was stirred, adding 20 mL of 2N hydrochloric acid aqueous solution, it was transferred to the separatory funnel, and it left still. The organic layer was separated, and the collected organic layer was combined with the organic layer extracted with 5 mL of toluene from the aqueous layer. The organic layer was washed twice with 5 mL of water, and then concentrated under reduced pressure to obtain 0.81 g of the title compound.

1H-NMR(400MHz, CDCl3)δ(ppm): 1.29(m, 6H), 3.49(m, 4H), 3.80(s, 2H), 3.82(s, 3H), 6.43(d, J=8.3Hz, 1H), 6.64(d, J=8.3Hz, 1H), 7.11(t, J=8.3Hz, 1H). 1 H-NMR (400 MHz, CDCl 3 ) δ (ppm): 1.29 (m, 6H), 3.49 (m, 4H), 3.80 (s, 2H), 3.82 (s, 3H), 6.43 (d, J = 8.3 Hz, 1H), 6.64 (d, J = 8.3 Hz, 1H), 7.11 (t, J = 8.3 Hz, 1H).

(참고예 7)(Reference Example 7)

4-메톡시-3H-벤조퓨란(benzofuran)-2-온의 합성Synthesis of 4-methoxy-3H-benzofuran-2-one

Figure 112007086393561-PCT00101
Figure 112007086393561-PCT00101

N,N-디에틸-(2-하이드록시-6-메톡시페닐)아세트아미드 0.47 g (2.0 mmol)의 톨루엔 5.0 mL 용액에 트리플루오로아세트산 0.92 mL (1.36 g, 12 mmol)을 첨가한 다음, 125℃의 유욕 상에서 71분간 가열 및 교반하였다. 얻어진 혼합물을 실온에서 냉각한 후, 교반하면서 0.5 규정의 수산화나트륨 수용액 24 mL를 첨가한 다음, 얻어진 혼합물을 분액 깔때기에 옮겨 넣고, 정치시켰다. 수층을 분액 폐기하고, 유기층을 물 5 mL로 2회 세정한 다음, 상기 용매를 증류에 의해 제거함으로써, 표기 화합물 0.27 g을 얻었다.To a 5.0 mL solution of 0.47 g (2.0 mmol) of N, N-diethyl- (2-hydroxy-6-methoxyphenyl) acetamide, add 0.92 mL (1.36 g, 12 mmol) of trifluoroacetic acid, And heated and stirred for 71 minutes on an oil bath at 125 ° C. After cooling the obtained mixture at room temperature, 24 mL of 0.5 N sodium hydroxide aqueous solution was added with stirring, and the obtained mixture was transferred to the separating funnel, and it left still. The aqueous layer was separated and discarded, and the organic layer was washed twice with 5 mL of water, and then the solvent was removed by distillation to obtain 0.27 g of the title compound.

1H-NMR(400MHz, CDCl3)δ(ppm): 3.66(s, 2H), 3.86(s, 3H), 6.67(d, J=8.3Hz, 1H), 6.75(d, J=8.0Hz, 1H), 7.26(t, J=8.3Hz, 1H). 1 H-NMR (400 MHz, CDCl 3 ) δ (ppm): 3.66 (s, 2H), 3.86 (s, 3H), 6.67 (d, J = 8.3 Hz, 1H), 6.75 (d, J = 8.0 Hz, 1H), 7.26 (t, J = 8.3 Hz, 1H).

(참고예 8)(Reference Example 8)

2-(2-하이드록시-6-메톡시페닐)에탄올의 합성Synthesis of 2- (2-hydroxy-6-methoxyphenyl) ethanol

Figure 112007086393561-PCT00102
Figure 112007086393561-PCT00102

4-메톡시-3H-벤조퓨란-2-온 10.76 g (65.5 mmol)의 에틸렌글리콜 디메틸 에테르 150 mL 용액에 수소화붕소나트륨 7.18 g (189 mmol)을 첨가하여 교반한 다음, 얻어진 혼합물을 빙수욕 상에서 냉각하면서, 농축 황산 5.25 mL(9.66 g, 94.5 mmol)의 에틸렌글리콜 디메틸 에테르 21 mL 용액을 30분간 적하하였다. 이렇게 하여 얻어진 혼합액을 50℃의 수욕 상에서 49분간 가열 및 교반한 다음, 빙수욕 상에서 교반하면서 메탄올 32 mL (25.3 g, 790 mmol)를 6분간 적하하였다. 이 혼합액을 50℃의 수욕 상에서 53분간 가열 및 교반한 다음, 실온에서 하룻밤 방치한 후, 아세트산 이소프로필 30O mL 및 물 20O mL를 투입하여, 5분간 교반한 다음, 분액 깔때기에 옮겨 넣고, 정치시켰다. 수층을 분액 폐기하고, 유기층을 물 100 mL로 2회 세정한 후, 상기 용매를 증류에 의해 제거하였다. 잔사를 아세트산 에틸-헥산으로부터 결정화하고, 얻어진 결정을 30℃에서 감압 건조하여, 표기 화합물 3.12 g을 얻었다.To a 150 mL solution of 10.76 g (65.5 mmol) of ethyleneglycol dimethyl ether of 4-methoxy-3H-benzofuran-2-one was added by stirring 7.18 g (189 mmol) of sodium borohydride, and the resulting mixture was stirred on an ice water bath. While cooling, a solution of 21 mL of 5.25 mL (9.66 g, 94.5 mmol) of ethylene glycol dimethyl ether in concentrated sulfuric acid was added dropwise for 30 minutes. The mixture thus obtained was heated and stirred for 49 minutes on a 50 ° C. water bath, and then 32 mL (25.3 g, 790 mmol) of methanol was added dropwise for 6 minutes while stirring on an ice water bath. The mixture was heated and stirred for 53 minutes on a 50 ° C. water bath, and then allowed to stand overnight at room temperature. Then, 30O mL of isopropyl acetate and 20OmL of water were added thereto, stirred for 5 minutes, then transferred to a separatory funnel and left to stand. . The aqueous layer was separated and discarded, and the organic layer was washed twice with 100 mL of water, and then the solvent was removed by distillation. The residue was crystallized from ethyl acetate-hexane, and the obtained crystals were dried under reduced pressure at 30 ° C. to obtain 3.12 g of the title compound.

1H-NMR(400MHz, CDCl3)δ(ppm): 2.98(t, J=5.1Hz, 2H), 3.79(s, 3H), 3.93(t, J=5.1Hz, 2H), 6.48(d, J=8.1Hz, 1H), 6.59(d, J=8.0Hz, 1H), 7.09(t, J=8.0Hz, 1H). 1 H-NMR (400 MHz, CDCl 3 ) δ (ppm): 2.98 (t, J = 5.1 Hz, 2H), 3.79 (s, 3H), 3.93 (t, J = 5.1 Hz, 2H), 6.48 (d, J = 8.1 Hz, 1H), 6.59 (d, J = 8.0 Hz, 1H), 7.09 (t, J = 8.0 Hz, 1H).

(참고예 9)(Reference Example 9)

아세트산 2-(2-하이드록시-6-메톡시페닐)에틸의 합성Synthesis of 2- (2-hydroxy-6-methoxyphenyl) ethyl acetate

Figure 112007086393561-PCT00103
Figure 112007086393561-PCT00103

빙수욕 상에서 냉각하면서, 2-(2-하이드록시-6-메톡시페닐)에탄올 0.27 g (1.6 mmol)의 아세트산 5.0 mL 용액에 농축 황산 1.0 mL (1.8 g, 18 mmol)를 적하하였다. 이 혼합액을 실온에서 5분간 교반한 다음, 에탄올 6.0 mL (4.7 g, 102 mmol)를 적하하였다. 그런 다음, 이 혼합액에 톨루엔 20 mL 및 물 20 mL를 투입하고, 5분간 교반한 후, 분액 깔때기에 옮겨 넣고, 정치시켰다. 수층을 분액 폐기하고, 유기층을 물 10 mL로 2회 세정한 후, 상기 용매를 증류에 의해 제거하여, 표기 화합물 0.16 g을 얻었다.While cooling on an ice water bath, 1.0 mL (1.8 g, 18 mmol) of concentrated sulfuric acid was added dropwise to a 5.0 mL solution of 0.27 g (1.6 mmol) of acetic acid of 2- (2-hydroxy-6-methoxyphenyl) ethanol. The mixture was stirred at room temperature for 5 minutes, and then 6.0 mL (4.7 g, 102 mmol) of ethanol was added dropwise. Then, 20 mL of toluene and 20 mL of water were added to this mixed solution, and after stirring for 5 minutes, the mixture was transferred to a separating funnel and allowed to stand. The aqueous layer was separated and discarded, and the organic layer was washed twice with 10 mL of water, and then the solvent was removed by distillation to obtain 0.16 g of the title compound.

1H-NMR(400MHz, CDCl3)δ(ppm): 2.09(s, 3H), 3.02(t, J=7.1Hz, 2H), 3.81(s, 3H), 4.21(t, J=7.1Hz, 2H), 6.48(d, J=8.3Hz, 1H), 6.53(d, J=7.8Hz, 1H), 7.10(t, J=8.3Hz, 1H). 1 H-NMR (400 MHz, CDCl 3 ) δ (ppm): 2.09 (s, 3H), 3.02 (t, J = 7.1 Hz, 2H), 3.81 (s, 3H), 4.21 (t, J = 7.1 Hz, 2H), 6.48 (d, J = 8.3 Hz, 1H), 6.53 (d, J = 7.8 Hz, 1H), 7.10 (t, J = 8.3 Hz, 1H).

(참고예 10)(Reference Example 10)

8-(2-아세톡시에틸)-7-메톡시-2,2-디메틸크로만-4-온의 합성Synthesis of 8- (2-acetoxyethyl) -7-methoxy-2,2-dimethylchroman-4-one

Figure 112007086393561-PCT00104
Figure 112007086393561-PCT00104

아세트산 2-(2-하이드록시-6-메톡시페닐)에틸 5.79 g (27.5 mmol), 2-메틸크로톤산 3.03 g (30.3 mmol) 및 오산화이인(diphosphorus pentaoxide) 3.26 g (16.9 mmol)의 메탄설폰산 29.0 mL 용액을 70℃에서 75분간 가열 및 교반하였다. 그런 다음, 실온에서 톨루엔 50 mL 및 물 50 mL를 투입하고, 5분간 교반한 다음, 얻어진 혼합물을 분액 깔때기에 옮겨 넣고, 정치시켰다. 수층을 분액 폐기하고, 유기층을 5% 탄산수소나트륨 수용액 25 mL 및 물 25 mL로 차례로 세정한 다음, 상기 용매를 증류에 의해 제거하여, 미정제 표기 화합물 7.85 g을 얻었다. 얻어진 물질을 실리카겔 크로마토그래피에 의해 정제(전개액 조성: 10% 아세트산 에틸-헥산(부피비), Rf값: 0.4)하여, 표기 화합물 2.96 g을 얻었다.5.79 g (27.5 mmol) of acetic acid 2- (2-hydroxy-6-methoxyphenyl) ethyl, 3.03 g (30.3 mmol) of 2-methylcrotonic acid and 3.26 g (16.9 mmol) of methanesulfuric acid diphosphorus pentaoxide The 29.0 mL solution of phonic acid was heated and stirred at 70 ° C. for 75 minutes. Then, 50 mL of toluene and 50 mL of water were added at room temperature, stirred for 5 minutes, and then the obtained mixture was transferred to a separating funnel and allowed to stand. The aqueous layer was separated and discarded, and the organic layer was washed with 25 mL of 5% aqueous sodium hydrogen carbonate solution and 25 mL of water, and then the solvent was removed by distillation to obtain 7.85 g of crude title compound. The obtained material was purified by silica gel chromatography (eluent composition: 10% ethyl acetate-hexane (volume ratio), Rf value: 0.4) to obtain 2.96 g of the title compound.

1H-NMR(400MHz, CDCl3)δ(ppm): 1.46(s, 6H), 2.04(s, 3H), 2.67(s, 2H), 2.99(t, J=7.3Hz, 2H), 3.88(s, 3H), 4.18(t, J=7.3Hz, 2H), 6.58(d, J=9.0Hz, 1H), 7.82(d, J=8.8Hz, 1H). 1 H-NMR (400 MHz, CDCl 3 ) δ (ppm): 1.46 (s, 6H), 2.04 (s, 3H), 2.67 (s, 2H), 2.99 (t, J = 7.3 Hz, 2H), 3.88 ( s, 3H), 4.18 (t, J = 7.3 Hz, 2H), 6.58 (d, J = 9.0 Hz, 1H), 7.82 (d, J = 8.8 Hz, 1H).

(참고예 11)(Reference Example 11)

8-(2-하이드록시에틸)-7-메톡시-2,2-디메틸크로만-4-온의 합성Synthesis of 8- (2-hydroxyethyl) -7-methoxy-2,2-dimethylchroman-4-one

Figure 112007086393561-PCT00105
Figure 112007086393561-PCT00105

8-(2-아세톡시에틸)-7-메톡시-2,2-디메틸크로만-4-온 2.80 g (9.58 mmol)의 에탄올 18.0 mL 용액에, 실온에서 교반하면서 농축 황산 1.80 mL(3.31 g,32.4 mmol)의 물 9.0 mL 용액을 투입한 다음, 얻어진 혼합물을 10O℃의 유욕 상에서 43분간 가열 및 교반하였다. 그런 다음, 상기 혼합물을 실온에서 냉각한 후, 톨루엔 90 mL 및 물 18 mL를 투입하자, 백색의 결정이 석출되었으며, 이로써, 상기 결정을 여과에 의해 얻고(결정 1), 그 여액을 빙냉하여 석출된 결정을 다시 여과에 의해 얻었다(결정 2). 여기서 얻은 여액을 분액 깔때기에 옮겨 넣고, 정치시켰다. 수층을 분액 폐기하고, 유기층을 1규정의 수산화칼륨 수용액 40 mL, 다시 물 20 mL로 2회 세정한 다음, 상기 용매를 증류에 의해 제거하여 얻어진 농축물에 DME 2 mL 및 물 5 mL를 첨가하고, 이렇게 하여 석출된 결정을 여과에 의해 얻었다(결정 3). 결정 1∼3을 합하여, 물 1O mL로 세정한 다음, 40℃에서 1시간 동안 감압 건조하여, 표기 화합물 2.44 g을 얻었다.To a 18.0 mL solution of 2.80 g (9.58 mmol) of ethanol in 8- (2-acetoxyethyl) -7-methoxy-2,2-dimethylchroman-4-one, 1.80 mL (3.31 g) of concentrated sulfuric acid with stirring at room temperature , 32 mL of a 9.0 mL solution of water was added, and the resulting mixture was heated and stirred for 43 minutes on a 100 ° C. oil bath. Then, after cooling the mixture at room temperature, 90 mL of toluene and 18 mL of water were added, and white crystals were precipitated, whereby the crystals were obtained by filtration (crystal 1), and the filtrate was cooled by ice and precipitated. The obtained crystals were again obtained by filtration (crystal 2). The filtrate obtained here was transferred to a separating funnel and allowed to stand. The aqueous layer was separated, and the organic layer was washed twice with 40 mL of a prescribed potassium hydroxide aqueous solution and again with 20 mL of water. Then, 2 mL of DME and 5 mL of water were added to the concentrate obtained by distillation. The crystal thus deposited was obtained by filtration (crystal 3). Crystals 1-3 were combined, washed with 10 mL of water, and dried under reduced pressure at 40 ° C. for 1 hour to obtain 2.44 g of the title compound.

1H-NMR(400MHz, CDCl3)δ(ppm): 1.45(s, 6H), 2.68(s, 2H), 2.96(t, J=6.8Hz, 2H), 3.77(t, J=6.8Hz, 2H), 3.89(s, 3H), 6.59(d, J=9.0Hz, 1H), 7.81(d, J=8.8Hz, 1H). 1 H-NMR (400 MHz, CDCl 3 ) δ (ppm): 1.45 (s, 6H), 2.68 (s, 2H), 2.96 (t, J = 6.8 Hz, 2H), 3.77 (t, J = 6.8 Hz, 2H), 3.89 (s, 3H), 6.59 (d, J = 9.0 Hz, 1H), 7.81 (d, J = 8.8 Hz, 1H).

본 발명에 의해, 1-{1-[2-(7-메톡시-2,2-디메틸-4-옥소크로만-8-일)에틸]피페리딘-4-일}-N-메틸-1H-인돌-6-카르복사미드를 공업적으로 제조하는 것이 가능해졌다.1- {1- [2- (7-methoxy-2,2-dimethyl-4-oxochroman-8-yl) ethyl] piperidin-4-yl} -N-methyl- It has become possible to industrially produce 1H-indole-6-carboxamide.

Claims (16)

하기 식 (a-6)으로 표시되는 8-(2-하이드록시에틸)-7-메톡시-2,2-디메틸크로만-4-온:8- (2-hydroxyethyl) -7-methoxy-2,2-dimethylchroman-4-one represented by the following formula (a-6):
Figure 112007086393561-PCT00106
을 산화함으로써 얻어지는 하기 식 (a):
Figure 112007086393561-PCT00106
The following formula (a) obtained by oxidizing:
Figure 112007086393561-PCT00107
로 표시되는 (7-메톡시-2,2-디메틸-4-옥소크로만-8-일)아세트알데하이드와, 하기 식 (b):
Figure 112007086393561-PCT00107
(7-methoxy-2,2-dimethyl-4-oxochromen-8-yl) acetaldehyde represented by the following formula (b):
Figure 112007086393561-PCT00108
로 표시되는 N-메틸-1-(피페리딘-4-일)-1H-인돌-6-카르복사미드를 커플링하는 단계를 포함하는, 하기 식 (i):
Figure 112007086393561-PCT00108
Coupling N-methyl-1- (piperidin-4-yl) -1H-indole-6-carboxamide represented by the following formula (i):
Figure 112007086393561-PCT00109
로 표시되는 1-{1-[2-(7- 메톡시-2,2-디메틸-4-옥소크로만-8-일)에틸]피페리딘-4-일}-N-메틸-1H-인돌-6-카르복사미드의 제조 방법.
Figure 112007086393561-PCT00109
1- {1- [2- (7-methoxy-2,2-dimethyl-4-oxochroman-8-yl) ethyl] piperidin-4-yl} -N-methyl-1H- represented by Process for the preparation of indole-6-carboxamide.
제1항에 있어서,The method of claim 1, 식 (a-6):Formula (a-6):
Figure 112007086393561-PCT00110
으로 표시되는 8-(2-하이드록시에틸)-7-메톡시-2,2-디메틸크로만-4-온은, 하기 식 (a-5):
Figure 112007086393561-PCT00110
8- (2-hydroxyethyl) -7-methoxy-2,2-dimethylchroman-4-one represented by the following formula (a-5):
Figure 112007086393561-PCT00111
로 표시되는 화합물[식 (a-5)에서, X는 수산기의 보호기를 나타냄]의 보호기를 제거하여 얻어지는 것을 특징으로 하는 제조 방법.
Figure 112007086393561-PCT00111
The manufacturing method characterized by removing the protecting group of the compound represented by the following formula (a (X), X represents a protecting group of a hydroxyl group).
제1항 또는 제2항에 있어서,The method according to claim 1 or 2, 식 (a-6):Formula (a-6):
Figure 112007086393561-PCT00112
으로 표시되는 8-(2-하이드록시에틸)-7-메톡시-2,2-디메틸크로만-4-온은, 하기 식 (a-4):
Figure 112007086393561-PCT00112
8- (2-hydroxyethyl) -7-methoxy-2,2-dimethylchroman-4-one represented by the following formula (a-4):
Figure 112007086393561-PCT00113
로 표시되는 화합물[식 (a-4)에서, X는 수산기의 보호기를 나타냄]과 메틸크로톤산을 반응시켜, 하기 식 (a-5):
Figure 112007086393561-PCT00113
In the compound represented by the formula (a (4), X represents a protecting group of a hydroxyl group) and methyl crotonic acid, the following formula (a-5):
Figure 112007086393561-PCT00114
로 표시되는 화합물[식 (a-5)에서, X는 위에서와 동일하게 정의됨]을 얻은 다음, 얻어진 화합물 (a-5)의 보호기를 제거함으로써 얻어지는 것을 특징으로 하는 제조 방법.
Figure 112007086393561-PCT00114
A compound obtained by obtaining a compound represented by the formula (A-5), wherein X is defined in the same manner as above, and then removing the protecting group of the obtained compound (a-5).
제1항 내지 제3항 중 어느 한 항에 있어서,The method according to any one of claims 1 to 3, 식 (a-6):Formula (a-6):
Figure 112007086393561-PCT00115
으로 표시되는 8-(2-하이드록시에틸)-7-메톡시-2,2-디메틸크로만-4-온은, 하기 식 (a-3):
Figure 112007086393561-PCT00115
8- (2-hydroxyethyl) -7-methoxy-2,2-dimethylchroman-4-one represented by the following formula (a-3):
Figure 112007086393561-PCT00116
으로 표시되는 화합물[식 (a-3)에서, X는 수산기의 보호기를 나타냄]과 산을 반응시켜, 하기 식 (a-4):
Figure 112007086393561-PCT00116
In the compound represented by the following formula (a-3), X represents a protecting group of a hydroxyl group, an acid is reacted with the following formula (a-4):
Figure 112007086393561-PCT00117
로 표시되는 화합물[식 (a-4)에서, X는 위에서와 동일하게 정의됨]을 얻은 다음, 얻어진 화합물 (a-4)와 메틸크로톤산을 반응시켜, 하기 식 (a-5):
Figure 112007086393561-PCT00117
To obtain a compound represented by the formula (a-4), X is the same as defined above, and then reacting the obtained compound (a-4) and methyl crotonic acid, the following formula (a-5):
Figure 112007086393561-PCT00118
로 표시되는 화합물[식 (a-5)에서, X는 위에서와 동일하게 정의됨]을 얻고, 얻어진 화합물 (a-5)의 보호기를 제거함으로써 얻어지는 것을 특징으로 하는 제조 방법.
Figure 112007086393561-PCT00118
It is obtained by obtaining the compound represented by the formula (wherein X is defined similarly to the above in formula (a-5)) and removing the protecting group of the obtained compound (a-5).
제1항 내지 제4항 중 어느 한 항에 있어서,The method according to any one of claims 1 to 4, 식 (a-6):Formula (a-6):
Figure 112007086393561-PCT00119
으로 표시되는 8-(2-하이드록시에틸)-7-메톡시-2,2-디메틸크로만-4-온은, 하기 식 (a-2):
Figure 112007086393561-PCT00119
8- (2-hydroxyethyl) -7-methoxy-2,2-dimethylchroman-4-one represented by the following formula (a-2):
Figure 112007086393561-PCT00120
로 표시되는 2-[2-(1-에톡시에톡시)-6-메톡시페닐]에탄올의 수산기를 보호하여, 하기 식 (a-3):
Figure 112007086393561-PCT00120
Protecting the hydroxyl group of 2- [2- (1-ethoxyethoxy) -6-methoxyphenyl] ethanol represented by the following formula (a-3):
Figure 112007086393561-PCT00121
으로 표시되는 화합물[식 (a-3)에서, X는 수산기의 보호기를 나타냄]을 얻은 다음, 얻어진 화합물 (a-3)과 산을 반응시켜, 하기 식 (a-4):
Figure 112007086393561-PCT00121
After obtaining the compound represented by Formula (a-3), X represents a protecting group of a hydroxyl group, and then reacting the obtained compound (a-3) with an acid, the following formula (a-4):
Figure 112007086393561-PCT00122
로 표시되는 화합물[식 (a-4)에서, X는 위에서와 동일하게 정의됨]을 얻고, 얻어진 화합물 (a-4)와 메틸크로톤산을 반응시켜, 하 기 식 (a-5):
Figure 112007086393561-PCT00122
To obtain a compound represented by the formula (a-4), X is the same as defined above, by reacting the obtained compound (a-4) and methyl crotonic acid, the formula (a-5):
Figure 112007086393561-PCT00123
로 표시되는 화합물[식 (a-5)에서, X는 위에서와 동일하게 정의됨]을 얻은 후, 얻어진 화합물 (a-5)의 보호기를 제거함으로써 얻어지는 것을 특징으로 하는 제조 방법.
Figure 112007086393561-PCT00123
It is obtained by removing the protecting group of the obtained compound (a-5) after obtaining the compound represented by the formula (In formula (a-5), X is defined similarly to the above.).
제1항 내지 제5항 중 어느 한 항에 있어서,The method according to any one of claims 1 to 5, 식 (a-6):Formula (a-6):
Figure 112007086393561-PCT00124
으로 표시되는 8-(2-하이드록시에틸)-7-메톡시-2,2-디메틸크로만-4-온은, 하기 식 (a-1):
Figure 112007086393561-PCT00124
8- (2-hydroxyethyl) -7-methoxy-2,2-dimethylchroman-4-one represented by the following formula (a-1):
Figure 112007086393561-PCT00125
로 표시되는 [2-(1-에톡시에톡시)-6-메톡시페닐]아세트산 에틸을 환원하여, 하기 식 (a-2):
Figure 112007086393561-PCT00125
Ethyl acetate of [2- (1-ethoxyethoxy) -6-methoxyphenyl] acetic acid is reduced to formula (a-2):
Figure 112007086393561-PCT00126
로 표시되는 2-[2-(1-에톡시에톡시)-6-메톡시페닐]에탄올을 얻고, 얻어진 화합물의 수산기를 보호하여, 하기 식 (a-3):
Figure 112007086393561-PCT00126
2- [2- (1-ethoxyethoxy) -6-methoxyphenyl] ethanol represented by the above was obtained, and the hydroxyl group of the obtained compound was protected to give the following formula (a-3):
Figure 112007086393561-PCT00127
으로 표시되는 화합물[식 (a-3)에서, X는 수산기의 보호기를 나타냄]을 얻은 다음, 얻어진 화합물 (a-3)과 산을 반응시켜, 하기 식 (a-4):
Figure 112007086393561-PCT00127
After obtaining the compound represented by Formula (a-3), X represents a protecting group of a hydroxyl group, and then reacting the obtained compound (a-3) with an acid, the following formula (a-4):
Figure 112007086393561-PCT00128
로 표시되는 화합물[식 (a-4)에서, X는 위에서와 동일하게 정의됨]을 얻고, 얻어진 화합물 (a-4)와 메틸크로톤산을 반응시켜, 하기 식 (a-5):
Figure 112007086393561-PCT00128
To obtain a compound represented by the formula (a-4), X is the same as defined above, by reacting the obtained compound (a-4) and methyl crotonic acid, the following formula (a-5):
Figure 112007086393561-PCT00129
로 표시되는 화합물[식 (a-5)에서, X는 위에서와 동일하게 정의됨]을 얻은 후, 얻어진 화합물 (a-5)의 보호기를 제거함으로써 얻어지는 것을 특징으로 하는 제조 방법.
Figure 112007086393561-PCT00129
It is obtained by removing the protecting group of the obtained compound (a-5) after obtaining the compound represented by the formula (In formula (a-5), X is defined similarly to the above.).
제1항 내지 제6항 중 어느 한 항에 있어서,The method according to any one of claims 1 to 6, 식 (a-6):Formula (a-6):
Figure 112007086393561-PCT00130
으로 표시되는 8-(2-하이드록시에틸)-7-메톡시-2,2-디메틸크로만-4-온은, 하기 식:
Figure 112007086393561-PCT00130
8- (2-hydroxyethyl) -7-methoxy-2,2-dimethylchroman-4-one represented by the following formula:
Figure 112007086393561-PCT00131
로 표시되는 1-(1-에톡시에톡시)-3-메톡시벤젠과 브로모아세트산 에틸을 반응시켜, 하기 식 (a-1):
Figure 112007086393561-PCT00131
1- (1-ethoxyethoxy) -3-methoxybenzene and ethyl bromoacetate are reacted with the following formula (a-1):
Figure 112007086393561-PCT00132
로 표시되는 [2-(1-에톡시에톡시)-6-메톡시페닐]아세트산 에틸을 얻고, 얻어진 화합물 (a-1)을 환원하여, 하기 식 (a-2):
Figure 112007086393561-PCT00132
[2- (1-Ethoxyethoxy) -6-methoxyphenyl] ethyl acetate represented by: was obtained, and the obtained compound (a-1) was reduced to give the following formula (a-2):
Figure 112007086393561-PCT00133
로 표시되는 2-[2-(1-에톡시에톡시)-6-메톡시페닐]에탄올을 얻고, 얻어진 화합물 (a-2)의 수산기를 보호하여, 하기 식 (a- 3):
Figure 112007086393561-PCT00133
2- [2- (1-ethoxyethoxy) -6-methoxyphenyl] ethanol represented by the above was obtained, and the hydroxyl group of the obtained compound (a-2) was protected to give the following formula (a-3):
Figure 112007086393561-PCT00134
으로 표시되는 화합물[식 (a-3)에서, X는 수산기의 보호기를 나타냄]을 얻은 다음, 얻어진 화합물 (a-3)과 산을 반응시켜, 하기 식 (a-4):
Figure 112007086393561-PCT00134
After obtaining the compound represented by Formula (a-3), X represents a protecting group of a hydroxyl group, and then reacting the obtained compound (a-3) with an acid, the following formula (a-4):
Figure 112007086393561-PCT00135
로 표시되는 화합물[식 (a-4)에서, X는 위에서와 동일하게 정의됨]을 얻고, 얻어진 화합물 (a-4)와 메틸크로톤산을 반응시켜, 하기 식 (a-5):
Figure 112007086393561-PCT00135
To obtain a compound represented by the formula (a-4), X is the same as defined above, by reacting the obtained compound (a-4) and methyl crotonic acid, the following formula (a-5):
Figure 112007086393561-PCT00136
로 표시되는 화합물[식 (a-5)에서, X는 위에서와 동일하게 정의됨]을 얻은 후, 얻어진 화합물 (a-5)의 보호기를 제거함으로써 얻어지는 것을 특징으로 하는 제조 방법.
Figure 112007086393561-PCT00136
It is obtained by removing the protecting group of the obtained compound (a-5) after obtaining the compound represented by the formula (In formula (a-5), X is defined similarly to the above.).
제2항 내지 제7항 중 어느 한 항에 있어서,The method according to any one of claims 2 to 7, X가 벤조일기인 것을 특징으로 하는 제조 방법.X is a benzoyl group, The manufacturing method characterized by the above-mentioned. 하기 식 (II)로 표시되는 화합물:Compound represented by the following formula (II):
Figure 112007086393561-PCT00137
Figure 112007086393561-PCT00137
[식 (II)에서, X1은 수소 원자 또는 수산기의 보호기를 나타냄].[In formula (II), X <1> represents the protecting group of a hydrogen atom or a hydroxyl group.
제9항에 있어서,The method of claim 9, 수산기의 보호기가 벤조일기인 것을 특징으로 하는 화합물.A compound wherein the protecting group of the hydroxyl group is a benzoyl group. 벤조산 2-(7-메톡시-2,2-디메틸-4-옥소크로만-8-일)에틸 또는 8-(2-하이드록시에틸)-7-메톡시-2,2-디메틸크로만-4-온.Benzoic acid 2- (7-methoxy-2,2-dimethyl-4-oxochroman-8-yl) ethyl or 8- (2-hydroxyethyl) -7-methoxy-2,2-dimethylchroman- 4-on. 하기 식 (c-3):Formula (c-3) below:
Figure 112007086393561-PCT00138
으로 표시되는 화합물과 메틸아민을 반응시키는 단계를 포함하는, 하기 식 (i):
Figure 112007086393561-PCT00138
Reaction of the compound and methylamine represented by the following formula (i):
Figure 112007086393561-PCT00139
로 표시되는 1-{1-[2-(7-메톡시-2,2-디메틸-4-옥소크로만-8-일)에틸]피페리딘-4-일}-N-메틸-1H-인돌-6-카르복사미드의 제조 방법.
Figure 112007086393561-PCT00139
1- {1- [2- (7-methoxy-2,2-dimethyl-4-oxochroman-8-yl) ethyl] piperidin-4-yl} -N-methyl-1H- represented by Process for the preparation of indole-6-carboxamide.
제12항에 있어서,The method of claim 12, 식 (c-3):Formula (c-3):
Figure 112007086393561-PCT00140
으로 표시되는 화합물은, 하기 식 (c-2):
Figure 112007086393561-PCT00140
The compound represented by the following formula (c-2):
Figure 112007086393561-PCT00141
로 표시되는 화합물을 가수분해함으로써 얻어지는 것을 특징으로 하는 제조 방법.
Figure 112007086393561-PCT00141
It is obtained by hydrolyzing the compound represented by the manufacturing method characterized by the above-mentioned.
제12항에 있어서,The method of claim 12, 식 (c-3):Formula (c-3):
Figure 112007086393561-PCT00142
으로 표시되는 화합물은, 하기 식 (a):
Figure 112007086393561-PCT00142
The compound represented by the following formula (a):
Figure 112007086393561-PCT00143
로 표시되는 화합물과, 하기 식 (c-1):
Figure 112007086393561-PCT00143
The compound represented by following formula (c-1):
Figure 112007086393561-PCT00144
로 표시되는 화합물 또는 그의 염을 반응시켜, 하기 식 (c-2):
Figure 112007086393561-PCT00144
By reacting the compound or its salt represented by following formula (c-2):
Figure 112007086393561-PCT00145
로 표시되는 화합물을 얻은 다음, 얻어진 화합물을 가수분해함으로써 얻어지는 것을 특징으로 하는 제조 방법.
Figure 112007086393561-PCT00145
Obtaining the compound represented by the following, The manufacturing method characterized by obtaining by hydrolyzing the obtained compound.
제12항에 있어서,The method of claim 12, 식 (c-3):Formula (c-3):
Figure 112007086393561-PCT00146
으로 표시되는 화합물은, 하기 식 (a):
Figure 112007086393561-PCT00146
The compound represented by the following formula (a):
Figure 112007086393561-PCT00147
로 표시되는 화합물과, 하기 식 (b'-4):
Figure 112007086393561-PCT00147
The compound represented by following formula (b'-4):
Figure 112007086393561-PCT00148
로 표시되는 화합물[식 (b'-4)에서, Y는 2급 아민의 보호기를 나타냄]의 보호기를 제거해서 얻어지는 하기 식 (c-1):
Figure 112007086393561-PCT00148
The following formula (c-1) obtained by removing the protecting group of the compound represented by the formula [wherein Y represents a protecting group of a secondary amine] in the formula (b'-4):
Figure 112007086393561-PCT00149
로 표시되는 화합물 또는 그의 염을 반응시켜, 하기 식 (c-2):
Figure 112007086393561-PCT00149
By reacting the compound or its salt represented by following formula (c-2):
Figure 112007086393561-PCT00150
로 표시되는 화합물을 얻은 다 음, 얻어진 화합물 (c-2)를 가수분해함으로써 얻어지는 것을 특징으로 하는 제조 방법.
Figure 112007086393561-PCT00150
The compound represented by the above is obtained, and then obtained by hydrolyzing the obtained compound (c-2).
제15항에 있어서,The method of claim 15, Y가 벤질옥시카르보닐인 것을 특징으로 하는 제조 방법.Y is benzyloxycarbonyl.
KR1020077027992A 2005-05-11 2006-05-11 Method for producing indole derivative having piperidine ring KR20080006001A (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US11/126,209 2005-05-11
WOPCT/JP2005/008632 2005-05-11
US11/126,209 US20050256103A1 (en) 2004-05-12 2005-05-11 Indole derivative having piperidine ring
PCT/JP2005/008632 WO2005108389A1 (en) 2004-05-12 2005-05-11 Indole derivatives having piperidine rings
JP2005325713 2005-11-10
JPJP-P-2005-00325713 2005-11-10

Publications (1)

Publication Number Publication Date
KR20080006001A true KR20080006001A (en) 2008-01-15

Family

ID=39215910

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020077027992A KR20080006001A (en) 2005-05-11 2006-05-11 Method for producing indole derivative having piperidine ring

Country Status (1)

Country Link
KR (1) KR20080006001A (en)

Similar Documents

Publication Publication Date Title
JP3902221B2 (en) Indole derivatives with piperidine ring
FI95246C (en) Process for the preparation of therapeutically useful substituted aminomethylbenzodihydropyrans and aminomethyl (di- and tetra) hydronaphthalenes
KR101893756B1 (en) Benzodioxane inhibitors of leukotriene production
JP4982886B2 (en) New azetidine compounds
JPWO2005073210A1 (en) Novel benzofuran derivatives, pharmaceutical compositions containing them, and uses thereof
AU2004226838B2 (en) 4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors
KR20090081028A (en) Novel intermediate and process useful in the preparation of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1h-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone
WO2015131773A1 (en) Piperidine derivatives as orexin receptor antagonist
WO2007096352A1 (en) 5-amino-6-bromo-n-{ [1- (tetrahydr0-2h-pyran-4-ylmethyl) -4-piperidinyl] methyl}-3, 4 -dihydro-2h-chromene-8-carboxamide as 5-ht4 receptor agonist
WO2006082872A1 (en) 1-(piperidin-4-yl)-1h-indole derivative
CA2607907C (en) Method for producing indole derivative having piperidine ring
WO2011061318A1 (en) Heterocylic compounds as antagonists of the orexin receptors
KR20240063198A (en) Solid forms of 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5h[1, 3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione
KR20050067212A (en) Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases
WO2015018289A1 (en) Novel method for synthesizing key intermediate of apixaban
JP4932717B2 (en) Method for producing indole derivative having piperidine ring
KR20080006001A (en) Method for producing indole derivative having piperidine ring
JP2020536944A (en) Solid 3- (5-fluorobenzofuran-3-yl) -4- (5-methyl-5H- [1,3] dioxolo [4,5-f] indole-7-yl) pyrrole-2,5-dione form
JPH0454181A (en) New heterocyclic compound and pharmaceutical composition
JP6748329B1 (en) Crystal form of sofupyronium bromide and method for producing the same
JP5315337B2 (en) Crystalline form of topotecan hydrochloride and method for producing the same
JP2003504364A (en) Benzofuran derivative
WO2017089458A1 (en) Hexahydropyrazinobenz- or -pyrido-oxazepines carrying an oxygen-containing substituent and use thereof in the treatment of 5-ht2c-dependent disorders
CN113493449A (en) NO donor coumarin furazan conjugate and pharmaceutical application thereof
JP3468589B2 (en) 5-aminoflavone derivative

Legal Events

Date Code Title Description
A201 Request for examination
E601 Decision to refuse application